Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

54670067 71425 96 None - 1 Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assayAgonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assay
ChEMBL 176 2 4 6 -1.4 O=C1O[C@H]([C@@H](O)CO)C(O)=C1O 10.1016/j.bmc.2009.01.065
CHEMBL196 71425 96 None - 1 Human 9.3 pEC50 = 9.3 Functional
Agonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assayAgonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assay
ChEMBL 176 2 4 6 -1.4 O=C1O[C@H]([C@@H](O)CO)C(O)=C1O 10.1016/j.bmc.2009.01.065
11360447 85001 0 None -23 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
CHEMBL223829 85001 0 None -23 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
11265631 136409 0 None -22 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
CHEMBL373535 136409 0 None -22 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
44371864 51141 0 None -85 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157955 51141 0 None -85 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
2765 943 19 None -95 7 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
515 943 19 None -95 7 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
CHEMBL13852 943 19 None -95 7 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
DB09202 943 19 None -95 7 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
45487145 197659 0 None -19 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 230 4 1 3 2.5 C=CCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL570973 197659 0 None -19 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 230 4 1 3 2.5 C=CCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
45487956 198367 0 None -25 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 230 3 1 3 2.6 CC(OC1=NCCN1)c1ccccc1C1CC1 10.1021/jm901262f
CHEMBL576623 198367 0 None -25 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 230 3 1 3 2.6 CC(OC1=NCCN1)c1ccccc1C1CC1 10.1021/jm901262f
49836301 18567 1 None -39 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysis
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml300064v
CHEMBL1276140 18567 1 None -39 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysis
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml300064v
49836301 18567 1 None -39 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/jm100977d
CHEMBL1276140 18567 1 None -39 2 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/jm100977d
49836305 18576 0 None -158 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276248 18576 0 None -158 3 Human 6.0 pEC50 = 6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
11265631 136409 0 None -22 3 Human 6.0 pEC50 = 6 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
CHEMBL373535 136409 0 None -22 3 Human 6.0 pEC50 = 6 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
44371745 49289 0 None -100 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 4 1 3 2.0 CCc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL156336 49289 0 None -100 2 Human 5.0 pEC50 = 5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 4 1 3 2.0 CCc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
57400959 71188 0 None -31 3 Human 5.0 pEC50 = 5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956200 71188 0 None -31 3 Human 5.0 pEC50 = 5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
57402717 71187 2 None -10 2 Human 4.0 pEC50 = 4 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 220 4 1 4 1.5 COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956199 71187 2 None -10 2 Human 4.0 pEC50 = 4 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 220 4 1 4 1.5 COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
11043720 92172 0 None -891 3 Human 4.0 pEC50 = 4 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL242265 92172 0 None -891 3 Human 4.0 pEC50 = 4 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
11043720 92172 0 None -891 3 Human 4.0 pEC50 = 4 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL242265 92172 0 None -891 3 Human 4.0 pEC50 = 4 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
9795515 204820 0 None - 1 Rat 6.0 pEC50 = 6.0 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 273 3 2 3 4.1 COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C 10.1021/jm9605142
CHEMBL75257 204820 0 None - 1 Rat 6.0 pEC50 = 6.0 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 273 3 2 3 4.1 COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C 10.1021/jm9605142
2803 955 58 None -14 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
516 955 58 None -14 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
704 955 58 None -14 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
CHEMBL134 955 58 None -14 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
DB00575 955 58 None -14 14 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm100977d
1593 2340 66 None -12 6 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
30668 2340 66 None -12 6 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
9868 2340 66 None -12 6 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
CHEMBL17860 2340 66 None -12 6 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
DB04948 2340 66 None -12 6 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
24906201 187353 0 None -15 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
CHEMBL493272 187353 0 None -15 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
57345629 71185 0 None -269 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956197 71185 0 None -269 2 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
44371755 48777 0 None -79 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL155866 48777 0 None -79 3 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
57345627 71182 0 None -13 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 230 4 1 3 2.5 C=C(C)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956194 71182 0 None -13 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 230 4 1 3 2.5 C=C(C)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
70695474 77672 0 None -794 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysis
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL2089156 77672 0 None -794 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysis
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
24906242 187247 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2c(cccc2-c2ccccc2)O1 10.1021/jm800250z
CHEMBL492647 187247 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2c(cccc2-c2ccccc2)O1 10.1021/jm800250z
57345625 71179 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 224 3 1 3 2.1 CC(Oc1ccccc1Cl)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956191 71179 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 224 3 1 3 2.1 CC(Oc1ccccc1Cl)C1=NCCN1 10.1016/j.bmc.2012.01.035
2803 955 58 None -14 14 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 955 58 None -14 14 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 955 58 None -14 14 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 955 58 None -14 14 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 955 58 None -14 14 Human 6.8 pEC50 = 6.8 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
3086326 204531 22 None -74 3 Human 6.8 pEC50 = 6.8 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 204531 22 None -74 3 Human 6.8 pEC50 = 6.8 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
44269140 33553 0 None -17 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 248 5 1 4 2.2 CC(C)Oc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL14208 33553 0 None -17 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 248 5 1 4 2.2 CC(C)Oc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
57395732 71191 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 342 5 1 3 4.8 CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956203 71191 0 None -2 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 342 5 1 3 4.8 CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1 10.1016/j.bmc.2012.01.035
23622576 172772 0 None -9 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL451229 172772 0 None -9 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
294234 102893 3 None -5 3 Human 6.7 pEC50 = 6.7 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102893 3 None -5 3 Human 6.7 pEC50 = 6.7 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
24906241 192817 0 None -7 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
CHEMBL522151 192817 0 None -7 2 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
57395663 71181 0 None 3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.5 CC(Oc1ccccc1C(F)(F)F)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956193 71181 0 None 3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 258 3 1 3 2.5 CC(Oc1ccccc1C(F)(F)F)C1=NCCN1 10.1016/j.bmc.2012.01.035
44269089 97005 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 4 1 3 2.6 CC(Oc1ccccc1C(C)C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL266613 97005 0 None 1 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 4 1 3 2.6 CC(Oc1ccccc1C(C)C)C1=NCCN1 10.1016/j.bmc.2012.01.035
45487958 198391 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 190 2 1 3 1.5 Cc1ccccc1COC1=NCCN1 10.1021/jm901262f
CHEMBL576819 198391 0 None 1 2 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 190 2 1 3 1.5 Cc1ccccc1COC1=NCCN1 10.1021/jm901262f
2435 722 100 None -26 10 Human 6.6 pEC50 = 6.6 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 722 100 None -26 10 Human 6.6 pEC50 = 6.6 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 722 100 None -26 10 Human 6.6 pEC50 = 6.6 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 722 100 None -26 10 Human 6.6 pEC50 = 6.6 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 722 100 None -26 10 Human 6.6 pEC50 = 6.6 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 722 100 None -26 10 Human 6.6 pEC50 = 6.6 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
57395731 71190 0 None -4 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956202 71190 0 None -4 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
218362 204800 5 None -3 3 Human 8.5 pEC50 = 8.5 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 204800 5 None -3 3 Human 8.5 pEC50 = 8.5 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
135453290 133606 33 None -1513 7 Human 5.5 pEC50 = 5.5 Functional
Activity at adrenergic alpha-2B receptor expressed in opposum kidney OK cell by adenylyl cyclase assayActivity at adrenergic alpha-2B receptor expressed in opposum kidney OK cell by adenylyl cyclase assay
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
CHEMBL371300 133606 33 None -1513 7 Human 5.5 pEC50 = 5.5 Functional
Activity at adrenergic alpha-2B receptor expressed in opposum kidney OK cell by adenylyl cyclase assayActivity at adrenergic alpha-2B receptor expressed in opposum kidney OK cell by adenylyl cyclase assay
ChEMBL 191 2 2 4 1.1 C[C@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
57345626 71180 2 None -31 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956192 71180 2 None -31 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1016/j.bmc.2012.01.035
57402718 71189 2 None -10 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956201 71189 2 None -10 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
57399145 71184 0 None 3 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 234 5 1 4 1.9 CCOc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956196 71184 0 None 3 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 234 5 1 4 1.9 CCOc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
57393922 71186 0 None -5 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 5 1 4 2.0 C=COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956198 71186 0 None -5 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 232 5 1 4 2.0 C=COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
45487955 198310 0 None -125 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 232 4 1 3 2.7 CCCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL576078 198310 0 None -125 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 232 4 1 3 2.7 CCCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
44549156 18570 0 None -79 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276218 18570 0 None -79 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
49836303 18572 1 None -89 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276220 18572 1 None -89 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
24906197 187666 0 None -8 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 323 7 1 5 3.0 CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL495097 187666 0 None -8 2 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 323 7 1 5 3.0 CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1 10.1021/jm800250z
57345628 71183 0 None -1659 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956195 71183 0 None -1659 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
57345628 71183 0 None -1659 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysis
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL1956195 71183 0 None -1659 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysis
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
44314200 102952 0 None -1 3 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102952 0 None -1 3 Human 7.5 pEC50 = 7.5 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
11140033 20683 0 None -40 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL130884 20683 0 None -40 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
70693375 77671 0 None -12 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysis
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL2089155 77671 0 None -12 2 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification measured after 4 mins by cytosensor microphysiometric analysis
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
24906159 187405 12 None -31 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
CHEMBL493675 187405 12 None -31 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
10176999 103554 21 None -6 3 Rat 7.4 pEC50 = 7.4 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
CHEMBL308570 103554 21 None -6 3 Rat 7.4 pEC50 = 7.4 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
42636938 172424 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assayAgonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assay
ChEMBL 387 0 2 5 1.4 NC1=N[C@]23CCCN2C(=O)c2cc(Br)c(Br)n2[C@@H]3N1 10.1016/j.bmc.2009.01.065
CHEMBL447696 172424 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assayAgonist activity at human adrenergic alpha2B receptor expressed in HEK293 cells coexpressing Gqi5 protein by FLIPR assay
ChEMBL 387 0 2 5 1.4 NC1=N[C@]23CCCN2C(=O)c2cc(Br)c(Br)n2[C@@H]3N1 10.1016/j.bmc.2009.01.065
9859437 168022 0 None -4 3 Rat 6.3 pEC50 = 6.3 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
CHEMBL432155 168022 0 None -4 3 Rat 6.3 pEC50 = 6.3 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
135399666 168763 7 None -54 6 Human 5.3 pEC50 = 5.3 Functional
Activity at adrenergic alpha-2B receptor expressed in opposum kidney OK cell by adenylyl cyclase assayActivity at adrenergic alpha-2B receptor expressed in opposum kidney OK cell by adenylyl cyclase assay
ChEMBL 191 2 2 4 1.1 C[C@@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
CHEMBL437314 168763 7 None -54 6 Human 5.3 pEC50 = 5.3 Functional
Activity at adrenergic alpha-2B receptor expressed in opposum kidney OK cell by adenylyl cyclase assayActivity at adrenergic alpha-2B receptor expressed in opposum kidney OK cell by adenylyl cyclase assay
ChEMBL 191 2 2 4 1.1 C[C@@H](N)Cn1ncc2ccc(O)cc21 10.1021/jm050663x
44371744 50321 0 None -8 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 270 7 1 3 2.9 C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157206 50321 0 None -8 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysisAgonist activity at human adrenoceptor aplha 2B expressed in CHO cells assessed as rate of extracellular acidification by cytosensor microphysiometric analysis
ChEMBL 270 7 1 3 2.9 C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
24906199 187665 15 None -50 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL495096 187665 15 None -50 3 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
45487089 197640 0 None -79 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 204 2 1 3 2.0 Cc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL570863 197640 0 None -79 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 204 2 1 3 2.0 Cc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
11346584 136984 0 None -112 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL374584 136984 0 None -112 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm0408215
11346584 136984 0 None -112 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL374584 136984 0 None -112 2 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
11346584 136984 0 None -112 2 Human 5.3 pEC50 = 5.3 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL374584 136984 0 None -112 2 Human 5.3 pEC50 = 5.3 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm061487a
2435 722 100 None -16 10 Rat 7.3 pEC50 = 7.3 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
395 722 100 None -16 10 Rat 7.3 pEC50 = 7.3 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
520 722 100 None -16 10 Rat 7.3 pEC50 = 7.3 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
5386 722 100 None -16 10 Rat 7.3 pEC50 = 7.3 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
CHEMBL844 722 100 None -16 10 Rat 7.3 pEC50 = 7.3 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
DB00484 722 100 None -16 10 Rat 7.3 pEC50 = 7.3 Functional
Effective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cellsEffective Concentration at Alpha-2B adrenergic receptor from CHO-RNG cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
44292232 101321 0 None -51 3 Human 6.3 pEC50 = 6.3 Functional
Alpha-2B adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2B adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL296660 101321 0 None -51 3 Human 6.3 pEC50 = 6.3 Functional
Alpha-2B adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2B adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
1960 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
439260 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
505 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
CHEMBL1437 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
DB00368 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm0408215
45487962 197485 0 None 2 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 218 4 1 3 2.1 CCCc1ccccc1COC1=NCCN1 10.1021/jm901262f
CHEMBL569933 197485 0 None 2 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 218 4 1 3 2.1 CCCc1ccccc1COC1=NCCN1 10.1021/jm901262f
1960 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
439260 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
505 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
CHEMBL1437 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
DB00368 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm800250z
1960 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
439260 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
505 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
CHEMBL1437 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
DB00368 2857 67 None -2 18 Human 7.2 pEC50 = 7.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm061487a
44352207 18856 1 None -11 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL128168 18856 1 None -11 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometryAgonist activity at human adrenergic alpha-2B receptor expressed in CHO cells assessed as extracellular acidification by cytosensor microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
44352207 18856 1 None -11 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL128168 18856 1 None -11 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
44352207 18856 1 None -11 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL128168 18856 1 None -11 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cellsAgonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
44352207 18856 1 None -11 3 Human 6.2 pEC50 = 6.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL128168 18856 1 None -11 3 Human 6.2 pEC50 = 6.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
10333157 151238 0 None -37 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL396013 151238 0 None -37 3 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometryAgonist activity at human alpha2B adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
10333157 151238 0 None -37 3 Human 6.2 pEC50 = 6.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL396013 151238 0 None -37 3 Human 6.2 pEC50 = 6.2 Functional
Agonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulationAgonistic potency at human adrenergic alpha-2B receptor expressed in CHO cells assessed as forskolin-induced cAMP accumulation
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
68712 100338 60 None -2 7 Human 6.1 pEC50 = 6.1 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 100338 60 None -2 7 Human 6.1 pEC50 = 6.1 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
185076 187090 5 None -64 3 Human 7.1 pEC50 = 7.1 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 187090 5 None -64 3 Human 7.1 pEC50 = 7.1 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
131829 204727 15 None -316 3 Human 6.1 pEC50 = 6.1 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 204727 15 None -316 3 Human 6.1 pEC50 = 6.1 Functional
Alpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesisAlpha-2B adrenergic receptor agonistic potency as inhibition of forskolin-stimulated cyclic adenosine monophosphate synthesis
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
44314198 104412 0 None -5 3 Human 8.0 pEC50 = 8.0 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 104412 0 None -5 3 Human 8.0 pEC50 = 8.0 Functional
Agonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphateAgonistic activity towards human Alpha-2B adrenergic receptor was measured as ability to inhibit forskolin-stimulated synthesis of cyclic adenosine monophosphate
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
9815707 101469 0 None -5 3 Human 8.0 pEC50 = 8.0 Functional
Alpha-2B adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2B adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297752 101469 0 None -5 3 Human 8.0 pEC50 = 8.0 Functional
Alpha-2B adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMPAlpha-2B adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
44579228 181654 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL477608 181654 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
44579229 189616 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL514837 189616 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
44579185 181814 1 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL477816 181814 1 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
44579271 187094 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491419 187094 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
44579230 181544 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
CHEMBL476569 181544 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
44579184 190953 4 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL518592 190953 4 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
10758200 63417 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL179648 63417 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
44579187 189679 0 None - 0 Human 7.6 pKi = 7.6 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
CHEMBL515331 189679 0 None - 0 Human 7.6 pKi = 7.6 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
25110718 193309 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL524153 193309 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
44579272 187095 0 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491420 187095 0 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPRAntagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
1343 1889 62 None -2 12 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1889 62 None -2 12 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1889 62 None -2 12 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1889 62 None -2 12 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1889 62 None -2 12 Human 8.2 pEC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
2435 722 100 None -26 10 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 722 100 None -26 10 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 722 100 None -26 10 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 722 100 None -26 10 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 722 100 None -26 10 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 722 100 None -26 10 Human 8.1 pEC50 = 8.1 Functional
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
2683 3834 60 None -2 6 Human 7.0 pEC50 = 7 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
5487 3834 60 None -2 6 Human 7.0 pEC50 = 7 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
7308 3834 60 None -2 6 Human 7.0 pEC50 = 7 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
CHEMBL1079 3834 60 None -2 6 Human 7.0 pEC50 = 7 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
DB00697 3834 60 None -2 6 Human 7.0 pEC50 = 7 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
12574 2605 88 None -5 8 Human 7.1 pEC50 = 7.1 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
4810 2605 88 None -5 8 Human 7.1 pEC50 = 7.1 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
CHEMBL19236 2605 88 None -5 8 Human 7.1 pEC50 = 7.1 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
DB09242 2605 88 None -5 8 Human 7.1 pEC50 = 7.1 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
523 4106 93 None 1 5 Human 7.4 pEC50 = 7.4 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
5707 4106 93 None 1 5 Human 7.4 pEC50 = 7.4 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
CHEMBL297362 4106 93 None 1 5 Human 7.4 pEC50 = 7.4 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
DB11477 4106 93 None 1 5 Human 7.4 pEC50 = 7.4 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
1028 291 71 None -25 19 Human 7.5 pEC50 = 7.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
139148732 291 71 None -25 19 Human 7.5 pEC50 = 7.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
479 291 71 None -25 19 Human 7.5 pEC50 = 7.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
5816 291 71 None -25 19 Human 7.5 pEC50 = 7.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL679 291 71 None -25 19 Human 7.5 pEC50 = 7.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00668 291 71 None -25 19 Human 7.5 pEC50 = 7.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
2435 722 100 None -26 10 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
395 722 100 None -26 10 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
520 722 100 None -26 10 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
5386 722 100 None -26 10 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
CHEMBL844 722 100 None -26 10 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
DB00484 722 100 None -26 10 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
1960 2857 67 None -2 18 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
439260 2857 67 None -2 18 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
505 2857 67 None -2 18 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL1437 2857 67 None -2 18 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00368 2857 67 None -2 18 Human 7.8 pEC50 = 7.8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
2803 955 58 None -14 14 Human 8.0 pEC50 = 8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
516 955 58 None -14 14 Human 8.0 pEC50 = 8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
704 955 58 None -14 14 Human 8.0 pEC50 = 8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
CHEMBL134 955 58 None -14 14 Human 8.0 pEC50 = 8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
DB00575 955 58 None -14 14 Human 8.0 pEC50 = 8 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
3952 1888 38 None 1 21 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5353646 1888 38 None 1 21 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5443 1888 38 None 1 21 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5702063 1888 38 None 1 21 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL1331786 1888 38 None 1 21 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL420 1888 38 None 1 21 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
1343 1889 62 None -2 12 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
3519 1889 62 None -2 12 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
522 1889 62 None -2 12 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
CHEMBL862 1889 62 None -2 12 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
DB01018 1889 62 None -2 12 Human 8.5 pEC50 = 8.5 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
521 1404 69 None 4 5 Human 9.2 pEC50 = 9.2 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
5311068 1404 69 None 4 5 Human 9.2 pEC50 = 9.2 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
835 1404 69 None 4 5 Human 9.2 pEC50 = 9.2 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
CHEMBL778 1404 69 None 4 5 Human 9.2 pEC50 = 9.2 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
DB00633 1404 69 None 4 5 Human 9.2 pEC50 = 9.2 Functional
ERK1/2 phosphorylationERK1/2 phosphorylation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
13181 193 0 None - 1 Rat 8.4 pEC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 306 2 2 4 3.1 N1=CC(=CC=C1)C2=C(C=CC(=C2)C(F)(F)F)NC=3NCCN3 25154730
71816200 193 0 None - 1 Rat 8.4 pEC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 306 2 2 4 3.1 N1=CC(=CC=C1)C2=C(C=CC(=C2)C(F)(F)F)NC=3NCCN3 25154730
1028 291 71 None -25 19 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
139148732 291 71 None -25 19 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
479 291 71 None -25 19 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
5816 291 71 None -25 19 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL679 291 71 None -25 19 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00668 291 71 None -25 19 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
2683 3834 60 None -2 6 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
5487 3834 60 None -2 6 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
7308 3834 60 None -2 6 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
CHEMBL1079 3834 60 None -2 6 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
DB00697 3834 60 None -2 6 Human 6.3 pEC50 = 6.3 Functional
cAMP generationcAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
523 4106 93 None 1 5 Human 6.4 pEC50 = 6.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
5707 4106 93 None 1 5 Human 6.4 pEC50 = 6.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
CHEMBL297362 4106 93 None 1 5 Human 6.4 pEC50 = 6.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
DB11477 4106 93 None 1 5 Human 6.4 pEC50 = 6.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
12574 2605 88 None -5 8 Human 6.5 pEC50 = 6.5 Functional
cAMP generationcAMP generation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
4810 2605 88 None -5 8 Human 6.5 pEC50 = 6.5 Functional
cAMP generationcAMP generation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
CHEMBL19236 2605 88 None -5 8 Human 6.5 pEC50 = 6.5 Functional
cAMP generationcAMP generation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
DB09242 2605 88 None -5 8 Human 6.5 pEC50 = 6.5 Functional
cAMP generationcAMP generation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
1960 2857 67 None -2 18 Human 6.9 pEC50 = 6.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
439260 2857 67 None -2 18 Human 6.9 pEC50 = 6.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
505 2857 67 None -2 18 Human 6.9 pEC50 = 6.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL1437 2857 67 None -2 18 Human 6.9 pEC50 = 6.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00368 2857 67 None -2 18 Human 6.9 pEC50 = 6.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
2435 722 100 None -26 10 Human 7.2 pEC50 = 7.2 Functional
cAMP generationcAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
395 722 100 None -26 10 Human 7.2 pEC50 = 7.2 Functional
cAMP generationcAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
520 722 100 None -26 10 Human 7.2 pEC50 = 7.2 Functional
cAMP generationcAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
5386 722 100 None -26 10 Human 7.2 pEC50 = 7.2 Functional
cAMP generationcAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
CHEMBL844 722 100 None -26 10 Human 7.2 pEC50 = 7.2 Functional
cAMP generationcAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
DB00484 722 100 None -26 10 Human 7.2 pEC50 = 7.2 Functional
cAMP generationcAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
2803 955 58 None -14 14 Human 7.4 pEC50 = 7.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
516 955 58 None -14 14 Human 7.4 pEC50 = 7.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
704 955 58 None -14 14 Human 7.4 pEC50 = 7.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
CHEMBL134 955 58 None -14 14 Human 7.4 pEC50 = 7.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
DB00575 955 58 None -14 14 Human 7.4 pEC50 = 7.4 Functional
cAMP generationcAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
1343 1889 62 None -2 12 Human 7.6 pEC50 = 7.6 Functional
cAMP generationcAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
3519 1889 62 None -2 12 Human 7.6 pEC50 = 7.6 Functional
cAMP generationcAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
522 1889 62 None -2 12 Human 7.6 pEC50 = 7.6 Functional
cAMP generationcAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
CHEMBL862 1889 62 None -2 12 Human 7.6 pEC50 = 7.6 Functional
cAMP generationcAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
DB01018 1889 62 None -2 12 Human 7.6 pEC50 = 7.6 Functional
cAMP generationcAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
124 2981 47 None -17 24 Human 7.7 pEC50 = 7.7 Functional
cAMP generationcAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
2032 2981 47 None -17 24 Human 7.7 pEC50 = 7.7 Functional
cAMP generationcAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
4636 2981 47 None -17 24 Human 7.7 pEC50 = 7.7 Functional
cAMP generationcAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
CHEMBL762 2981 47 None -17 24 Human 7.7 pEC50 = 7.7 Functional
cAMP generationcAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
DB00935 2981 47 None -17 24 Human 7.7 pEC50 = 7.7 Functional
cAMP generationcAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
3658 4107 53 None -1 18 Human 7.8 pEC50 = 7.8 Functional
cAMP generationcAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
517 4107 53 None -1 18 Human 7.8 pEC50 = 7.8 Functional
cAMP generationcAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
5709 4107 53 None -1 18 Human 7.8 pEC50 = 7.8 Functional
cAMP generationcAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
CHEMBL312448 4107 53 None -1 18 Human 7.8 pEC50 = 7.8 Functional
cAMP generationcAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
DB06694 4107 53 None -1 18 Human 7.8 pEC50 = 7.8 Functional
cAMP generationcAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
3952 1888 38 None 1 21 Human 7.9 pEC50 = 7.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5353646 1888 38 None 1 21 Human 7.9 pEC50 = 7.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5443 1888 38 None 1 21 Human 7.9 pEC50 = 7.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5702063 1888 38 None 1 21 Human 7.9 pEC50 = 7.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL1331786 1888 38 None 1 21 Human 7.9 pEC50 = 7.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL420 1888 38 None 1 21 Human 7.9 pEC50 = 7.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
521 1404 69 None 4 5 Human 9.9 pEC50 = 9.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
5311068 1404 69 None 4 5 Human 9.9 pEC50 = 9.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
835 1404 69 None 4 5 Human 9.9 pEC50 = 9.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
CHEMBL778 1404 69 None 4 5 Human 9.9 pEC50 = 9.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
DB00633 1404 69 None 4 5 Human 9.9 pEC50 = 9.9 Functional
cAMP generationcAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
1427 2013 54 None -60 30 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
357 2013 54 None -60 30 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
3696 2013 54 None -60 30 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
CHEMBL11 2013 54 None -60 30 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
DB00458 2013 54 None -60 30 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
1225 1471 26 None -3 11 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 1471 26 None -3 11 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 1471 26 None -3 11 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 1471 26 None -3 11 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 1471 26 None -3 11 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
180 401 56 None -56 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 401 56 None -56 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 401 56 None -56 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 401 56 None -56 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 401 56 None -56 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
521 1404 69 None 4 5 Human 10.9 pIC50 = 10.9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
5311068 1404 69 None 4 5 Human 10.9 pIC50 = 10.9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
835 1404 69 None 4 5 Human 10.9 pIC50 = 10.9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
CHEMBL778 1404 69 None 4 5 Human 10.9 pIC50 = 10.9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
DB00633 1404 69 None 4 5 Human 10.9 pIC50 = 10.9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
12574 2605 88 None -5 8 Human 7.5 pIC50 = 7.5 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
4810 2605 88 None -5 8 Human 7.5 pIC50 = 7.5 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
CHEMBL19236 2605 88 None -5 8 Human 7.5 pIC50 = 7.5 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
DB09242 2605 88 None -5 8 Human 7.5 pIC50 = 7.5 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
1028 291 71 None -25 19 Human 7.6 pIC50 = 7.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
139148732 291 71 None -25 19 Human 7.6 pIC50 = 7.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
479 291 71 None -25 19 Human 7.6 pIC50 = 7.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
5816 291 71 None -25 19 Human 7.6 pIC50 = 7.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL679 291 71 None -25 19 Human 7.6 pIC50 = 7.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00668 291 71 None -25 19 Human 7.6 pIC50 = 7.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
523 4106 93 None 1 5 Human 7.7 pIC50 = 7.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
5707 4106 93 None 1 5 Human 7.7 pIC50 = 7.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
CHEMBL297362 4106 93 None 1 5 Human 7.7 pIC50 = 7.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
DB11477 4106 93 None 1 5 Human 7.7 pIC50 = 7.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
1960 2857 67 None -2 18 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
439260 2857 67 None -2 18 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
505 2857 67 None -2 18 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL1437 2857 67 None -2 18 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00368 2857 67 None -2 18 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
2683 3834 60 None -2 6 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
5487 3834 60 None -2 6 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
7308 3834 60 None -2 6 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
CHEMBL1079 3834 60 None -2 6 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
DB00697 3834 60 None -2 6 Human 7.8 pIC50 = 7.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
2435 722 100 None -26 10 Human 8.4 pIC50 = 8.4 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
395 722 100 None -26 10 Human 8.4 pIC50 = 8.4 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
520 722 100 None -26 10 Human 8.4 pIC50 = 8.4 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
5386 722 100 None -26 10 Human 8.4 pIC50 = 8.4 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
CHEMBL844 722 100 None -26 10 Human 8.4 pIC50 = 8.4 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
DB00484 722 100 None -26 10 Human 8.4 pIC50 = 8.4 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
2803 955 58 None -14 14 Human 8.6 pIC50 = 8.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
516 955 58 None -14 14 Human 8.6 pIC50 = 8.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
704 955 58 None -14 14 Human 8.6 pIC50 = 8.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
CHEMBL134 955 58 None -14 14 Human 8.6 pIC50 = 8.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
DB00575 955 58 None -14 14 Human 8.6 pIC50 = 8.6 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
1343 1889 62 None -2 12 Human 8.7 pIC50 = 8.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
3519 1889 62 None -2 12 Human 8.7 pIC50 = 8.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
522 1889 62 None -2 12 Human 8.7 pIC50 = 8.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
CHEMBL862 1889 62 None -2 12 Human 8.7 pIC50 = 8.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
DB01018 1889 62 None -2 12 Human 8.7 pIC50 = 8.7 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
124 2981 47 None -17 24 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
2032 2981 47 None -17 24 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
4636 2981 47 None -17 24 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
CHEMBL762 2981 47 None -17 24 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
DB00935 2981 47 None -17 24 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
3658 4107 53 None -1 18 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
517 4107 53 None -1 18 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
5709 4107 53 None -1 18 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
CHEMBL312448 4107 53 None -1 18 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
DB06694 4107 53 None -1 18 Human 8.8 pIC50 = 8.8 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
3952 1888 38 None 1 21 Human 9.0 pIC50 = 9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5353646 1888 38 None 1 21 Human 9.0 pIC50 = 9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5443 1888 38 None 1 21 Human 9.0 pIC50 = 9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5702063 1888 38 None 1 21 Human 9.0 pIC50 = 9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL1331786 1888 38 None 1 21 Human 9.0 pIC50 = 9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL420 1888 38 None 1 21 Human 9.0 pIC50 = 9 Functional
inhibition of forskolin stimulated cAMP generationinhibition of forskolin stimulated cAMP generation
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

5479537 66802 35 None - 0 Human 9.3 pAC50 = 9.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 480 7 2 10 -1.3 CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1 10.1038/s41467-023-40064-9
CHEMBL186 66802 35 None - 0 Human 9.3 pAC50 = 9.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 480 7 2 10 -1.3 CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1 10.1038/s41467-023-40064-9
46780481 107531 20 None -20 53 Human 8.9 pAC50 = 8.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
9903970 107531 20 None -20 53 Human 8.9 pAC50 = 8.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL3187365 107531 20 None -20 53 Human 8.9 pAC50 = 8.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL3544974 107531 20 None -20 53 Human 8.9 pAC50 = 8.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
2284 3182 33 None -3 29 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 3182 33 None -3 29 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 3182 33 None -3 29 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 3182 33 None -3 29 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 3182 33 None -3 29 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2202 3132 96 None -1 21 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
4850 3132 96 None -1 21 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
49 3132 96 None -1 21 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
CHEMBL1371770 3132 96 None -1 21 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
DB12478 3132 96 None -1 21 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
22323 15299 32 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9571037 15299 32 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1213553 15299 32 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
5357 98736 41 None - 3 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 7 1 5 1.7 CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC 10.1038/s41467-023-40064-9
CHEMBL277945 98736 41 None - 3 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 7 1 5 1.7 CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC 10.1038/s41467-023-40064-9
9417 133512 54 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 133512 54 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 133512 54 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
2142 3096 58 None -5 36 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3096 58 None -5 36 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3096 58 None -5 36 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3096 58 None -5 36 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3096 58 None -5 36 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3096 58 None -5 36 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
2342 599 39 None -1 6 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC 10.1038/s41467-023-40064-9
331 599 39 None -1 6 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC 10.1038/s41467-023-40064-9
7124 599 39 None -1 6 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC 10.1038/s41467-023-40064-9
CHEMBL1201250 599 39 None -1 6 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC 10.1038/s41467-023-40064-9
DB00767 599 39 None -1 6 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC 10.1038/s41467-023-40064-9
3294 2006 111 None -47 45 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 2006 111 None -47 45 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 2006 111 None -47 45 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 2006 111 None -47 45 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 2006 111 None -47 45 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
5472 205818 75 None 1 3 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL1717 205818 75 None 1 3 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL833 205818 75 None 1 3 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
2762 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
5587 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
7318 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL1241 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
DB00792 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
25382 9157 37 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL110094 9157 37 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
55645 84370 8 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
CHEMBL2218861 84370 8 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
CHEMBL502835 188512 0 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 539 7 2 7 3.6 COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1 10.1038/s41467-023-40064-9
191 403 98 None -30 29 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 403 98 None -30 29 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 403 98 None -30 29 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 403 98 None -30 29 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 403 98 None -30 29 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
135398745 2914 112 None -37 65 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 2914 112 None -37 65 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 2914 112 None -37 65 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 2914 112 None -37 65 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
2540 4401 111 None -1 4 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 4401 111 None -1 4 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
1960 2857 67 None -69 26 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 2857 67 None -69 26 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 2857 67 None -69 26 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 2857 67 None -69 26 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 2857 67 None -69 26 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
102 4127 48 None -10 49 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 4127 48 None -10 49 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 4127 48 None -10 49 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 4127 48 None -10 49 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 4127 48 None -10 49 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
2286 3183 51 None -4 30 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3183 51 None -4 30 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3183 51 None -4 30 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3183 51 None -4 30 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3183 51 None -4 30 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
1524 2181 96 None -27 52 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 2181 96 None -27 52 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 2181 96 None -27 52 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 2181 96 None -27 52 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 2181 96 None -27 52 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 2181 96 None -27 52 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
11980903 14492 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
22526 14492 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5281035 14492 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201303 14492 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
51755 57406 54 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 454 8 0 4 7.3 Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1651990 57406 54 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 454 8 0 4 7.3 Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1 10.1038/s41467-023-40064-9
4413 98073 57 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 347 4 5 4 2.6 N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 10.1038/s41467-023-40064-9
CHEMBL273264 98073 57 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 347 4 5 4 2.6 N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 10.1038/s41467-023-40064-9
135398735 136968 32 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 136968 32 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 136968 32 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
2389 3331 118 None -104 67 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3331 118 None -104 67 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3331 118 None -104 67 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3331 118 None -104 67 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3331 118 None -104 67 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
2419 3463 84 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 3463 84 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 3463 84 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 3463 84 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 3463 84 None - 6 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
7029 13669 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 205 5 0 2 2.6 CCN(CC)C(C)C(=O)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1194666 13669 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 205 5 0 2 2.6 CCN(CC)C(C)C(=O)c1ccccc1 10.1038/s41467-023-40064-9
2782 32000 67 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
CHEMBL1407943 32000 67 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
CHEMBL3216363 32000 67 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
3547 141373 71 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 2 1 4 1.2 O=S(=O)(c1cccc2cnccc12)N1CCCNCC1 10.1038/s41467-023-40064-9
CHEMBL38380 141373 71 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 2 1 4 1.2 O=S(=O)(c1cccc2cnccc12)N1CCCNCC1 10.1038/s41467-023-40064-9
CHEMBL541388 141373 71 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 2 1 4 1.2 O=S(=O)(c1cccc2cnccc12)N1CCCNCC1 10.1038/s41467-023-40064-9
2407 3372 76 None - 7 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
59227 3372 76 None - 7 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
941 3372 76 None - 7 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
CHEMBL1303 3372 76 None - 7 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
DB05271 3372 76 None - 7 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
5284550 41721 15 None -1 9 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1492500 41721 15 None -1 9 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
16351 102730 47 None - 6 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL304902 102730 47 None - 6 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
2179 167518 76 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL1256655 167518 76 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL43 167518 76 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
209 3057 97 None -38 23 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
2113 3057 97 None -38 23 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4748 3057 97 None -38 23 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL567 3057 97 None -38 23 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00850 3057 97 None -38 23 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
5365247 138429 33 None - 1 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 316 4 0 2 3.8 CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1 10.1038/s41467-023-40064-9
CHEMBL37744 138429 33 None - 1 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 316 4 0 2 3.8 CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1 10.1038/s41467-023-40064-9
1816 2540 102 None -851 18 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1038/s41467-023-40064-9
4205 2540 102 None -851 18 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1038/s41467-023-40064-9
7241 2540 102 None -851 18 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1038/s41467-023-40064-9
CHEMBL654 2540 102 None -851 18 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1038/s41467-023-40064-9
DB00370 2540 102 None -851 18 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1038/s41467-023-40064-9
104870 98880 47 None -3 21 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
5374 98880 47 None -3 21 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
CHEMBL279085 98880 47 None -3 21 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
30323 62485 57 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL1563 62485 57 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL178 62485 57 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
70691408 78212 0 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 326 1 2 4 1.6 CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O 10.1038/s41467-023-40064-9
CHEMBL2105617 78212 0 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 326 1 2 4 1.6 CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O 10.1038/s41467-023-40064-9
1613 2348 53 None -7 44 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2348 53 None -7 44 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2348 53 None -7 44 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2348 53 None -7 44 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2348 53 None -7 44 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
2803 955 58 None -1 19 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 955 58 None -1 19 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 955 58 None -1 19 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 955 58 None -1 19 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 955 58 None -1 19 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
9429 202133 58 None - 5 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 202133 58 None - 5 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
179 400 115 None - 49 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC 10.1038/s41467-023-40064-9
2159 400 115 None - 49 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC 10.1038/s41467-023-40064-9
963 400 115 None - 49 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC 10.1038/s41467-023-40064-9
CHEMBL243712 400 115 None - 49 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC 10.1038/s41467-023-40064-9
DB06288 400 115 None - 49 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 7 2 6 1.3 CCN1CCCC1CNC(=O)c1cc(c(cc1OC)N)S(=O)(=O)CC 10.1038/s41467-023-40064-9
8249 59405 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1528839 59405 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL170988 59405 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
2448 99323 70 None - 18 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL28218 99323 70 None - 18 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
3191 102858 97 None -9 25 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
CHEMBL305660 102858 97 None -9 25 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
4746 204891 31 None - 4 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 4 1 1 5.3 C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1 10.1038/s41467-023-40064-9
CHEMBL1334033 204891 31 None - 4 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 4 1 1 5.3 C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1 10.1038/s41467-023-40064-9
CHEMBL75880 204891 31 None - 4 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 4 1 1 5.3 C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1 10.1038/s41467-023-40064-9
1201549 597 24 None -13 20 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
333 597 24 None -13 20 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7601 597 24 None -13 20 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201203 597 24 None -13 20 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL438151 597 24 None -13 20 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00245 597 24 None -13 20 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
4066 204626 78 None - 7 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL73451 204626 78 None - 7 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
23480 124090 23 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 281 5 1 1 5.0 CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL363295 124090 23 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 281 5 1 1 5.0 CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C 10.1038/s41467-023-40064-9
135 2532 43 None -8 58 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2532 43 None -8 58 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2532 43 None -8 58 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2532 43 None -8 58 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2532 43 None -8 58 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
2398 954 62 None -2 29 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 954 62 None -2 29 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 954 62 None -2 29 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 954 62 None -2 29 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 954 62 None -2 29 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2136 3095 30 None -3 6 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
4768 3095 30 None -3 6 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
7268 3095 30 None -3 6 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL753 3095 30 None -3 6 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
DB00925 3095 30 None -3 6 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
100 3805 58 None -35 55 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 3805 58 None -35 55 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 3805 58 None -35 55 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 3805 58 None -35 55 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 3805 58 None -35 55 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2472 67284 48 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 5 1 7 2.1 CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1 10.1038/s41467-023-40064-9
CHEMBL188185 67284 48 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 5 1 7 2.1 CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1 10.1038/s41467-023-40064-9
9801 91585 35 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL24072 91585 35 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
138402398 28134 56 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 379 3 3 5 1.6 NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O 10.1038/s41467-023-40064-9
2904 28134 56 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 379 3 3 5 1.6 NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O 10.1038/s41467-023-40064-9
CHEMBL1373254 28134 56 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 379 3 3 5 1.6 NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O 10.1038/s41467-023-40064-9
56959 31556 103 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 31556 103 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1526084 31556 103 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
5573 67581 92 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 9 0 6 3.7 CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1325297 67581 92 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 9 0 6 3.7 CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C 10.1038/s41467-023-40064-9
CHEMBL190044 67581 92 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 9 0 6 3.7 CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C 10.1038/s41467-023-40064-9
CHEMBL3039583 210949 0 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O 10.1038/s41467-023-40064-9
1836 2592 59 None - 15 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
3340 2592 59 None - 15 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
5281040 2592 59 None - 15 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
CHEMBL787 2592 59 None - 15 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
DB00471 2592 59 None - 15 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 585 12 2 4 8.9 OC(=O)CC1(CS[C@@H](c2cccc(c2)/C=C/c2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1 10.1038/s41467-023-40064-9
42890 9425 59 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 497 3 5 10 1.0 CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
CHEMBL1117 9425 59 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 497 3 5 10 1.0 CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
2780 110529 36 None - 10 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL325109 110529 36 None - 10 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
60753 194684 40 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 384 14 2 4 4.2 CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1 10.1038/s41467-023-40064-9
CHEMBL533 194684 40 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 384 14 2 4 4.2 CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1 10.1038/s41467-023-40064-9
168871 89130 14 None - 0 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 563 4 3 6 2.1 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
CHEMBL2365712 89130 14 None - 0 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 563 4 3 6 2.1 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
2585 803 103 None -29 21 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 803 103 None -29 21 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 803 103 None -29 21 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 803 103 None -29 21 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 803 103 None -29 21 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
2662 11384 131 None -1 30 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL118 11384 131 None -1 30 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 10.1038/s41467-023-40064-9
12574 2605 88 None -3890 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
4810 2605 88 None -3890 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
CHEMBL19236 2605 88 None -3890 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
DB09242 2605 88 None -3890 6 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
24826799 10798 104 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
CHEMBL1171837 10798 104 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
47472 19437 57 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 7 0 3 6.6 Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1295 19437 57 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 7 0 3 6.6 Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1 10.1038/s41467-023-40064-9
3949 100614 50 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 468 8 0 5 4.9 COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL29188 100614 50 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 468 8 0 5 4.9 COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC 10.1038/s41467-023-40064-9
55483 205097 40 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 356 13 4 4 3.6 Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O 10.1038/s41467-023-40064-9
CHEMBL77622 205097 40 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 356 13 4 4 3.6 Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O 10.1038/s41467-023-40064-9
2564 206184 51 None - 3 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 290 6 0 3 3.4 CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL864 206184 51 None - 3 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 290 6 0 3 3.4 CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1 10.1038/s41467-023-40064-9
119607 206203 113 None -97 27 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
CHEMBL865 206203 113 None -97 27 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 10.1038/s41467-023-40064-9
11079 2733 63 None -3 5 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3369 2733 63 None -3 5 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
4436 2733 63 None -3 5 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
5509 2733 63 None -3 5 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL761 2733 63 None -3 5 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB06711 2733 63 None -3 5 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
129211 3749 78 None - 15 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
2562 3749 78 None - 15 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
488 3749 78 None - 15 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
CHEMBL836 3749 78 None - 15 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
DB00706 3749 78 None - 15 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
3394 196435 120 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 244 3 1 1 3.7 CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1 10.1038/s41467-023-40064-9
CHEMBL563 196435 120 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 244 3 1 1 3.7 CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1 10.1038/s41467-023-40064-9
16362 3125 71 None -363 30 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3125 71 None -363 30 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3125 71 None -363 30 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3125 71 None -363 30 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3125 71 None -363 30 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2435 3590 83 None -104 48 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 3590 83 None -104 48 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 3590 83 None -104 48 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 3590 83 None -104 48 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 3590 83 None -104 48 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
176 398 66 None -4 31 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2157 398 66 None -4 31 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2566 398 66 None -4 31 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
CHEMBL633 398 66 None -4 31 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
DB01118 398 66 None -4 31 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
29566 78204 82 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 2 2 6 -2.7 O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1 10.1038/s41467-023-40064-9
CHEMBL2105420 78204 82 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 2 2 6 -2.7 O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1 10.1038/s41467-023-40064-9
3658 4107 53 None -114 8 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 4107 53 None -114 8 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 4107 53 None -114 8 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 4107 53 None -114 8 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 4107 53 None -114 8 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
3158 56267 27 None -218 20 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56267 27 None -218 20 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
68602 205126 80 None -3 7 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1038/s41467-023-40064-9
CHEMBL77921 205126 80 None -3 7 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1038/s41467-023-40064-9
26879 37294 63 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 204 1 0 3 2.1 c1ccc([C@H]2CN3CCSC3=N2)cc1 10.1038/s41467-023-40064-9
CHEMBL1454 37294 63 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 204 1 0 3 2.1 c1ccc([C@H]2CN3CCSC3=N2)cc1 10.1038/s41467-023-40064-9
65709 59881 39 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 365 8 0 5 3.3 CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1729803 59881 39 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 365 8 0 5 3.3 CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21 10.1038/s41467-023-40064-9
1343 1889 62 None -91 9 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 1889 62 None -91 9 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 1889 62 None -91 9 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 1889 62 None -91 9 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 1889 62 None -91 9 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
20628 96548 28 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 324 6 1 5 3.7 CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12 10.1038/s41467-023-40064-9
CHEMBL26291 96548 28 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 324 6 1 5 3.7 CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12 10.1038/s41467-023-40064-9
2318 154856 29 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL400599 154856 29 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
2995 204405 53 None - 23 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1696 204405 53 None - 23 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL72 204405 53 None - 23 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
2470 3653 50 None - 59 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3653 50 None - 59 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3653 50 None - 59 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3653 50 None - 59 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3653 50 None - 59 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
213046 2385 59 None - 9 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 2385 59 None - 9 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 2385 59 None - 9 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 2385 59 None - 9 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 2385 59 None - 9 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
3698 18929 92 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 187 1 2 3 1.0 Nc1cc(-c2ccncc2)c[nH]c1=O 10.1038/s41467-023-40064-9
CHEMBL12856 18929 92 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 187 1 2 3 1.0 Nc1cc(-c2ccncc2)c[nH]c1=O 10.1038/s41467-023-40064-9
104850 3330 96 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 3330 96 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 3330 96 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 3330 96 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 3330 96 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
54841 203127 52 None - 27 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL641 203127 52 None - 27 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 10.1038/s41467-023-40064-9
2105 3054 37 None -35 33 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
47811 3054 37 None -35 33 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
48 3054 37 None -35 33 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
CHEMBL531 3054 37 None -35 33 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
DB01186 3054 37 None -35 33 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
443955 204370 92 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 350 3 0 4 4.1 CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32 10.1038/s41467-023-40064-9
CHEMBL71752 204370 92 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 350 3 0 4 4.1 CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c(n1c1ccccc41)[C@@H]32 10.1038/s41467-023-40064-9
2713 205271 82 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 205271 82 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 205271 82 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 205271 82 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 205271 82 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 205271 82 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 205271 82 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
4640 78266 30 None - 0 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 379 6 1 4 3.9 COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2107011 78266 30 None - 0 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 379 6 1 4 3.9 COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC 10.1038/s41467-023-40064-9
37 778 60 None -9 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 778 60 None -9 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 778 60 None -9 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 778 60 None -9 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 778 60 None -9 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
24965990 3714 59 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 3 0 7 4.1 Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1 10.1038/s41467-023-40064-9
2890 3714 59 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 3 0 7 4.1 Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1 10.1038/s41467-023-40064-9
4881 3714 59 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 3 0 7 4.1 Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1 10.1038/s41467-023-40064-9
CHEMBL1083659 3714 59 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 3 0 7 4.1 Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1 10.1038/s41467-023-40064-9
DB09034 3714 59 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 3 0 7 4.1 Cc1ccc(c(c1)C(=O)N1CCN(CC[C@H]1C)c1oc2c(n1)cc(cc2)Cl)n1nccn1 10.1038/s41467-023-40064-9
131411 15392 70 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 476 7 1 6 5.2 CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12 10.1038/s41467-023-40064-9
28446253 15392 70 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 476 7 1 6 5.2 CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12 10.1038/s41467-023-40064-9
CHEMBL1214598 15392 70 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 476 7 1 6 5.2 CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12 10.1038/s41467-023-40064-9
2473 163183 47 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 248 5 2 4 1.7 CC(C)(C)NCC(O)COc1ccccc1C#N 10.1038/s41467-023-40064-9
CHEMBL418134 163183 47 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 248 5 2 4 1.7 CC(C)(C)NCC(O)COc1ccccc1C#N 10.1038/s41467-023-40064-9
4452 2762 19 None - 19 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
983 2762 19 None - 19 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
CHEMBL20734 2762 19 None - 19 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
1547484 940 74 None -12 20 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
654 940 74 None -12 20 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
9072 940 74 None -12 20 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL43064 940 74 None -12 20 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00568 940 74 None -12 20 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
54454 5258 88 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL1064 5258 88 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
228 445 28 None -3 24 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
33 445 28 None -3 24 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
6005 445 28 None -3 24 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
CHEMBL53 445 28 None -3 24 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
DB00714 445 28 None -3 24 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
180 401 56 None -7 40 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 401 56 None -7 40 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 401 56 None -7 40 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 401 56 None -7 40 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 401 56 None -7 40 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
5311017 120604 11 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3545985 120604 11 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
2333 142335 97 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
CHEMBL388590 142335 97 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
72093 35061 9 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL1433361 35061 9 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL2103773 35061 9 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
68617 205527 62 None -3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1709 205527 62 None -3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 205527 62 None -3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
25181577 78219 56 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 574 9 2 9 5.0 CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1 10.1038/s41467-023-40064-9
CHEMBL2105695 78219 56 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 574 9 2 9 5.0 CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1 10.1038/s41467-023-40064-9
65700 78260 28 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 238 1 1 2 3.3 CNC1Cc2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2106919 78260 28 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 238 1 1 2 3.3 CNC1Cc2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
4031 99313 28 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 429 13 0 6 4.6 CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1 10.1038/s41467-023-40064-9
CHEMBL282121 99313 28 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 429 13 0 6 4.6 CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1 10.1038/s41467-023-40064-9
5591 157531 90 None - 2 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 157531 90 None - 2 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
2683 3834 60 None -20 4 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 3834 60 None -20 4 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 3834 60 None -20 4 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 3834 60 None -20 4 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 3834 60 None -20 4 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
123606 352 70 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 335 6 1 3 2.2 CN(CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N1CCCC1)C 10.1038/s41467-023-40064-9
128 352 70 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 335 6 1 3 2.2 CN(CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N1CCCC1)C 10.1038/s41467-023-40064-9
7110 352 70 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 335 6 1 3 2.2 CN(CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N1CCCC1)C 10.1038/s41467-023-40064-9
CHEMBL1505 352 70 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 335 6 1 3 2.2 CN(CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N1CCCC1)C 10.1038/s41467-023-40064-9
DB00918 352 70 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 335 6 1 3 2.2 CN(CCc1c[nH]c2c1cc(cc2)CS(=O)(=O)N1CCCC1)C 10.1038/s41467-023-40064-9
54697325 58979 35 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 556 6 6 10 1.3 CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O 10.1038/s41467-023-40064-9
CHEMBL1689772 58979 35 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 556 6 6 10 1.3 CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O 10.1038/s41467-023-40064-9
4418 34222 85 None - 6 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 34222 85 None - 6 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
4260 52558 31 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
CHEMBL159226 52558 31 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
1427 2013 54 None - 27 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 2013 54 None - 27 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 2013 54 None - 27 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 2013 54 None - 27 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 2013 54 None - 27 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
4940 14470 35 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 340 5 0 4 4.8 CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1201210 14470 35 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 340 5 0 4 4.8 CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
5311507 194815 41 None - 1 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL53904 194815 41 None - 1 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
4756 16649 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1201022 16649 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1242 16649 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
47979 78210 59 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 8 2 6 0.7 C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL2105581 78210 59 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 8 2 6 0.7 C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC 10.1038/s41467-023-40064-9
154257 178619 67 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
CHEMBL46740 178619 67 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
4209 3163 75 None -309 33 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3163 75 None -309 33 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3163 75 None -309 33 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3163 75 None -309 33 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3163 75 None -309 33 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3163 75 None -309 33 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
135409453 3773 41 None - 2 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3773 41 None - 2 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3773 41 None - 2 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
242 470 124 None -64 51 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 470 124 None -64 51 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 470 124 None -64 51 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 470 124 None -64 51 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 470 124 None -64 51 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
1890 2759 49 None -1 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 2759 49 None -1 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 2759 49 None -1 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 2759 49 None -1 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 2759 49 None -1 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
108000 56853 39 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 2 1 3 2.9 Cn1cc(C(=O)[C@@H]2CCc3[nH]cnc3C2)c2ccccc21 10.1038/s41467-023-40064-9
135418340 56853 39 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 2 1 3 2.9 Cn1cc(C(=O)[C@@H]2CCc3[nH]cnc3C2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1643895 56853 39 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 2 1 3 2.9 Cn1cc(C(=O)[C@@H]2CCc3[nH]cnc3C2)c2ccccc21 10.1038/s41467-023-40064-9
213 3853 55 None -3 44 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
2717 3853 55 None -3 44 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5533 3853 55 None -3 44 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL621 3853 55 None -3 44 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00656 3853 55 None -3 44 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
150 2509 21 None -27 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 2509 21 None -27 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 2509 21 None -27 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 2509 21 None -27 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 2509 21 None -27 16 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
5453 203619 102 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 189 3 0 1 0.2 S=P(N1CC1)(N1CC1)N1CC1 10.1038/s41467-023-40064-9
CHEMBL671 203619 102 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 189 3 0 1 0.2 S=P(N1CC1)(N1CC1)N1CC1 10.1038/s41467-023-40064-9
3236 67609 43 None -1 2 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 259 5 0 2 3.6 CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL1902981 67609 43 None -1 2 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 259 5 0 2 3.6 CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 10.1038/s41467-023-40064-9
1212 1662 50 None -38 65 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
204 1662 50 None -38 65 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
3372 1662 50 None -38 65 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL726 1662 50 None -38 65 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00623 1662 50 None -38 65 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
10531 1420 21 None -10 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 1420 21 None -10 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 1420 21 None -10 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 1420 21 None -10 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 1420 21 None -10 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
2267 559 71 None - 7 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
271 559 71 None - 7 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
7121 559 71 None - 7 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL639 559 71 None - 7 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00972 559 71 None - 7 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3149 12614 15 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1187011 12614 15 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 334 15 0 1 6.1 CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 10.1038/s41467-023-40064-9
4846 27987 53 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 308 1 2 6 2.2 O=C(O)c1cc(O)c2c3nc4ccccc4oc-3cc(=O)c2n1 10.1038/s41467-023-40064-9
CHEMBL1372341 27987 53 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 308 1 2 6 2.2 O=C(O)c1cc(O)c2c3nc4ccccc4oc-3cc(=O)c2n1 10.1038/s41467-023-40064-9
2726 919 68 None -8 72 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
621 919 68 None -8 72 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
83 919 68 None -8 72 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL71 919 68 None -8 72 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB00477 919 68 None -8 72 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
1209 1658 75 None -12 32 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 1658 75 None -12 32 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 1658 75 None -12 32 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 1658 75 None -12 32 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 1658 75 None -12 32 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
1043 1582 14 None -19 28 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
149 1582 14 None -19 28 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
8223 1582 14 None -19 28 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL442 1582 14 None -19 28 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00696 1582 14 None -19 28 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
202 1508 77 None - 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 1508 77 None - 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 1508 77 None - 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 1508 77 None - 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 1508 77 None - 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3584 3777 64 None -21 13 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3777 64 None -21 13 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3777 64 None -21 13 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3777 64 None -21 13 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3777 64 None -21 13 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
1028 291 71 None -128 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 291 71 None -128 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 291 71 None -128 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 291 71 None -128 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 291 71 None -128 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 291 71 None -128 30 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
3947 206395 53 None - 16 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL87708 206395 53 None - 16 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
1971 2866 38 None -3 30 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 2866 38 None -3 30 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 2866 38 None -3 30 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 2866 38 None -3 30 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 2866 38 None -3 30 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2435 722 100 None -36 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
395 722 100 None -36 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
520 722 100 None -36 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
5386 722 100 None -36 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL844 722 100 None -36 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
DB00484 722 100 None -36 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
1228 3866 34 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
2763 3866 34 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
5282443 3866 34 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL855 3866 34 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
DB00427 3866 34 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
5210 33338 48 None 123 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 10.1038/s41467-023-40064-9
CHEMBL1200765 33338 48 None 123 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 10.1038/s41467-023-40064-9
CHEMBL1419 33338 48 None 123 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 10.1038/s41467-023-40064-9
5329102 194726 86 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194726 86 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
3689 102771 55 None - 0 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1372983 102771 55 None - 0 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL305187 102771 55 None - 0 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
118422671 2757 65 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
1887 2757 65 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
71301 2757 65 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
7246 2757 65 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL434394 2757 65 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
DB04861 2757 65 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
16960 14487 23 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 318 5 0 2 3.9 CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL1201287 14487 23 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 318 5 0 2 3.9 CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1 10.1038/s41467-023-40064-9
2337 3256 77 None -12 62 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3256 77 None -12 62 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3256 77 None -12 62 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3256 77 None -12 62 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3256 77 None -12 62 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
135398737 958 93 None -9 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 958 93 None -9 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 958 93 None -9 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 958 93 None -9 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 958 93 None -9 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
6436173 55116 45 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL1617 55116 45 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
1210 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
1213 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
2725 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
33036 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
4411 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
616 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
6976 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
716121 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1201353 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1554789 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL505 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB01114 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB13679 918 51 None -234 21 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
2601 3780 33 None -1 21 Human 8.3 pAC50 = 8.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
443951 3780 33 None -1 21 Human 8.3 pAC50 = 8.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
56 3780 33 None -1 21 Human 8.3 pAC50 = 8.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL73151 3780 33 None -1 21 Human 8.3 pAC50 = 8.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB13399 3780 33 None -1 21 Human 8.3 pAC50 = 8.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
21772 78399 31 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 293 4 0 1 4.5 CC(CC1c2ccccc2CCc2ccccc21)CN(C)C 10.1038/s41467-023-40064-9
CHEMBL2110816 78399 31 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 293 4 0 1 4.5 CC(CC1c2ccccc2CCc2ccccc21)CN(C)C 10.1038/s41467-023-40064-9
2220 3134 82 None - 14 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
27400 3134 82 None - 14 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
93 3134 82 None - 14 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL294951 3134 82 None - 14 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB06153 3134 82 None - 14 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
1164 1630 26 None - 12 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 336 6 0 2 4.1 CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1 10.1038/s41467-023-40064-9
1626 1630 26 None - 12 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 336 6 0 2 4.1 CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1 10.1038/s41467-023-40064-9
3345 1630 26 None - 12 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 336 6 0 2 4.1 CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL596 1630 26 None - 12 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 336 6 0 2 4.1 CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1 10.1038/s41467-023-40064-9
DB00813 1630 26 None - 12 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 336 6 0 2 4.1 CCC(=O)N(c1ccccc1)C1CCN(CC1)CCc1ccccc1 10.1038/s41467-023-40064-9
3157 1470 71 None - 10 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1470 71 None - 10 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1470 71 None - 10 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1470 71 None - 10 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1470 71 None - 10 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
17676 7072 29 None - 3 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
5281082 7072 29 None - 3 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1085 7072 29 None - 3 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
11658860 2344 51 None - 3 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
2941 2344 51 None - 3 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
4374 2344 51 None - 3 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
CHEMBL360328 2344 51 None - 3 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
DB04871 2344 51 None - 3 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 195 0 1 1 2.6 Clc1ccc2c(c1)[C@@H](C)CNCC2 10.1038/s41467-023-40064-9
103 4153 61 None -5 53 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2875 4153 61 None -5 53 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5736 4153 61 None -5 53 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL285802 4153 61 None -5 53 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB09225 4153 61 None -5 53 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2351 3286 64 None -15 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
2820 3286 64 None -15 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
5035 3286 64 None -15 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
CHEMBL81 3286 64 None -15 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
DB00481 3286 64 None -15 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
2351 4300 49 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 4300 49 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1257078 4300 49 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
36811 1454 37 None -4 7 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 1454 37 None -4 7 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 1454 37 None -4 7 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 1454 37 None -4 7 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 1454 37 None -4 7 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
1222 1664 49 None -30 33 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3396 1664 49 None -30 33 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
85 1664 49 None -30 33 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL46516 1664 49 None -30 33 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
DB04842 1664 49 None -30 33 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
134 2514 24 None -93 67 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
1775 2514 24 None -93 67 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
9681 2514 24 None -93 67 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
CHEMBL1065 2514 24 None -93 67 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
DB00247 2514 24 None -93 67 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
4976 203579 29 None - 12 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 4 1 1 4.3 CNCCCC1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL668 203579 29 None - 12 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 4 1 1 4.3 CNCCCC1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
2865 4143 73 None -38 53 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4143 73 None -38 53 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4143 73 None -38 53 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4143 73 None -38 53 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4143 73 None -38 53 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
441074 19414 82 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
CHEMBL1294 19414 82 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
19675 51670 43 None - 0 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1584 51670 43 None - 0 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
3081361 93934 123 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 474 5 1 5 4.4 COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 10.1038/s41467-023-40064-9
CHEMBL24828 93934 123 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 474 5 1 5 4.4 COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 10.1038/s41467-023-40064-9
2402 3370 62 None -4 24 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
5095 3370 62 None -4 24 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
7295 3370 62 None -4 24 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
CHEMBL589 3370 62 None -4 24 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
DB00268 3370 62 None -4 24 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
2274 3173 58 None -3 31 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 3173 58 None -3 31 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 3173 58 None -3 31 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 3173 58 None -3 31 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 3173 58 None -3 31 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
135564886 14493 5 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
135673376 14493 5 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
137157436 14493 5 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
145948239 14493 5 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
71587099 14493 5 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1201304 14493 5 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
2169 44847 35 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 44847 35 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
1224 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
3100 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
8980 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
916 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL657 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
DB01075 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
1353 1911 93 None -85 83 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1911 93 None -85 83 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1911 93 None -85 83 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1911 93 None -85 83 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1911 93 None -85 83 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
319 1324 44 None - 9 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
321 1324 44 None - 9 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
444031 1324 44 None - 9 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
784 1324 44 None - 9 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
CHEMBL1346 1324 44 None - 9 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
DB00496 1324 44 None - 9 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
4567 9948 34 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 9948 34 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
1593 2340 66 None -6 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
30668 2340 66 None -6 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
9868 2340 66 None -6 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL17860 2340 66 None -6 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
DB04948 2340 66 None -6 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
2343 14454 57 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 431 5 2 6 2.2 NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O 10.1038/s41467-023-40064-9
CHEMBL1201039 14454 57 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 431 5 2 6 2.2 NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O 10.1038/s41467-023-40064-9
68712 100338 60 None 1 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
CHEMBL289480 100338 60 None 1 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
1549120 196486 85 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 196486 85 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
4450 178228 69 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 253 1 0 2 3.2 CN1CCOC(c2ccccc2)c2ccccc2C1 10.1038/s41467-023-40064-9
CHEMBL465026 178228 69 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 253 1 0 2 3.2 CN1CCOC(c2ccccc2)c2ccccc2C1 10.1038/s41467-023-40064-9
3926 207241 40 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL92870 207241 40 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
31101 729 40 None -33 36 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 729 40 None -33 36 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 729 40 None -33 36 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 729 40 None -33 36 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 729 40 None -33 36 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
1028 291 71 None -128 30 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 291 71 None -128 30 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 291 71 None -128 30 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 291 71 None -128 30 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 291 71 None -128 30 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 291 71 None -128 30 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2695 3841 81 None -69 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
5504 3841 81 None -69 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
7310 3841 81 None -69 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL770 3841 81 None -69 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00797 3841 81 None -69 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
212 3806 47 None -6 25 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 3806 47 None -6 25 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 3806 47 None -6 25 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 3806 47 None -6 25 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 3806 47 None -6 25 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
1530 2182 50 None -46 21 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
3827 2182 50 None -46 21 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
7206 2182 50 None -46 21 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
CHEMBL534 2182 50 None -46 21 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
DB00920 2182 50 None -46 21 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
1400 1957 70 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 1957 70 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 1957 70 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 1957 70 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 1957 70 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 1957 70 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
41684 31221 105 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 31221 105 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
71398 106439 44 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 106439 44 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
260 3869 54 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 2 1 3 3.0 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2775 3869 54 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 2 1 3 3.0 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2 10.1038/s41467-023-40064-9
656665 3869 54 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 2 1 3 3.0 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL56564 3869 54 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 2 1 3 3.0 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB11699 3869 54 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 2 1 3 3.0 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)c1c[nH]c2c1cccc2 10.1038/s41467-023-40064-9
216416 111581 48 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL328190 111581 48 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
2146 3100 67 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3100 67 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3100 67 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3100 67 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3100 67 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
21722 17992 31 None - 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 17992 31 None - 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
16363 596 53 None - 7 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
312 596 53 None - 7 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
9215 596 53 None - 7 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL297302 596 53 None - 7 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB12867 596 53 None - 7 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
3151 1462 97 None -97 27 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 1462 97 None -97 27 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 1462 97 None -97 27 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 1462 97 None -97 27 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 1462 97 None -97 27 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
4011 82408 49 None -16 24 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 10.1038/s41467-023-40064-9
CHEMBL21731 82408 49 None -16 24 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 10.1038/s41467-023-40064-9
10184653 10997 107 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 485 8 2 7 4.4 CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1 10.1038/s41467-023-40064-9
CHEMBL1173655 10997 107 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 485 8 2 7 4.4 CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1 10.1038/s41467-023-40064-9
3052776 206556 90 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 171 2 1 1 1.9 C#CCN[C@@H]1CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL887 206556 90 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 171 2 1 1 1.9 C#CCN[C@@H]1CCc2ccccc21 10.1038/s41467-023-40064-9
19910 37408 106 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 190 1 1 4 1.8 O=[N+]([O-])c1ccc(O)c2ncccc12 10.1038/s41467-023-40064-9
CHEMBL1454910 37408 106 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 190 1 1 4 1.8 O=[N+]([O-])c1ccc(O)c2ncccc12 10.1038/s41467-023-40064-9
115 343 71 None - 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
2092 343 71 None - 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
7109 343 71 None - 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
CHEMBL709 343 71 None - 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
DB00346 343 71 None - 6 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
7699 28294 55 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 603 32 1 12 2.8 CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1 10.1038/s41467-023-40064-9
CHEMBL1374379 28294 55 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 603 32 1 12 2.8 CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1 10.1038/s41467-023-40064-9
68867 78173 38 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 402 7 2 6 3.1 CCOc1cc(N)c([N+](=O)[O-])cc1C(=O)NC1CCN(CC2CC=CCC2)CC1 10.1038/s41467-023-40064-9
CHEMBL2104523 78173 38 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 402 7 2 6 3.1 CCOc1cc(N)c([N+](=O)[O-])cc1C(=O)NC1CCN(CC2CC=CCC2)CC1 10.1038/s41467-023-40064-9
1830 2590 44 None -10 28 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
207 2590 44 None -10 28 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
23897 2590 44 None -10 28 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL460 2590 44 None -10 28 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
DB01618 2590 44 None -10 28 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
2335 11848 22 None -2 12 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 11848 22 None -2 12 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 11848 22 None -2 12 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 11848 22 None -2 12 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
65859 19049 88 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 236 4 2 4 0.2 OC[C@@H](O)CN1CCN(c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1288810 19049 88 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 236 4 2 4 0.2 OC[C@@H](O)CN1CCN(c2ccccc2)CC1 10.1038/s41467-023-40064-9
214 3860 58 None -39 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
2740 3860 58 None -39 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5566 3860 58 None -39 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
66064 3860 58 None -39 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL422 3860 58 None -39 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00831 3860 58 None -39 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
1210 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
1213 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
2725 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
33036 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
4411 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
616 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
6976 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
716121 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1201353 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1554789 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL505 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB01114 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB13679 918 51 None -234 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
5639 98895 75 None - 5 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 98895 75 None - 5 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
4979271 101178 58 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 363 2 1 6 1.7 CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1 10.1038/s41467-023-40064-9
58258 101178 58 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 363 2 1 6 1.7 CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1 10.1038/s41467-023-40064-9
CHEMBL295619 101178 58 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 363 2 1 6 1.7 CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1 10.1038/s41467-023-40064-9
2765 943 19 None -15 9 Human 6.0 pEC50 = 6 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
515 943 19 None -15 9 Human 6.0 pEC50 = 6 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
CHEMBL13852 943 19 None -15 9 Human 6.0 pEC50 = 6 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
DB09202 943 19 None -15 9 Human 6.0 pEC50 = 6 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
49836301 18567 1 None -11 4 Human 6.0 pEC50 = 6 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml400232p
CHEMBL1276140 18567 1 None -11 4 Human 6.0 pEC50 = 6 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml400232p
28918670 92487 2 None -6 4 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 254 3 1 3 1.8 Brc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL2431279 92487 2 None -6 4 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 254 3 1 3 1.8 Brc1ccccc1OCC1=NCCN1 10.1021/ml400232p
57345629 71185 0 None -70 4 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1956197 71185 0 None -70 4 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1021/ml400232p
70695474 77672 0 None -70 4 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL2089156 77672 0 None -70 4 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
72947314 92490 0 None -6 4 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 230 5 1 3 2.0 c1ccc(OCC2=NCCN2)c(CC2CC2)c1 10.1021/ml400232p
CHEMBL2431281 92490 0 None -6 4 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 230 5 1 3 2.0 c1ccc(OCC2=NCCN2)c(CC2CC2)c1 10.1021/ml400232p
44269013 30342 1 None -11 4 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 218 5 1 3 2.0 CCCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL13917 30342 1 None -11 4 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 218 5 1 3 2.0 CCCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
134156190 151365 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 215 5 2 3 1.8 C=CCc1ccccc1NCC1=NCCN1 10.1021/acsmedchemlett.6b00290
CHEMBL3961335 151365 0 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 215 5 2 3 1.8 C=CCc1ccccc1NCC1=NCCN1 10.1021/acsmedchemlett.6b00290
57345626 71180 2 None -15 4 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1021/ml400232p
CHEMBL1956192 71180 2 None -15 4 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1021/ml400232p
44549156 18570 0 None -42 4 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276218 18570 0 None -42 4 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
49836303 18572 1 None -43 4 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276220 18572 1 None -43 4 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
72947315 92489 0 None -10 4 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 232 5 1 4 1.6 c1ccc(OC2CC2)c(OCC2=NCCN2)c1 10.1021/ml400232p
CHEMBL2431280 92489 0 None -10 4 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 232 5 1 4 1.6 c1ccc(OC2CC2)c(OCC2=NCCN2)c1 10.1021/ml400232p
129928082 144194 1 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 189 3 2 3 1.4 Cc1ccccc1NCC1=NCCN1 10.1021/acsmedchemlett.6b00290
CHEMBL3904276 144194 1 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 189 3 2 3 1.4 Cc1ccccc1NCC1=NCCN1 10.1021/acsmedchemlett.6b00290
57345628 71183 0 None -38 4 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1956195 71183 0 None -38 4 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
70693375 77671 0 None -8 4 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL2089155 77671 0 None -8 4 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
134137108 142727 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 217 5 2 3 2.1 CCCc1ccccc1NCC1=NCCN1 10.1021/acsmedchemlett.6b00290
CHEMBL3892351 142727 0 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 217 5 2 3 2.1 CCCc1ccccc1NCC1=NCCN1 10.1021/acsmedchemlett.6b00290
73291731 92491 0 None -38 4 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 232 5 1 3 2.4 CCCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
CHEMBL2431282 92491 0 None -38 4 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 232 5 1 3 2.4 CCCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
13123534 189453 1 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/acsmedchemlett.6b00290
CHEMBL51358 189453 1 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 209 3 2 3 1.8 Clc1ccccc1NCC1=NCCN1 10.1021/acsmedchemlett.6b00290
44352155 116808 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 251 4 2 3 2.8 c1ccc(-c2ccccc2NCC2=NCCN2)cc1 10.1021/acsmedchemlett.6b00290
CHEMBL337862 116808 0 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysisAgonist activity at human alpha2b-AR expressed in CHO cells assessed as rate of acidification after 240 mins by cytosensor microphysiometric analysis
ChEMBL 251 4 2 3 2.8 c1ccc(-c2ccccc2NCC2=NCCN2)cc1 10.1021/acsmedchemlett.6b00290
44269006 32353 1 None -10 4 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 216 5 1 3 1.8 C=CCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL14107 32353 1 None -10 4 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human alpha2B ARAgonist activity at human alpha2B AR
ChEMBL 216 5 1 3 1.8 C=CCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
1588 2325 27 None -1 44 Human 9.3 pIC50 = 9.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2325 27 None -1 44 Human 9.3 pIC50 = 9.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2325 27 None -1 44 Human 9.3 pIC50 = 9.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2325 27 None -1 44 Human 9.3 pIC50 = 9.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2325 27 None -1 44 Human 9.3 pIC50 = 9.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
44377036 120156 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351483 120156 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376993 56484 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163247 56484 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44377200 57420 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165350 57420 1 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376923 56427 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163190 56427 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
22120322 55921 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162370 55921 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
6761 67799 19 None -1 18 Human 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67799 19 None -1 18 Human 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
44376900 56268 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162826 56268 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376927 55637 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162147 55637 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2274 3173 58 None -3 31 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3173 58 None -3 31 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3173 58 None -3 31 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3173 58 None -3 31 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3173 58 None -3 31 Human 8.0 pIC50 = 8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44376936 57474 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165776 57474 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2337 3256 77 None -12 62 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3256 77 None -12 62 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3256 77 None -12 62 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3256 77 None -12 62 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3256 77 None -12 62 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5511 5488 40 None - 1 Human 6.0 pIC50 = 6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 4 0 2 3.3 Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1 nan
CHEMBL1076211 5488 40 None - 1 Human 6.0 pIC50 = 6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 4 0 2 3.3 Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1 nan
59271992 118048 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of alpha-adrenoceptor 2B (unknown origin)Inhibition of alpha-adrenoceptor 2B (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
CHEMBL3403995 118048 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibition of alpha-adrenoceptor 2B (unknown origin)Inhibition of alpha-adrenoceptor 2B (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
2398 954 62 None -2 29 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2801 954 62 None -2 29 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
701 954 62 None -2 29 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
CHEMBL415 954 62 None -2 29 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
DB01242 954 62 None -2 29 Human 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2435 722 100 None -36 12 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 722 100 None -36 12 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 722 100 None -36 12 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 722 100 None -36 12 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 722 100 None -36 12 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 722 100 None -36 12 Human 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
9951544 57376 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165181 57376 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
240 944 43 None -11 24 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 944 43 None -11 24 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 944 43 None -11 24 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 944 43 None -11 24 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 944 43 None -11 24 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 944 43 None -11 24 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 944 43 None -11 24 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
3033538 1319 39 None -11 9 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
7155 1319 39 None -11 9 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
781 1319 39 None -11 9 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
CHEMBL1201216 1319 39 None -11 9 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
DB00298 1319 39 None -11 9 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
448537 160250 89 None -33 25 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 160250 89 None -33 25 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
2406 100404 89 None -10 12 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
CHEMBL290106 100404 89 None -10 12 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
15730 71118 80 None -2 10 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
CHEMBL195437 71118 80 None -2 10 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
11057 176149 23 None -1 20 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
3468 176149 23 None -1 20 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL459265 176149 23 None -1 20 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL64894 176149 23 None -1 20 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
124 2981 47 None -977 33 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2981 47 None -977 33 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2981 47 None -977 33 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2981 47 None -977 33 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2981 47 None -977 33 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
176 398 66 None -4 31 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 398 66 None -4 31 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 398 66 None -4 31 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 398 66 None -4 31 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 398 66 None -4 31 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2750 204061 76 None -3 12 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
CHEMBL7002 204061 76 None -3 12 Human 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
1353 1911 93 None -85 83 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1911 93 None -85 83 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1911 93 None -85 83 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1911 93 None -85 83 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1911 93 None -85 83 Human 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3952 1888 38 None -18 12 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1888 38 None -18 12 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1888 38 None -18 12 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1888 38 None -18 12 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1888 38 None -18 12 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1888 38 None -18 12 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
2662 11384 131 None -1 30 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL118 11384 131 None -1 30 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 nan
1209 1658 75 None -12 32 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
203 1658 75 None -12 32 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
3386 1658 75 None -12 32 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
CHEMBL41 1658 75 None -12 32 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
DB00472 1658 75 None -12 32 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
1548953 207679 27 None -3 17 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
CHEMBL954 207679 27 None -3 17 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
133 2496 52 None -14 42 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2496 52 None -14 42 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2496 52 None -14 42 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2496 52 None -14 42 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2496 52 None -14 42 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
8447 188949 84 None 2 13 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
CHEMBL508112 188949 84 None 2 13 Human 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
102 4127 48 None -10 49 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4127 48 None -10 49 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4127 48 None -10 49 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4127 48 None -10 49 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4127 48 None -10 49 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
5029 15545 92 None -13 4 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C nan
CHEMBL1219 15545 92 None -13 4 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C nan
2683 102888 25 None -112 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL305906 102888 25 None -112 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL334255 102888 25 None -112 16 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
2142 3096 58 None -5 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3096 58 None -5 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3096 58 None -5 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3096 58 None -5 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3096 58 None -5 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3096 58 None -5 36 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
2284 3182 33 None -3 29 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3182 33 None -3 29 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3182 33 None -3 29 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3182 33 None -3 29 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3182 33 None -3 29 Human 7.8 pIC50 = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
42574 15287 90 None -15 3 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 662 4 2 3 7.1 Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O nan
CHEMBL12131 15287 90 None -15 3 Human 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 662 4 2 3 7.1 Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O nan
3823 50221 42 None -43 10 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 50221 42 None -43 10 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 50221 42 None -43 10 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
68617 205527 62 None -3 26 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL1709 205527 62 None -3 26 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL809 205527 62 None -3 26 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
237 204865 48 None -1 13 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL546257 204865 48 None -1 13 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL554190 204865 48 None -1 13 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL7568 204865 48 None -1 13 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL508338 188966 0 None -2 6 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL None None None None nan
12488 1657 56 None -12 23 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1657 56 None -12 23 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1657 56 None -12 23 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1657 56 None -12 23 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
4601 206747 35 None -3 16 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL1201023 206747 35 None -3 16 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL900 206747 35 None -3 16 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
12575 1988 30 None -53 17 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
54459 1988 30 None -53 17 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
CHEMBL10316 1988 30 None -53 17 Human 7.7 pIC50 = 7.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
119584 2595 102 None -2 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
1848 2595 102 None -2 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
242 2595 102 None -2 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
CHEMBL60889 2595 102 None -2 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
DB11675 2595 102 None -2 5 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
44376845 55545 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
CHEMBL162058 55545 1 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
6518171 168296 55 None -8 8 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 495 12 2 6 4.9 CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1 nan
CHEMBL434063 168296 55 None -8 8 Human 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 495 12 2 6 4.9 CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1 nan
22120332 56045 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
CHEMBL162490 56045 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
44376984 56223 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162682 56223 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44377035 120130 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351200 120130 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
3045401 56059 32 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162501 56059 32 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
44376958 57479 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL165796 57479 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
44376954 55740 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162232 55740 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
3151 1462 97 None -97 27 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1462 97 None -97 27 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1462 97 None -97 27 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1462 97 None -97 27 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1462 97 None -97 27 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
124087 1389 114 None -28 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
7157 1389 114 None -28 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
814 1389 114 None -28 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
CHEMBL1172 1389 114 None -28 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
DB00967 1389 114 None -28 15 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
3168 9262 92 None -39 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9262 92 None -39 21 Human 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
1816 2540 102 None -851 18 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
4205 2540 102 None -851 18 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
7241 2540 102 None -851 18 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
CHEMBL654 2540 102 None -851 18 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
DB00370 2540 102 None -851 18 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
1547484 940 74 None -12 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 940 74 None -12 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 940 74 None -12 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 940 74 None -12 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 940 74 None -12 20 Human 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
135398737 958 93 None -9 89 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 958 93 None -9 89 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 958 93 None -9 89 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 958 93 None -9 89 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 958 93 None -9 89 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
28417 40039 49 None -1 12 Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
CHEMBL1479 40039 49 None -1 12 Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
5210 33338 48 None 123 4 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 nan
CHEMBL1200765 33338 48 None 123 4 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 nan
CHEMBL1419 33338 48 None 123 4 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 nan
1343 1889 62 None -91 9 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1889 62 None -91 9 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1889 62 None -91 9 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1889 62 None -91 9 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1889 62 None -91 9 Human 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
56645570 121489 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of adrenergic alpha-2B receptor (unknown origin)Inhibition of adrenergic alpha-2B receptor (unknown origin)
ChEMBL 289 2 0 3 3.9 Fc1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1 10.1021/acsmedchemlett.5b00054
CHEMBL3582472 121489 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibition of adrenergic alpha-2B receptor (unknown origin)Inhibition of adrenergic alpha-2B receptor (unknown origin)
ChEMBL 289 2 0 3 3.9 Fc1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1 10.1021/acsmedchemlett.5b00054
7000 54744 99 None - 1 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 123 1 1 2 1.3 COc1ccccc1N nan
CHEMBL1612004 54744 99 None - 1 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 123 1 1 2 1.3 COc1ccccc1N nan
134551 358 27 None -7 21 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 358 27 None -7 21 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 358 27 None -7 21 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 358 27 None -7 21 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
2726 919 68 None -8 72 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 919 68 None -8 72 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 919 68 None -8 72 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 919 68 None -8 72 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 919 68 None -8 72 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
2389 3331 118 None -104 67 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3331 118 None -104 67 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3331 118 None -104 67 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3331 118 None -104 67 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3331 118 None -104 67 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
55245 18580 81 None -3 3 Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 429 2 1 3 5.4 CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C nan
CHEMBL1276308 18580 81 None -3 3 Human 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 429 2 1 3 5.4 CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C nan
196129 67798 17 None -15 15 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67798 17 None -15 15 Human 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
441383 20333 57 None -4 16 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20333 57 None -4 16 Human 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
1042 1581 23 None -47 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
148 1581 23 None -47 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
443884 1581 23 None -47 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
CHEMBL119443 1581 23 None -47 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
DB01253 1581 23 None -47 17 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
1212 1662 50 None -38 65 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1662 50 None -38 65 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1662 50 None -38 65 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1662 50 None -38 65 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1662 50 None -38 65 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
4209 3163 75 None -309 33 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3163 75 None -309 33 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3163 75 None -309 33 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3163 75 None -309 33 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3163 75 None -309 33 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3163 75 None -309 33 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4011 82408 49 None -16 24 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 82408 49 None -16 24 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
36811 1454 37 None -4 7 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 1454 37 None -4 7 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 1454 37 None -4 7 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 1454 37 None -4 7 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 1454 37 None -4 7 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
73453 29616 24 None -1 17 Human 8.5 pIC50 = 8.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29616 24 None -1 17 Human 8.5 pIC50 = 8.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
1043 1582 14 None -19 28 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1582 14 None -19 28 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1582 14 None -19 28 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1582 14 None -19 28 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1582 14 None -19 28 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
10531 1420 21 None -10 23 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1420 21 None -10 23 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1420 21 None -10 23 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1420 21 None -10 23 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1420 21 None -10 23 Human 8.4 pIC50 = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
3236 67609 43 None -1 2 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 259 5 0 2 3.6 CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 nan
CHEMBL1902981 67609 43 None -1 2 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 259 5 0 2 3.6 CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 nan
5472 205818 75 None 1 3 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL1717 205818 75 None 1 3 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL833 205818 75 None 1 3 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
26987 949 33 None -281 21 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 949 33 None -281 21 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 949 33 None -281 21 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 949 33 None -281 21 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 949 33 None -281 21 Human 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
3038525 13549 114 None -3 3 Human 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
CHEMBL119385 13549 114 None -3 3 Human 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
25014630 83539 1 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibition of alpha2B adrenergic receptorInhibition of alpha2B adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
CHEMBL2203713 83539 1 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibition of alpha2B adrenergic receptorInhibition of alpha2B adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
3117 207841 103 None -2 16 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 207841 103 None -2 16 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
4098 32505 30 None -23 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1255739 32505 30 None -23 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1411979 32505 30 None -23 11 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
31101 729 40 None -33 36 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 729 40 None -33 36 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 729 40 None -33 36 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 729 40 None -33 36 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 729 40 None -33 36 Human 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
1016 3747 78 None -18 35 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3747 78 None -18 35 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3747 78 None -18 35 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3747 78 None -18 35 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3747 78 None -18 35 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3747 78 None -18 35 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5318 15576 49 None -1 13 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1200348 15576 49 None -1 13 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1221 15576 49 None -1 13 Human 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
4189 206922 96 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1559 206922 96 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 206922 96 None -18 34 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
5353853 17986 47 None -17 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
9556529 17986 47 None -17 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1262 17986 47 None -17 15 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
2351 3286 64 None -15 21 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3286 64 None -15 21 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3286 64 None -15 21 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3286 64 None -15 21 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3286 64 None -15 21 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
26757 207978 31 None 1 2 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
CHEMBL972 207978 31 None 1 2 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
277 1301 62 None -13 50 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1301 62 None -13 50 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1301 62 None -13 50 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1301 62 None -13 50 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1301 62 None -13 50 Human 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
100 3805 58 None -35 55 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3805 58 None -35 55 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3805 58 None -35 55 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3805 58 None -35 55 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3805 58 None -35 55 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2247 505 81 None -57 42 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 505 81 None -57 42 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 505 81 None -57 42 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 505 81 None -57 42 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 505 81 None -57 42 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2541 786 120 None -2691 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
587 786 120 None -2691 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
6907 786 120 None -2691 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
CHEMBL1016 786 120 None -2691 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
DB00796 786 120 None -2691 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
DB13919 786 120 None -2691 6 Human 5.4 pIC50 = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
213 3853 55 None -3 44 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3853 55 None -3 44 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3853 55 None -3 44 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3853 55 None -3 44 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3853 55 None -3 44 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
6075 150108 42 None -6 16 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 150108 42 None -6 16 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
44376975 55986 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
CHEMBL162436 55986 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
44377007 57148 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL164612 57148 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
135398745 2914 112 None -37 65 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2914 112 None -37 65 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2914 112 None -37 65 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2914 112 None -37 65 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
3584 3777 64 None -21 13 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3777 64 None -21 13 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3777 64 None -21 13 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3777 64 None -21 13 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3777 64 None -21 13 Human 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
1210 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
1213 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
2725 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
33036 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
4411 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
616 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
6976 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
716121 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1201353 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1554789 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL505 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
DB01114 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
DB13679 918 51 None -234 21 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
150 2509 21 None -27 16 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
1764 2509 21 None -27 16 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
8226 2509 21 None -27 16 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
CHEMBL1201356 2509 21 None -27 16 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
DB00353 2509 21 None -27 16 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
56645363 121490 12 None -2 4 Human 5.3 pIC50 = 5.3 Binding
Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRA2BSelectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRA2B
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
CHEMBL3582478 121490 12 None -2 4 Human 5.3 pIC50 = 5.3 Binding
Selectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRA2BSelectivity interaction (Enzyme panel (Eurofins-Panlabs radioligand binding assays)) EUB0000313b ADRA2B
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
134 2514 24 None -93 67 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
1775 2514 24 None -93 67 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
9681 2514 24 None -93 67 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
CHEMBL1065 2514 24 None -93 67 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
DB00247 2514 24 None -93 67 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
135 2532 43 None -8 58 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2532 43 None -8 58 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2532 43 None -8 58 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2532 43 None -8 58 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2532 43 None -8 58 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
2286 3183 51 None -4 30 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3183 51 None -4 30 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3183 51 None -4 30 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3183 51 None -4 30 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3183 51 None -4 30 Human 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
10660 14416 58 None -67 12 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
CHEMBL1200406 14416 58 None -67 12 Human 5.3 pIC50 = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
3561 19077 39 None -1 11 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
CHEMBL1289 19077 39 None -1 11 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
191 403 98 None -30 29 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 403 98 None -30 29 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 403 98 None -30 29 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 403 98 None -30 29 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 403 98 None -30 29 Human 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
3198 205513 76 None -24 34 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 205513 76 None -24 34 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 205513 76 None -24 34 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
2353 101112 82 None 1 4 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 336 2 0 4 3.1 COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2 nan
CHEMBL12089 101112 82 None 1 4 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 336 2 0 4 3.1 COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2 nan
CHEMBL295124 101112 82 None 1 4 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 336 2 0 4 3.1 COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2 nan
9885114 119604 5 None -87 12 Rat 6.2 pIC50 = 6.2 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119604 5 None -87 12 Rat 6.2 pIC50 = 6.2 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
2105 3054 37 None -35 33 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 3054 37 None -35 33 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 3054 37 None -35 33 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 3054 37 None -35 33 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 3054 37 None -35 33 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
2335 11848 22 None -2 12 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
8478 11848 22 None -2 12 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL1182210 11848 22 None -2 12 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL221753 11848 22 None -2 12 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
1201549 597 24 None -13 20 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 597 24 None -13 20 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 597 24 None -13 20 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 597 24 None -13 20 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 597 24 None -13 20 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 597 24 None -13 20 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
5282379 194984 69 None -2 3 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1 nan
CHEMBL547 194984 69 None -2 3 Human 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1 nan
107715 200945 22 None -13 19 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 200945 22 None -13 19 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 200945 22 None -13 19 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
3158 56267 27 None -218 20 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 56267 27 None -218 20 Human 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
1530 2182 50 None -46 21 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3827 2182 50 None -46 21 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
7206 2182 50 None -46 21 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
CHEMBL534 2182 50 None -46 21 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
DB00920 2182 50 None -46 21 Human 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3191 102858 97 None -9 25 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102858 97 None -9 25 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
44240743 6757 15 None - 1 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to adrenergic alpha2B receptorBinding affinity to adrenergic alpha2B receptor
ChEMBL 370 7 2 3 4.3 O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1 10.1021/jm901692q
CHEMBL1083787 6757 15 None - 1 Human 5.1 pIC50 = 5.1 Binding
Binding affinity to adrenergic alpha2B receptorBinding affinity to adrenergic alpha2B receptor
ChEMBL 370 7 2 3 4.3 O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1 10.1021/jm901692q
44190762 176880 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of radioligand from adrenergic alpha2B receptorDisplacement of radioligand from adrenergic alpha2B receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
CHEMBL461571 176880 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of radioligand from adrenergic alpha2B receptorDisplacement of radioligand from adrenergic alpha2B receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
44377006 57463 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccc(Cl)cc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165677 57463 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccc(Cl)cc3c2C1 10.1016/s0960-894x(99)00591-0
155540582 172538 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 470 3 1 5 4.1 CCOc1cc(N2CCC3(CC2)C(=O)Nc2ccc(Br)cc23)nnc1C(F)(F)F 10.1021/acsmedchemlett.9b00350
CHEMBL4483761 172538 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 470 3 1 5 4.1 CCOc1cc(N2CCC3(CC2)C(=O)Nc2ccc(Br)cc23)nnc1C(F)(F)F 10.1021/acsmedchemlett.9b00350
70788951 27155 1 None -1 5 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL None None None None nan
CHEMBL1366 27155 1 None -1 5 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL None None None None nan
180 401 56 None -7 40 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 401 56 None -7 40 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 401 56 None -7 40 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 401 56 None -7 40 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 401 56 None -7 40 Human 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
118112300 155994 18 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human alpha2B-adrenergic receptorAntagonist activity at human alpha2B-adrenergic receptor
ChEMBL 430 6 2 6 3.8 O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F 10.1016/j.bmcl.2017.03.085
CHEMBL4061793 155994 18 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human alpha2B-adrenergic receptorAntagonist activity at human alpha2B-adrenergic receptor
ChEMBL 430 6 2 6 3.8 O=S(=O)(Nc1nccs1)c1cc(Cl)c(NCC23CCCN2CCC3)cc1F 10.1016/j.bmcl.2017.03.085
2812 4779 101 None -29 34 Human 5.1 pIC50 = 5.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4779 101 None -29 34 Human 5.1 pIC50 = 5.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
2803 955 58 None -1 19 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 955 58 None -1 19 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 955 58 None -1 19 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 955 58 None -1 19 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 955 58 None -1 19 Human 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
1028 291 71 None -128 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 291 71 None -128 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 291 71 None -128 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 291 71 None -128 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 291 71 None -128 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 291 71 None -128 30 Human 6.1 pIC50 = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
2585 803 103 None -29 21 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 803 103 None -29 21 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 803 103 None -29 21 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 803 103 None -29 21 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 803 103 None -29 21 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
1971 2866 38 None -3 30 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
2404 2866 38 None -3 30 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
4543 2866 38 None -3 30 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
CHEMBL445 2866 38 None -3 30 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
DB00540 2866 38 None -3 30 Human 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
42636941 178949 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]RX821002 form human recombinant alpha2B adrenergic receptorDisplacement of [3H]RX821002 form human recombinant alpha2B adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
CHEMBL470432 178949 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]RX821002 form human recombinant alpha2B adrenergic receptorDisplacement of [3H]RX821002 form human recombinant alpha2B adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
49781228 17205 1 None -2 4 Human 10.0 pKi = 10.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17205 1 None -2 4 Human 10.0 pKi = 10.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
49781228 17205 1 None -2 4 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17205 1 None -2 4 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
52944548 17152 0 None -1 4 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.0 CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255723 17152 0 None -1 4 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.0 CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
52941512 17198 0 None -1 4 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256378 17198 0 None -1 4 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
1588 2325 27 None -1 44 Human 9.6 pKi = 9.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2325 27 None -1 44 Human 9.6 pKi = 9.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2325 27 None -1 44 Human 9.6 pKi = 9.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2325 27 None -1 44 Human 9.6 pKi = 9.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2325 27 None -1 44 Human 9.6 pKi = 9.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
49781228 17205 1 None -2 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
CHEMBL1256414 17205 1 None -2 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 196 1 1 1 2.4 c1ccc2c(c1)C[C@]1(c3c[nH]cn3)C[C@H]21 10.1021/jm1006269
52948958 17153 0 None 1 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.4 CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255724 17153 0 None 1 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.4 CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1c[nH]cn1 10.1021/jm1006269
49781222 17251 0 None -3 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 3.0 C[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256609 17251 0 None -3 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 3.0 C[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
6761 67799 19 None -1 18 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67799 19 None -1 18 Human 9.1 pKi = 9.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
52943739 17159 0 None -2 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@]12C[C@@]1(c1c[nH]cn1)Cc1ccccc12 10.1021/jm1006269
CHEMBL1255771 17159 0 None -2 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 210 1 1 1 2.6 C[C@]12C[C@@]1(c1c[nH]cn1)Cc1ccccc12 10.1021/jm1006269
52950140 17158 0 None -1 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 1 1 1 3.0 CC1(C)[C@@H]2c3ccccc3C[C@@]21c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255770 17158 0 None -1 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 1 1 1 3.0 CC1(C)[C@@H]2c3ccccc3C[C@@]21c1c[nH]cn1 10.1021/jm1006269
102 4127 48 None -10 49 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
3659 4127 48 None -10 49 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
8969 4127 48 None -10 49 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
CHEMBL15245 4127 48 None -10 49 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
DB01392 4127 48 None -10 49 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/acs.jmedchem.9b01465
73453 29616 24 None -1 17 Human 8.9 pKi = 8.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29616 24 None -1 17 Human 8.9 pKi = 8.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
16655023 107441 2 None -5 7 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 107441 2 None -5 7 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
49781223 17252 0 None -3 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.3 CC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256610 17252 0 None -3 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 224 2 1 1 3.3 CC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
108094 3423 27 None -6 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
526 3423 27 None -6 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
528 3423 27 None -6 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
CHEMBL10332 3423 27 None -6 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 10.1021/jm800250z
1043 1582 14 None -19 28 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1582 14 None -19 28 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1582 14 None -19 28 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1582 14 None -19 28 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1582 14 None -19 28 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
10531 1420 21 None -10 23 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1420 21 None -10 23 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1420 21 None -10 23 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1420 21 None -10 23 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1420 21 None -10 23 Human 8.8 pKi = 8.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
49781887 17144 0 None -3 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 17144 0 None -3 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
25142456 82406 2 None -5 9 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha 2B receptor receptorBinding affinity to human cloned adrenergic alpha 2B receptor receptor
ChEMBL 269 0 3 4 2.1 Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2 10.1021/jm0604979
CHEMBL217299 82406 2 None -5 9 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha 2B receptor receptorBinding affinity to human cloned adrenergic alpha 2B receptor receptor
ChEMBL 269 0 3 4 2.1 Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2 10.1021/jm0604979
44579229 189616 0 None -6 3 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL514837 189616 0 None -6 3 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
44579230 181544 0 None -8 3 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
CHEMBL476569 181544 0 None -8 3 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 468 10 1 7 2.8 CCCCOc1cccc(C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)n1 10.1016/j.bmcl.2008.08.055
135398737 958 93 None -9 89 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
38 958 93 None -9 89 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
722 958 93 None -9 89 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
CHEMBL42 958 93 None -9 89 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
DB00363 958 93 None -9 89 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
135398745 2914 112 None -37 65 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
47 2914 112 None -37 65 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
CHEMBL715 2914 112 None -37 65 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
DB00334 2914 112 None -37 65 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
10220232 99721 6 None -3 6 Human 7.0 pKi = 7 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
CHEMBL284795 99721 6 None -3 6 Human 7.0 pKi = 7 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm990569e
12575 1988 30 None -53 17 Human 7.0 pKi = 7 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
54459 1988 30 None -53 17 Human 7.0 pKi = 7 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
CHEMBL10316 1988 30 None -53 17 Human 7.0 pKi = 7 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmcl.2006.12.094
10220232 99721 6 None -3 6 Rat 7.0 pKi = 7 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm000128r
CHEMBL284795 99721 6 None -3 6 Rat 7.0 pKi = 7 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 230 1 1 2 3.5 Cc1sc(C)c2c1CCC=C2c1c[nH]cn1 10.1021/jm000128r
12574 2605 88 None -12 6 Rat 6.0 pKi = 6 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
4810 2605 88 None -12 6 Rat 6.0 pKi = 6 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
CHEMBL19236 2605 88 None -12 6 Rat 6.0 pKi = 6 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
DB09242 2605 88 None -12 6 Rat 6.0 pKi = 6 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1021/jm960012o
242 470 124 None -64 51 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
34 470 124 None -64 51 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
60795 470 124 None -64 51 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
CHEMBL1112 470 124 None -64 51 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
DB01238 470 124 None -64 51 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
2337 3256 77 None -12 62 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
50 3256 77 None -12 62 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
5002 3256 77 None -12 62 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
CHEMBL716 3256 77 None -12 62 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
DB01224 3256 77 None -12 62 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
2389 3331 118 None -104 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
5073 3331 118 None -104 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
96 3331 118 None -104 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
CHEMBL85 3331 118 None -104 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
DB00734 3331 118 None -104 67 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
24906203 187218 0 None -2 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
CHEMBL492445 187218 0 None -2 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
11199581 136559 0 None -3 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccccc1O)C1=NCCN1 10.1021/jm0408215
CHEMBL373830 136559 0 None -3 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccccc1O)C1=NCCN1 10.1021/jm0408215
49836307 18785 0 None -10 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL1278085 18785 0 None -10 3 Human 6.0 pKi = 6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
164615845 185190 0 None 1 6 Human 6.0 pKi = 6 Binding
Inhibition of alpha2b adrenergic receptor (unknown origin)Inhibition of alpha2b adrenergic receptor (unknown origin)
ChEMBL 389 2 1 4 3.7 O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1 10.1016/j.bmcl.2021.128008
CHEMBL4857492 185190 0 None 1 6 Human 6.0 pKi = 6 Binding
Inhibition of alpha2b adrenergic receptor (unknown origin)Inhibition of alpha2b adrenergic receptor (unknown origin)
ChEMBL 389 2 1 4 3.7 O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1 10.1016/j.bmcl.2021.128008
11448533 84691 0 None -1 3 Human 5.0 pKi = 5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 0 3 3.6 CC(Oc1ccccc1-c1ccccc1)C1=NCCO1 10.1021/jm0408215
CHEMBL222591 84691 0 None -1 3 Human 5.0 pKi = 5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 0 3 3.6 CC(Oc1ccccc1-c1ccccc1)C1=NCCO1 10.1021/jm0408215
11473729 84692 0 None -1 3 Human 5.0 pKi = 5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 265 4 0 2 4.4 CC(Oc1ccccc1-c1ccccc1)C1=NCCC1 10.1021/jm0408215
CHEMBL222593 84692 0 None -1 3 Human 5.0 pKi = 5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 265 4 0 2 4.4 CC(Oc1ccccc1-c1ccccc1)C1=NCCC1 10.1021/jm0408215
9856041 24114 3 None -2754 8 Rat 5.0 pKi = 5 Binding
Inhibitory constant against Alpha-2B adrenergic receptor using [3H]MK-912 radioligandInhibitory constant against Alpha-2B adrenergic receptor using [3H]MK-912 radioligand
ChEMBL 230 2 2 2 2.4 CC(N)Cc1c[nH]c2ccc3c(c12)CCCO3 10.1021/jm030205t
CHEMBL133868 24114 3 None -2754 8 Rat 5.0 pKi = 5 Binding
Inhibitory constant against Alpha-2B adrenergic receptor using [3H]MK-912 radioligandInhibitory constant against Alpha-2B adrenergic receptor using [3H]MK-912 radioligand
ChEMBL 230 2 2 2 2.4 CC(N)Cc1c[nH]c2ccc3c(c12)CCCO3 10.1021/jm030205t
73355415 92533 0 None -5 13 Human 6.0 pKi = 6 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 277 3 1 1 2.1 C1C2C3CC4C2C2C1C3[C@H](NCC13C5C6C7C5C1C7C63)C42 10.1016/j.bmc.2013.07.045
CHEMBL2432039 92533 0 None -5 13 Human 6.0 pKi = 6 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 277 3 1 1 2.1 C1C2C3CC4C2C2C1C3[C@H](NCC13C5C6C7C5C1C7C63)C42 10.1016/j.bmc.2013.07.045
3168 9262 92 None -39 21 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9262 92 None -39 21 Human 7.0 pKi = 7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
44292386 101482 0 None -6 3 Human 7.0 pKi = 7.0 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297827 101482 0 None -6 3 Human 7.0 pKi = 7.0 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 296 4 1 3 3.5 C(=C/c1ccccc1)\C[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
1547484 940 74 None -12 20 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 940 74 None -12 20 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 940 74 None -12 20 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 940 74 None -12 20 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 940 74 None -12 20 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
132584404 143349 0 None -2 5 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]Rauwolscine from human Alpha2B receptor expressed in HEK-T cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]Rauwolscine from human Alpha2B receptor expressed in HEK-T cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 416 3 0 2 6.7 CCCN1CC[C@H]2c3cc4ccc(C(F)(F)F)cc4nc3[C@H](CC)[C@H]3CCC[C@@H]1[C@@H]32 10.1016/j.bmcl.2016.10.065
CHEMBL3897499 143349 0 None -2 5 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]Rauwolscine from human Alpha2B receptor expressed in HEK-T cells measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]Rauwolscine from human Alpha2B receptor expressed in HEK-T cells measured after 90 mins by microbeta scintillation counting method
ChEMBL 416 3 0 2 6.7 CCCN1CC[C@H]2c3cc4ccc(C(F)(F)F)cc4nc3[C@H](CC)[C@H]3CCC[C@@H]1[C@@H]32 10.1016/j.bmcl.2016.10.065
57345629 71185 0 None -70 4 Human 6.0 pKi = 6.0 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1956197 71185 0 None -70 4 Human 6.0 pKi = 6.0 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1021/ml400232p
57345629 71185 0 None -70 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956197 71185 0 None -70 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 246 5 1 4 2.0 CC(Oc1ccccc1OC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
28417 40039 49 None -1 12 Human 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
CHEMBL1479 40039 49 None -1 12 Human 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C nan
24906243 187248 0 None -8 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2cccc(-c3ccccc3)c2O1 10.1021/jm800250z
CHEMBL492648 187248 0 None -8 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 310 3 1 5 2.5 COC1(C2=NCCN2)COc2cccc(-c3ccccc3)c2O1 10.1021/jm800250z
24906201 187353 0 None -1 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
CHEMBL493272 187353 0 None -1 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
9809007 172564 8 None -1047 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL448620 172564 8 None -1047 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
5210 33338 48 None 123 4 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 nan
CHEMBL1200765 33338 48 None 123 4 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 nan
CHEMBL1419 33338 48 None 123 4 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 nan
135398737 958 93 None -9 89 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 958 93 None -9 89 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 958 93 None -9 89 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 958 93 None -9 89 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 958 93 None -9 89 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
9928332 97180 5 None -5 9 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/s0960-894x(03)00525-0
CHEMBL268258 97180 5 None -5 9 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1016/s0960-894x(03)00525-0
9928332 97180 5 None -5 9 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1021/jm049619s
CHEMBL268258 97180 5 None -5 9 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 349 6 0 3 5.0 COc1cccc2c1CCC[C@H]2CN(C)CCc1ccc2ccoc2c1 10.1021/jm049619s
49781008 17250 0 None 3 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 3 1 2 3.3 CC(C)O[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256608 17250 0 None 3 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 3 1 2 3.3 CC(C)O[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
16090596 82291 0 None -158 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2c(C)cccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217177 82291 0 None -158 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2c(C)cccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
16090598 82455 0 None -8 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cccc(Cl)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217568 82455 0 None -8 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cccc(Cl)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
5280953 97362 109 None -1 8 Human 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 212 1 1 2 3.0 COc1ccc2c(c1)[nH]c1c(C)nccc12 10.1016/j.bmcl.2003.09.027
CHEMBL269538 97362 109 None -1 8 Human 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 212 1 1 2 3.0 COc1ccc2c(c1)[nH]c1c(C)nccc12 10.1016/j.bmcl.2003.09.027
136680386 207703 0 None -234 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44328801 207703 0 None -234 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95578 207703 0 None -234 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
1343 1889 62 None -91 9 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1889 62 None -91 9 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1889 62 None -91 9 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1889 62 None -91 9 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1889 62 None -91 9 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
7000 54744 99 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 123 1 1 2 1.3 COc1ccccc1N nan
CHEMBL1612004 54744 99 None - 1 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 123 1 1 2 1.3 COc1ccccc1N nan
11140033 20683 0 None -12 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL130884 20683 0 None -12 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 265 4 2 3 3.2 CC(Nc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
16090595 141401 0 None -138 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL383978 141401 0 None -138 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
135418497 63039 0 None -501 4 Human 6.9 pKi = 6.9 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL1788222 63039 0 None -501 4 Human 6.9 pKi = 6.9 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
1268096 16165 26 None -4 4 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL122404 16165 26 None -4 4 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]12 10.1021/jm00019a001
9809007 172564 8 None -1047 6 Human 5.9 pKi = 5.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL448620 172564 8 None -1047 6 Human 5.9 pKi = 5.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
21392988 204817 4 None 1 3 Human 4.9 pKi = 4.9 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 156 0 0 4 -0.3 C1COC(N2CCOCC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL75201 204817 4 None 1 3 Human 4.9 pKi = 4.9 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 156 0 0 4 -0.3 C1COC(N2CCOCC2)=N1 10.1016/0960-894X(94)85032-1
134551 358 27 None -7 21 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 358 27 None -7 21 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 358 27 None -7 21 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 358 27 None -7 21 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
2726 919 68 None -8 72 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 919 68 None -8 72 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 919 68 None -8 72 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 919 68 None -8 72 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 919 68 None -8 72 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
2389 3331 118 None -104 67 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3331 118 None -104 67 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3331 118 None -104 67 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3331 118 None -104 67 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3331 118 None -104 67 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
196129 67798 17 None -15 15 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67798 17 None -15 15 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
136019934 144530 0 None -12 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 144530 0 None -12 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
44324887 165015 0 None -15 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL422597 165015 0 None -15 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
10398419 116641 0 None -13 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CCC1(CN=CN1)C2 10.1021/jm00020a021
CHEMBL336970 116641 0 None -13 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CCC1(CN=CN1)C2 10.1021/jm00020a021
3072540 82415 13 None -32 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 382 4 1 4 5.3 CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1 10.1021/jm060262x
CHEMBL217366 82415 13 None -32 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 382 4 1 4 5.3 CCN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1 10.1021/jm060262x
9794524 204843 2 None -38 3 Rat 5.9 pKi = 5.9 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 225 2 2 4 2.4 Cc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
CHEMBL75491 204843 2 None -38 3 Rat 5.9 pKi = 5.9 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 225 2 2 4 2.4 Cc1c(Nc2ncc[nH]2)ccc2nccnc12 10.1021/jm9605142
24906160 169456 0 None -1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 247 5 1 5 1.4 CO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL442815 169456 0 None -1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 247 5 1 5 1.4 CO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
55245 18580 81 None -3 3 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 429 2 1 3 5.4 CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C nan
CHEMBL1276308 18580 81 None -3 3 Human 4.9 pKi = 4.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 429 2 1 3 5.4 CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C nan
101333429 117076 0 None -3090 6 Human 5.9 pKi = 5.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
CHEMBL3392247 117076 0 None -3090 6 Human 5.9 pKi = 5.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
44421258 84746 0 None -3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL1204386 84746 0 None -3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL222933 84746 0 None -3 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
441383 20333 57 None -4 16 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20333 57 None -4 16 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
10651654 111483 0 None -676 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
CHEMBL327712 111483 0 None -676 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
10674896 206644 0 None -691 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
CHEMBL89243 206644 0 None -691 6 Human 5.9 pKi = 5.9 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
50898777 56440 0 None -11748 8 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2B adrenergic receptorBinding affinity to alpha2B adrenergic receptor
ChEMBL 441 9 1 6 3.6 COC(=O)CCCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1 10.1016/j.bmc.2010.10.011
CHEMBL1632158 56440 0 None -11748 8 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha2B adrenergic receptorBinding affinity to alpha2B adrenergic receptor
ChEMBL 441 9 1 6 3.6 COC(=O)CCCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1 10.1016/j.bmc.2010.10.011
11043720 92172 0 None -6 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL242265 92172 0 None -6 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
11043720 92172 0 None -6 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL242265 92172 0 None -6 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
10473701 83238 0 None -234 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 360 3 1 4 4.8 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)(C)C2)cc1 10.1021/jm060262x
CHEMBL218679 83238 0 None -234 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 360 3 1 4 4.8 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)(C)C2)cc1 10.1021/jm060262x
73349361 92548 0 None -1 7 Human 5.9 pKi = 5.9 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 279 4 0 1 3.3 CN(CCc1ccccc1)[C@H]1C2C3CC4C5C3CC2C5C41 10.1016/j.bmc.2013.07.045
CHEMBL2432058 92548 0 None -1 7 Human 5.9 pKi = 5.9 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 279 4 0 1 3.3 CN(CCc1ccccc1)[C@H]1C2C3CC4C5C3CC2C5C41 10.1016/j.bmc.2013.07.045
10044968 96545 0 None -85 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL262901 96545 0 None -85 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
10326069 39296 1 None -72 9 Human 5.9 pKi = 5.9 Binding
Binding affinity for recombinant human Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand.Binding affinity for recombinant human Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand.
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39296 1 None -72 9 Human 5.9 pKi = 5.9 Binding
Binding affinity for recombinant human Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand.Binding affinity for recombinant human Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand.
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
4209 3163 75 None -309 33 Human 7.9 pKi = 7.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
4893 3163 75 None -309 33 Human 7.9 pKi = 7.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
503 3163 75 None -309 33 Human 7.9 pKi = 7.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
5385 3163 75 None -309 33 Human 7.9 pKi = 7.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
CHEMBL2 3163 75 None -309 33 Human 7.9 pKi = 7.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
DB00457 3163 75 None -309 33 Human 7.9 pKi = 7.9 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
1212 1662 50 None -38 65 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1662 50 None -38 65 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1662 50 None -38 65 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1662 50 None -38 65 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1662 50 None -38 65 Human 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
10527469 156265 3 None -28 15 Rat 7.9 pKi = 7.9 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 156265 3 None -28 15 Rat 7.9 pKi = 7.9 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
11203101 71683 0 None -1995 3 Human 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-2b adrenergic receptorIn vitro binding affinity towards alpha-2b adrenergic receptor
ChEMBL 515 7 3 5 4.1 O=C(CCCNC(=O)[C@@H]1C2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)OCc1ccccc1 10.1016/j.bmcl.2005.03.116
CHEMBL196451 71683 0 None -1995 3 Human 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-2b adrenergic receptorIn vitro binding affinity towards alpha-2b adrenergic receptor
ChEMBL 515 7 3 5 4.1 O=C(CCCNC(=O)[C@@H]1C2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O)OCc1ccccc1 10.1016/j.bmcl.2005.03.116
57399145 71184 0 None -13 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 234 5 1 4 1.9 CCOc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956196 71184 0 None -13 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 234 5 1 4 1.9 CCOc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
12699315 76298 0 None 1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 243 1 2 3 2.8 CC1CNC(Nc2c(Cl)cccc2Cl)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058631 76298 0 None 1 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 243 1 2 3 2.8 CC1CNC(Nc2c(Cl)cccc2Cl)=N1 10.1016/j.bmc.2012.06.008
1042 1581 23 None -47 17 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
148 1581 23 None -47 17 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
443884 1581 23 None -47 17 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
CHEMBL119443 1581 23 None -47 17 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
DB01253 1581 23 None -47 17 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C nan
16090594 82125 0 None -15 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL216674 82125 0 None -15 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
4209 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4011 82408 49 None -16 24 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 82408 49 None -16 24 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
10045713 166105 0 None -575 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 386 3 1 4 5.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN4CCCCC4C3)cc2)c1C 10.1021/jm060262x
CHEMBL425983 166105 0 None -575 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 386 3 1 4 5.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN4CCCCC4C3)cc2)c1C 10.1021/jm060262x
10350094 13817 0 None -77 2 Human 6.9 pKi = 6.9 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1195716 13817 0 None -77 2 Human 6.9 pKi = 6.9 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL555190 13817 0 None -77 2 Human 6.9 pKi = 6.9 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 746 8 6 6 5.4 O=C(NCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
36811 1454 37 None -4 7 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 1454 37 None -4 7 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 1454 37 None -4 7 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 1454 37 None -4 7 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 1454 37 None -4 7 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
44438168 93818 0 None -389 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL247665 93818 0 None -389 3 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 10.1016/j.bmcl.2006.12.094
3236 67609 43 None -1 2 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 259 5 0 2 3.6 CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 nan
CHEMBL1902981 67609 43 None -1 2 Human 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 259 5 0 2 3.6 CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 nan
5472 205818 75 None 1 3 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL1717 205818 75 None 1 3 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
CHEMBL833 205818 75 None 1 3 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 nan
44424855 85454 0 None -1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85454 0 None -1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
44324765 111568 0 None -7 5 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328114 111568 0 None -7 5 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324972 163372 0 None -70 4 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL419316 163372 0 None -70 4 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324737 207238 0 None -12 5 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL92860 207238 0 None -12 5 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324765 111568 0 None -7 5 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL328114 111568 0 None -7 5 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
44324972 163372 0 None -70 4 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL419316 163372 0 None -70 4 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
44324737 207238 0 None -12 5 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL92860 207238 0 None -12 5 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1021/jm049619s
518 3612 1 None 1 6 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
9839317 3612 1 None 1 6 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
CHEMBL123138 3612 1 None 1 6 Human 7.9 pKi = 7.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
25110718 193309 0 None -16 3 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL524153 193309 0 None -16 3 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(C[C@H]2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
441975 16451 56 None -2 3 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL123325 16451 56 None -2 3 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 352 1 1 4 3.2 COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
599482 202984 9 None -1 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity at alpha 2B adrenergic receptor of rat.Binding affinity at alpha 2B adrenergic receptor of rat.
ChEMBL 202 1 2 2 1.8 COc1ccc2c3c([nH]c2c1)CNCC3 10.1016/j.bmcl.2003.11.078
CHEMBL6310 202984 9 None -1 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity at alpha 2B adrenergic receptor of rat.Binding affinity at alpha 2B adrenergic receptor of rat.
ChEMBL 202 1 2 2 1.8 COc1ccc2c3c([nH]c2c1)CNCC3 10.1016/j.bmcl.2003.11.078
599482 202984 9 None 1 5 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 202 1 2 2 1.8 COc1ccc2c3c([nH]c2c1)CNCC3 10.1016/j.bmcl.2003.09.027
CHEMBL6310 202984 9 None 1 5 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 202 1 2 2 1.8 COc1ccc2c3c([nH]c2c1)CNCC3 10.1016/j.bmcl.2003.09.027
9816048 187278 0 None -14 3 Rat 6.9 pKi = 6.9 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 231 1 4 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCN2 10.1021/jm960359r
CHEMBL49284 187278 0 None -14 3 Rat 6.9 pKi = 6.9 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 231 1 4 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCN2 10.1021/jm960359r
9816063 103074 0 None -10 6 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
CHEMBL30739 103074 0 None -10 6 Human 6.9 pKi = 6.9 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm990569e
9816063 103074 0 None -10 6 Rat 6.9 pKi = 6.9 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
CHEMBL30739 103074 0 None -10 6 Rat 6.9 pKi = 6.9 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 232 1 1 2 3.6 Cc1sc(C)c2c1CCCC2c1c[nH]cn1 10.1021/jm000128r
9971924 184226 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL48341 184226 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 298 5 1 3 3.4 c1ccc(CCC[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
122295 9868 7 None -4 9 Human 6.9 pKi = 6.9 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
CHEMBL114166 9868 7 None -4 9 Human 6.9 pKi = 6.9 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00018a001
26987 949 33 None -281 21 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 949 33 None -281 21 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 949 33 None -281 21 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 949 33 None -281 21 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 949 33 None -281 21 Human 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
122295 9868 7 None -4 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
CHEMBL114166 9868 7 None -4 9 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
56645363 121490 12 None -2 4 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRA2B
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
CHEMBL3582478 121490 12 None -2 4 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000313b ADRA2B
ChEMBL 311 3 1 4 3.8 CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1 10.6019/CHEMBL5212743
49781005 17214 0 None -3 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17214 0 None -3 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
132060720 162489 0 None -3 9 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 315 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
CHEMBL4167315 162489 0 None -3 9 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 315 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
9827677 168422 0 None -724 7 Human 6.8 pKi = 6.8 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43491 168422 0 None -724 7 Human 6.8 pKi = 6.8 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
3038525 13549 114 None -3 3 Human 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
CHEMBL119385 13549 114 None -3 3 Human 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 435 3 0 5 5.5 O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl nan
3117 207841 103 None -2 16 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 207841 103 None -2 16 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
16090630 83237 0 None -389 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 390 4 2 5 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)(C)C3)cc2)c1CO 10.1021/jm060262x
CHEMBL218675 83237 0 None -389 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 390 4 2 5 4.3 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)(C)C3)cc2)c1CO 10.1021/jm060262x
102 4127 48 None -10 49 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
3659 4127 48 None -10 49 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
8969 4127 48 None -10 49 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
CHEMBL15245 4127 48 None -10 49 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
DB01392 4127 48 None -10 49 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2006.12.094
44324800 206948 0 None -22 7 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91157 206948 0 None -22 7 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
10946567 16469 0 None -12 6 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL123448 16469 0 None -12 6 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
44579272 187095 0 None -5 3 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491420 187095 0 None -5 3 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 499 7 0 9 4.3 c1ccc(Oc2ncccc2-c2noc(CN3CCCN(CC4COc5ccccc5O4)CC3)n2)cc1 10.1016/j.bmcl.2008.08.055
3930 2151 43 None -53 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
540335 2151 43 None -53 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
CHEMBL106525 2151 43 None -53 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 368 3 1 4 4.9 CN1CCN(CC1)c1ccc(cc1)Nc1c2ccccc2nc2c1cccc2 10.1021/jm060262x
10490084 204958 1 None -7 3 Rat 5.8 pKi = 5.8 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 237 2 2 2 2.9 Brc1ccccc1Nc1ncc[nH]1 10.1021/jm9605142
CHEMBL76457 204958 1 None -7 3 Rat 5.8 pKi = 5.8 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 237 2 2 2 2.9 Brc1ccccc1Nc1ncc[nH]1 10.1021/jm9605142
12114850 13248 0 None -57 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1191424 13248 0 None -57 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL542520 13248 0 None -57 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 704 5 6 6 4.2 O=C(NCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
10841190 107042 0 None -213 6 Human 5.8 pKi = 5.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
CHEMBL315538 107042 0 None -213 6 Human 5.8 pKi = 5.8 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
4098 32505 30 None -23 11 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1255739 32505 30 None -23 11 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
CHEMBL1411979 32505 30 None -23 11 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 nan
10081626 21095 0 None -12 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 204 0 1 2 1.7 Fc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL131220 21095 0 None -12 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 204 0 1 2 1.7 Fc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
44438166 93817 0 None -371 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL247664 93817 0 None -371 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 10.1016/j.bmcl.2006.12.094
9906978 42711 2 None -125 12 Human 5.8 pKi = 5.8 Binding
Binding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42711 2 None -125 12 Human 5.8 pKi = 5.8 Binding
Binding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
11221758 84617 0 None -8 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccccc1[N+](=O)[O-])C1=NCCN1 10.1021/jm0408215
CHEMBL222138 84617 0 None -8 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccccc1[N+](=O)[O-])C1=NCCN1 10.1021/jm0408215
122442272 138348 0 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to human alpha-2B adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2B adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3769968 138348 0 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to human alpha-2B adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2B adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3771384 138348 0 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to human alpha-2B adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2B adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
118717249 115125 0 None -2 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
CHEMBL3343700 115125 0 None -2 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1cccc2cnn(N=C3NCCN3)c12 10.1016/j.ejmech.2014.09.083
44269140 33553 0 None -19 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 248 5 1 4 2.2 CC(C)Oc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL14208 33553 0 None -19 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 248 5 1 4 2.2 CC(C)Oc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
16757182 153251 0 None -21 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL397753 153251 0 None -21 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
16757182 153251 0 None -21 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL397753 153251 0 None -21 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
10262765 116555 0 None -13 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CCC1(CN=CN1)C2 10.1021/jm00020a021
CHEMBL336332 116555 0 None -13 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CCC1(CN=CN1)C2 10.1021/jm00020a021
31101 729 40 None -33 36 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 729 40 None -33 36 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 729 40 None -33 36 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 729 40 None -33 36 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 729 40 None -33 36 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
44324906 206787 0 None -31 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)OCC1C2=NOC1CN1CCN(C/C=C/c2ccccc2)CC1 10.1016/s0960-894x(03)00525-0
CHEMBL90247 206787 0 None -31 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 419 6 0 6 3.1 COc1ccc2c(c1)OCC1C2=NOC1CN1CCN(C/C=C/c2ccccc2)CC1 10.1016/s0960-894x(03)00525-0
123981 16459 22 None -8 8 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL123349 16459 22 None -8 8 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL536803 16459 22 None -8 8 Human 7.8 pKi = 7.8 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
11750482 147421 0 None -19 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392991 147421 0 None -19 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 10.1016/j.bmcl.2006.12.094
3303 2244 46 None -234 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2B adrenergic receptor (unknown origin)Inhibition of alpha2B adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
5311200 2244 46 None -234 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2B adrenergic receptor (unknown origin)Inhibition of alpha2B adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
CHEMBL267014 2244 46 None -234 15 Human 6.8 pKi = 6.8 Binding
Inhibition of alpha2B adrenergic receptor (unknown origin)Inhibition of alpha2B adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
2803 955 58 None -1 19 Rat 6.8 pKi = 6.8 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
516 955 58 None -1 19 Rat 6.8 pKi = 6.8 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
704 955 58 None -1 19 Rat 6.8 pKi = 6.8 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
CHEMBL134 955 58 None -1 19 Rat 6.8 pKi = 6.8 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
DB00575 955 58 None -1 19 Rat 6.8 pKi = 6.8 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm000128r
CHEMBL5273955 193788 0 None 1 2 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]RX821002 from human alpha2B receptor stably expressed in HEK293T cells by Cheng-Prusoff equation analysisDisplacement of [3H]RX821002 from human alpha2B receptor stably expressed in HEK293T cells by Cheng-Prusoff equation analysis
ChEMBL 305 3 2 2 4.1 C#Cc1cc(Nc2ccccc2C(=O)O)cc(C(F)(F)F)c1 10.1021/acs.jmedchem.2c01997
1016 3747 78 None -18 35 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3747 78 None -18 35 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3747 78 None -18 35 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3747 78 None -18 35 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3747 78 None -18 35 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3747 78 None -18 35 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
44424855 85454 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85454 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
44288945 168915 0 None -407 7 Human 6.8 pKi = 6.8 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43860 168915 0 None -407 7 Human 6.8 pKi = 6.8 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
11000184 13052 0 None -37 6 Human 5.8 pKi = 5.8 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 13052 0 None -37 6 Human 5.8 pKi = 5.8 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 13052 0 None -37 6 Human 5.8 pKi = 5.8 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
57395663 71181 0 None -8 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 258 3 1 3 2.5 CC(Oc1ccccc1C(F)(F)F)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956193 71181 0 None -8 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 258 3 1 3 2.5 CC(Oc1ccccc1C(F)(F)F)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL4576555 214017 5 None -1 19 Human 5.8 pKi = 5.8 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL4507307
5318 15576 49 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1200348 15576 49 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1221 15576 49 None -1 13 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
4189 206922 96 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1559 206922 96 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL91 206922 96 None -18 34 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL4576555 214017 5 None -1 19 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA2B
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL5212743
CHEMBL4576555 214017 5 None -1 19 Human 5.8 pKi = 5.8 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL4507307
44269122 98109 2 None -6 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL273485 98109 2 None -6 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm800250z
45487144 197701 0 None -6 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.7 CC(OC1=NCCN1)c1ccccc1 10.1021/jm901262f
CHEMBL571314 197701 0 None -6 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.7 CC(OC1=NCCN1)c1ccccc1 10.1021/jm901262f
44269122 98109 2 None -6 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL273485 98109 2 None -6 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 190 3 1 3 1.5 CC(Oc1ccccc1)C1=NCCN1 10.1021/jm100977d
11034737 204528 0 None -8 6 Human 5.8 pKi = 5.8 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 204528 0 None -8 6 Human 5.8 pKi = 5.8 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
24906202 187217 0 None -5 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
CHEMBL492444 187217 0 None -5 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2ccc3c(c2)OCC(C2=NCCN2)O3)cc1 10.1021/jm800250z
10123375 13250 0 None -123 2 Human 6.8 pKi = 6.8 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1191431 13250 0 None -123 2 Human 6.8 pKi = 6.8 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL542527 13250 0 None -123 2 Human 6.8 pKi = 6.8 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 760 9 6 6 5.8 O=C(NCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
5353853 17986 47 None -17 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
9556529 17986 47 None -17 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
CHEMBL1262 17986 47 None -17 15 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 nan
16090600 169181 0 None -16 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 360 6 2 4 5.1 Cc1nc2ccccc2c(Nc2ccc(NCCN3CCCC3)cc2)c1C 10.1021/jm060262x
CHEMBL440594 169181 0 None -16 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 360 6 2 4 5.1 Cc1nc2ccccc2c(Nc2ccc(NCCN3CCCC3)cc2)c1C 10.1021/jm060262x
2351 3286 64 None -15 21 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3286 64 None -15 21 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3286 64 None -15 21 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3286 64 None -15 21 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3286 64 None -15 21 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
9894665 103813 1 None -512 8 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligandBinding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL309106 103813 1 None -512 8 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligandBinding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
127036932 137348 0 None -5 22 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752900 137348 0 None -5 22 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
131801156 157155 14 None -77 5 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000316b ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000316b ADRA2B
ChEMBL 417 5 2 6 4.4 O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1 10.6019/CHEMBL5212743
132486799 157155 14 None -77 5 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000316b ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000316b ADRA2B
ChEMBL 417 5 2 6 4.4 O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1 10.6019/CHEMBL5212743
CHEMBL4075278 157155 14 None -77 5 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000316b ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000316b ADRA2B
ChEMBL 417 5 2 6 4.4 O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1 10.6019/CHEMBL5212743
9926529 9389 2 None -25 4 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111496 9389 2 None -25 4 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
185076 187090 5 None -4 7 Rat 7.8 pKi = 7.8 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm960359r
CHEMBL49137 187090 5 None -4 7 Rat 7.8 pKi = 7.8 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm960359r
277 1301 62 None -13 50 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1301 62 None -13 50 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1301 62 None -13 50 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1301 62 None -13 50 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1301 62 None -13 50 Human 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
185076 187090 5 None -4 7 Rat 7.8 pKi = 7.8 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm9605142
CHEMBL49137 187090 5 None -4 7 Rat 7.8 pKi = 7.8 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1021/jm9605142
44579231 181567 0 None -1 3 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 396 6 1 6 1.7 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1 10.1016/j.bmcl.2008.08.055
CHEMBL476774 181567 0 None -1 3 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 396 6 1 6 1.7 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1 10.1016/j.bmcl.2008.08.055
10070896 83196 0 None -338 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 422 4 1 4 6.1 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1-c1ccccc1 10.1021/jm060262x
CHEMBL218457 83196 0 None -338 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 422 4 1 4 6.1 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1-c1ccccc1 10.1021/jm060262x
26757 207978 31 None 1 2 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
CHEMBL972 207978 31 None 1 2 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 nan
155545843 173481 0 None -13 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assayDisplacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assay
ChEMBL 399 3 2 5 4.7 Clc1cccc(CNc2nc(C#Cc3ccc(Cl)s3)nc3[nH]cnc23)c1 10.1039/C8MD00317C
CHEMBL4530091 173481 0 None -13 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assayDisplacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assay
ChEMBL 399 3 2 5 4.7 Clc1cccc(CNc2nc(C#Cc3ccc(Cl)s3)nc3[nH]cnc23)c1 10.1039/C8MD00317C
44312037 204619 1 None -1 6 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73392 204619 1 None -1 6 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
100 3805 58 None -35 55 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3805 58 None -35 55 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3805 58 None -35 55 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3805 58 None -35 55 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3805 58 None -35 55 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
10475736 165863 0 None -34 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 394 4 2 5 4.1 CN1CCN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL424917 165863 0 None -34 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 394 4 2 5 4.1 CN1CCN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CC1(C)C 10.1021/jm060262x
2247 505 81 None -57 42 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 505 81 None -57 42 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 505 81 None -57 42 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 505 81 None -57 42 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 505 81 None -57 42 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2541 786 120 None -2691 6 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
587 786 120 None -2691 6 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
6907 786 120 None -2691 6 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
CHEMBL1016 786 120 None -2691 6 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
DB00796 786 120 None -2691 6 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
DB13919 786 120 None -2691 6 Human 5.8 pKi = 5.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 440 7 2 7 4.0 CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O nan
44288877 168599 0 None -251 5 Human 5.8 pKi = 5.8 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43594 168599 0 None -251 5 Human 5.8 pKi = 5.8 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
16090632 141716 0 None -87 3 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 348 4 3 5 3.3 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1 10.1021/jm060262x
CHEMBL385722 141716 0 None -87 3 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 348 4 3 5 3.3 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1 10.1021/jm060262x
213 3853 55 None -3 44 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3853 55 None -3 44 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3853 55 None -3 44 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3853 55 None -3 44 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3853 55 None -3 44 Human 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
114697 3687 4 None 1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
513 3687 4 None 1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
CHEMBL101340 3687 4 None 1 3 Rat 6.8 pKi = 6.8 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 263 1 2 3 2.7 Clc1ccc(cc1NC1=NCCN1)C(F)(F)F 10.1021/jm00020a021
9883506 70564 0 None -1 6 Human 7.8 pKi = 7.8 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL194849 70564 0 None -1 6 Human 7.8 pKi = 7.8 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
44371848 13625 0 None -15 2 Human 7.7 pKi = 7.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1194334 13625 0 None -15 2 Human 7.7 pKi = 7.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL551711 13625 0 None -15 2 Human 7.7 pKi = 7.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 845 15 6 6 8.1 O=C(NCCCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
10056237 13744 0 None -47 2 Human 7.7 pKi = 7.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1195197 13744 0 None -47 2 Human 7.7 pKi = 7.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL554019 13744 0 None -47 2 Human 7.7 pKi = 7.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 817 13 6 6 7.3 O=C(NCCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
16090601 82392 0 None -199 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1c(CO)nc2ccccc2c1Nc1ccc(N2CCN(C)[C@H](C)C2)cc1 10.1021/jm060262x
CHEMBL217254 82392 0 None -199 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 376 4 2 5 3.9 Cc1c(CO)nc2ccccc2c1Nc1ccc(N2CCN(C)[C@H](C)C2)cc1 10.1021/jm060262x
6075 150108 42 None -6 16 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 150108 42 None -6 16 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
44371755 48777 0 None -15 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL155866 48777 0 None -15 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 218 3 1 3 2.1 Cc1cccc(C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
10508132 107017 0 None -30 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
CHEMBL315392 107017 0 None -30 6 Human 5.7 pKi = 5.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
44311789 204735 0 None -1 5 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL74342 204735 0 None -1 5 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL4566600 214014 0 None 1 6 Human 5.7 pKi = 5.7 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000337aCl ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000337aCl ADRA2B
ChEMBL None None None Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12 10.6019/CHEMBL5212743
CHEMBL4745071 214014 0 None 1 6 Human 5.7 pKi = 5.7 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000337aCl ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000337aCl ADRA2B
ChEMBL None None None Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12 10.6019/CHEMBL5212743
9879119 9446 0 None -8 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111771 9446 0 None -8 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
43260 5482 65 None -1 4 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
CHEMBL1076 5482 65 None -1 4 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
12114851 13041 0 None -12 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189965 13041 0 None -12 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL539824 13041 0 None -12 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 732 7 6 6 5.0 O=C(NCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
23622576 172772 0 None -2 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL451229 172772 0 None -2 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 272 4 1 3 3.5 CC(Oc1ccccc1C1CCCCC1)C1=NCCN1 10.1021/jm800250z
24906199 187665 15 None -7 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL495096 187665 15 None -7 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 258 4 1 3 3.1 CC(Oc1ccccc1C1CCCC1)C1=NCCN1 10.1021/jm800250z
CHEMBL5274312 193809 0 None -1 5 Human 5.7 pKi = 5.7 Binding
Binding affinity to adrenergic alpha 2b receptor (unknown origin)Binding affinity to adrenergic alpha 2b receptor (unknown origin)
ChEMBL 383 4 0 3 5.0 CC[Si](C#Cc1cccc2c1OC(C(F)(F)F)C([N+](=O)[O-])=C2)(CC)CC 10.1016/j.bmcl.2022.128981
10474679 97177 0 None -295 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 376 4 2 5 4.0 CN1CCN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL268217 97177 0 None -295 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 376 4 2 5 4.0 CN1CCN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CC1(C)C 10.1021/jm060262x
135398745 2914 112 None -37 65 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2914 112 None -37 65 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2914 112 None -37 65 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2914 112 None -37 65 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
44579184 190953 4 None -2 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL518592 190953 4 None -2 3 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 340 4 0 5 2.7 COc1ccccc1N1CCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
3584 3777 64 None -21 13 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3777 64 None -21 13 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3777 64 None -21 13 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3777 64 None -21 13 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3777 64 None -21 13 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
10579368 106004 0 None 1 6 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL313251 106004 0 None 1 6 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
75306277 109254 0 None -99 23 Human 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
CHEMBL3217984 109254 0 None -99 23 Human 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
44421258 84746 0 None -3 3 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL1204386 84746 0 None -3 3 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL222933 84746 0 None -3 3 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 264 3 1 3 2.8 c1ccc(-c2ccccc2C2OC2C2=NCCN2)cc1 10.1021/jm0408215
44324937 206913 0 None -2 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1 10.1016/s0960-894x(03)00525-0
CHEMBL90943 206913 0 None -2 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 389 5 0 5 3.1 C(=C/c1ccccc1)\CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1 10.1016/s0960-894x(03)00525-0
102 4127 48 None -10 49 Rat 8.7 pKi = 8.7 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
3659 4127 48 None -10 49 Rat 8.7 pKi = 8.7 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
8969 4127 48 None -10 49 Rat 8.7 pKi = 8.7 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
CHEMBL15245 4127 48 None -10 49 Rat 8.7 pKi = 8.7 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
DB01392 4127 48 None -10 49 Rat 8.7 pKi = 8.7 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm990277d
102 4127 48 None -10 49 Human 8.7 pKi = 8.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
3659 4127 48 None -10 49 Human 8.7 pKi = 8.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
8969 4127 48 None -10 49 Human 8.7 pKi = 8.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
CHEMBL15245 4127 48 None -10 49 Human 8.7 pKi = 8.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
DB01392 4127 48 None -10 49 Human 8.7 pKi = 8.7 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/s0960-894x(00)00068-8
218362 204800 5 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 204800 5 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
12576 514 94 None -7 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
71310 514 94 None -7 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
CHEMBL353972 514 94 None -7 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
DB11481 514 94 None -7 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 10.1021/jm1006269
49781224 17143 0 None -2 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.7 CCC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1255616 17143 0 None -2 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 238 3 1 1 3.7 CCC[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
49781005 17214 0 None -3 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17214 0 None -3 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
9837600 23320 0 None -12 2 Rat 7.7 pKi = 7.7 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 236 0 1 3 1.9 NC1=NC2(CCc3cccc(Cl)c3C2)CO1 10.1021/jm00020a021
CHEMBL133231 23320 0 None -12 2 Rat 7.7 pKi = 7.7 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 236 0 1 3 1.9 NC1=NC2(CCc3cccc(Cl)c3C2)CO1 10.1021/jm00020a021
16090625 82430 0 None -23 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2cccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL217452 82430 0 None -23 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1nc2cccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
10651080 105942 0 None -23 6 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL312871 105942 0 None -23 6 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
9817231 158236 22 None -2 7 Human 4.7 pKi = 4.7 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 282 4 0 3 4.1 CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1 10.1038/s41586-020-2286-9
CHEMBL4088272 158236 22 None -2 7 Human 4.7 pKi = 4.7 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 282 4 0 3 4.1 CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1 10.1038/s41586-020-2286-9
44438165 166784 0 None -223 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL428407 166784 0 None -223 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 10.1016/j.bmcl.2006.12.094
57402718 71189 2 None -1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956201 71189 2 None -1 3 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 218 4 1 4 1.3 CC(Oc1ccccc1C=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
16655023 107441 2 None -5 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 107441 2 None -5 7 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
150 2509 21 None -27 16 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
1764 2509 21 None -27 16 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
8226 2509 21 None -27 16 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
CHEMBL1201356 2509 21 None -27 16 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
DB00353 2509 21 None -27 16 Human 6.7 pKi = 6.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO nan
1210 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
1213 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
2725 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
33036 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
4411 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
616 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
6976 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
716121 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1201353 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL1554789 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
CHEMBL505 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
DB01114 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
DB13679 918 51 None -234 21 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C nan
11360447 85001 0 None -12 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
CHEMBL223829 85001 0 None -12 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1cccs1)C1=NCCN1 10.1021/jm0408215
134 2514 24 None -93 67 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
1775 2514 24 None -93 67 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
9681 2514 24 None -93 67 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
CHEMBL1065 2514 24 None -93 67 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
DB00247 2514 24 None -93 67 Human 5.7 pKi = 5.7 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO nan
9828476 206924 0 None -954 6 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91022 206924 0 None -954 6 Human 6.7 pKi = 6.7 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10198248 187449 40 None 1 6 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL49395 187449 40 None 1 6 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
127026052 137553 0 None -13 19 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754496 137553 0 None -13 19 Human 6.7 pKi = 6.7 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
73213195 104459 0 None -75 12 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104092 104459 0 None -75 12 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
73213195 104459 0 None -75 12 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104092 104459 0 None -75 12 Human 5.7 pKi = 5.7 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.6 CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1 10.1016/j.bmcl.2013.12.024
11347303 111380 0 None 1 4 Rat 7.7 pKi = 7.7 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL327116 111380 0 None 1 4 Rat 7.7 pKi = 7.7 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
44292381 101394 0 None -1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 244 2 1 3 2.7 c1ccc([C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL297228 101394 0 None -1 3 Human 7.7 pKi = 7.7 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 244 2 1 3 2.7 c1ccc([C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
12575 1988 30 None -53 17 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
54459 1988 30 None -53 17 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
CHEMBL10316 1988 30 None -53 17 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm800250z
12575 1988 30 None -53 17 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
54459 1988 30 None -53 17 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
CHEMBL10316 1988 30 None -53 17 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/j.bmc.2012.02.016
9795515 204820 0 None -44 3 Rat 6.7 pKi = 6.7 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 273 3 2 3 4.1 COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C 10.1021/jm9605142
CHEMBL75257 204820 0 None -44 3 Rat 6.7 pKi = 6.7 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 273 3 2 3 4.1 COc1c(C(C)(C)C)cc(C)c(Nc2ncc[nH]2)c1C 10.1021/jm9605142
132060776 162402 0 None -7 16 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
CHEMBL4165863 162402 0 None -7 16 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
15853467 208134 0 None -69 6 Human 6.6 pKi = 6.6 Binding
Binding affinity against human Alpha-2B adrenergic receptorBinding affinity against human Alpha-2B adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
CHEMBL98063 208134 0 None -69 6 Human 6.6 pKi = 6.6 Binding
Binding affinity against human Alpha-2B adrenergic receptorBinding affinity against human Alpha-2B adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
127036953 137515 0 None -22 22 Human 6.6 pKi = 6.6 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754166 137515 0 None -22 22 Human 6.6 pKi = 6.6 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
10793665 106952 0 None -1288 6 Human 5.6 pKi = 5.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
CHEMBL314960 106952 0 None -1288 6 Human 5.6 pKi = 5.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
10220053 206920 0 None -3 3 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1016/s0960-894x(03)00525-0
CHEMBL90997 206920 0 None -3 3 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1016/s0960-894x(03)00525-0
10220053 206920 0 None -3 3 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1021/jm049619s
CHEMBL90997 206920 0 None -3 3 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 218 2 1 2 1.9 Fc1ccc2c(c1)CC(CC1CN=CN1)C2 10.1021/jm049619s
49781004 17213 0 None -2 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256502 17213 0 None -2 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1c[nH]cn1 10.1021/jm1006269
10859076 13682 0 None -40 6 Human 5.6 pKi = 5.6 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13682 0 None -40 6 Human 5.6 pKi = 5.6 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13682 0 None -40 6 Human 5.6 pKi = 5.6 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
44329026 208425 0 None -46 6 Human 6.6 pKi = 6.6 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL99864 208425 0 None -46 6 Human 6.6 pKi = 6.6 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
21830793 91835 10 None -1584 45 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin)Binding affinity to adrenergic alpha2B receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
CHEMBL2413154 91835 10 None -1584 45 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin)Binding affinity to adrenergic alpha2B receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
135 2532 43 None -8 58 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2532 43 None -8 58 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2532 43 None -8 58 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2532 43 None -8 58 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2532 43 None -8 58 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
2286 3183 51 None -4 30 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3183 51 None -4 30 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3183 51 None -4 30 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3183 51 None -4 30 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3183 51 None -4 30 Human 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
44456400 12834 0 None 1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL1188501 12834 0 None 1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL2436555 12834 0 None 1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL536539 12834 0 None 1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
132060763 162861 0 None -9 8 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 405 5 0 4 4.1 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)CC3)CC1 10.1016/j.ejmech.2018.02.024
CHEMBL4173095 162861 0 None -9 8 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 405 5 0 4 4.1 C=C(C)CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)CC3)CC1 10.1016/j.ejmech.2018.02.024
4038180 204 14 None -23 7 Rat 6.6 pKi = 6.6 Binding
Binding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lungBinding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lung
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 204 14 None -23 7 Rat 6.6 pKi = 6.6 Binding
Binding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lungBinding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lung
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 204 14 None -23 7 Rat 6.6 pKi = 6.6 Binding
Binding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lungBinding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lung
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
44456400 12834 0 None 1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL1188501 12834 0 None 1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL2436555 12834 0 None 1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
CHEMBL536539 12834 0 None 1 10 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysisDisplacement of [3H]Rauwolscine from human recombinant alpha2B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis
ChEMBL 181 0 2 3 1.4 NC1=Nc2ccc(Cl)cc2CN1 10.1016/j.bmcl.2013.08.072
4038180 204 14 None -23 7 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
480 204 14 None -23 7 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109783 204 14 None -23 7 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
10660 14416 58 None -67 12 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
CHEMBL1200406 14416 58 None -67 12 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 469 6 1 7 3.0 CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O nan
44424855 85454 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
CHEMBL226636 85454 0 None -1 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 467 7 0 7 3.3 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccc(F)cc4)CC3)C1CO2 10.1016/j.bmc.2007.03.053
44314200 102952 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102952 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
16090599 81545 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 360 3 1 4 5.0 Cc1nc2c(C)cccc2c(Nc2ccc(N3CCCN(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL216072 81545 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 360 3 1 4 5.0 Cc1nc2c(C)cccc2c(Nc2ccc(N3CCCN(C)C3)cc2)c1C 10.1021/jm060262x
10609673 103776 0 None -19 3 Rat 5.6 pKi = 5.6 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 233 4 2 4 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1OC 10.1021/jm9605142
CHEMBL308863 103776 0 None -19 3 Rat 5.6 pKi = 5.6 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 233 4 2 4 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1OC 10.1021/jm9605142
3561 19077 39 None -1 11 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
CHEMBL1289 19077 39 None -1 11 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl nan
250 3386 8 None -70794 12 Human 5.6 pKi = 5.6 Binding
Compound was evaluated for binding affinity against Alpha-2B adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2B adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
5311416 3386 8 None -70794 12 Human 5.6 pKi = 5.6 Binding
Compound was evaluated for binding affinity against Alpha-2B adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2B adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
CHEMBL69733 3386 8 None -70794 12 Human 5.6 pKi = 5.6 Binding
Compound was evaluated for binding affinity against Alpha-2B adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-2B adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
10337773 101585 0 None -63 10 Human 4.6 pKi = 4.6 Binding
Binding affinity against Alpha-2B adrenergic receptorBinding affinity against Alpha-2B adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL298612 101585 0 None -63 10 Human 4.6 pKi = 4.6 Binding
Binding affinity against Alpha-2B adrenergic receptorBinding affinity against Alpha-2B adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
181743 178572 5 None -125 22 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Clonidine from human adrenergic alpha2B receptorDisplacement of [3H]Clonidine from human adrenergic alpha2B receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
CHEMBL467094 178572 5 None -125 22 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]Clonidine from human adrenergic alpha2B receptorDisplacement of [3H]Clonidine from human adrenergic alpha2B receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
135559170 102060 0 None -389 7 Human 6.6 pKi = 6.6 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
CHEMBL302021 102060 0 None -389 7 Human 6.6 pKi = 6.6 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
73352414 92532 0 None -3 5 Human 5.6 pKi = 5.6 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 257 3 1 1 3.3 C1CCC(CN[C@H]2C3C4CC5C6C4CC3C6C52)CC1 10.1016/j.bmc.2013.07.045
CHEMBL2432038 92532 0 None -3 5 Human 5.6 pKi = 5.6 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 257 3 1 1 3.3 C1CCC(CN[C@H]2C3C4CC5C6C4CC3C6C52)CC1 10.1016/j.bmc.2013.07.045
136680384 207655 0 None -575 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328799 207655 0 None -575 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95290 207655 0 None -575 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
191 403 98 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 403 98 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 403 98 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 403 98 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 403 98 None -30 29 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
9895326 207027 0 None -239 6 Human 6.6 pKi = 6.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
CHEMBL91550 207027 0 None -239 6 Human 6.6 pKi = 6.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
CHEMBL4778870 214047 8 None -7 5 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None CC1CCN(c2ccnc(NCc3cn(C)cn3)n2)CC1 10.6019/CHEMBL4800732
CHEMBL4778870 214047 8 None -7 5 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None CC1CCN(c2ccnc(NCc3cn(C)cn3)n2)CC1 10.6019/CHEMBL4800732
3584 3777 64 None -21 13 Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
5401 3777 64 None -21 13 Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
7302 3777 64 None -21 13 Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
CHEMBL611 3777 64 None -21 13 Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
DB01162 3777 64 None -21 13 Human 7.6 pKi = 7.6 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
136019934 144530 0 None -12 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 144530 0 None -12 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
16090624 82401 0 None -34 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL217278 82401 0 None -34 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 3 1 4 5.0 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
16090602 82448 0 None -288 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 362 4 2 5 3.6 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1C 10.1021/jm060262x
CHEMBL217542 82448 0 None -288 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 362 4 2 5 3.6 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccccc34)cc2)CCN1C 10.1021/jm060262x
16090628 141787 0 None -309 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 4 1 4 5.3 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(N2CCCN(C)CC2)cc1 10.1021/jm060262x
CHEMBL386169 141787 0 None -309 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 4 1 4 5.3 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(N2CCCN(C)CC2)cc1 10.1021/jm060262x
49836303 18572 1 None -43 4 Human 6.6 pKi = 6.6 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276220 18572 1 None -43 4 Human 6.6 pKi = 6.6 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
49836303 18572 1 None -43 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276220 18572 1 None -43 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
162265 202274 22 None 5 43 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
4786 202274 22 None 5 43 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
CHEMBL61006 202274 22 None 5 43 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
3198 205513 76 None -24 34 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 205513 76 None -24 34 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 205513 76 None -24 34 Human 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
44371864 51141 0 None -8 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157955 51141 0 None -8 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 246 5 1 3 2.6 CCc1cccc(CC)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
11211035 85003 0 None -18 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL223836 85003 0 None -18 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm061487a
11211035 85003 0 None -18 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL223836 85003 0 None -18 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 284 4 1 3 3.3 CC(Oc1ccccc1-c1cccc(F)c1)C1=NCCN1 10.1021/jm0408215
45487089 197640 0 None -10 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 204 2 1 3 2.0 Cc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL570863 197640 0 None -10 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 204 2 1 3 2.0 Cc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
11380133 169367 0 None -9 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccncc1)C1=NCCN1 10.1021/jm0408215
CHEMBL442045 169367 0 None -9 3 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccncc1)C1=NCCN1 10.1021/jm0408215
3080926 155595 21 None -10 3 Human 4.6 pKi = 4.6 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/ml400232p
CHEMBL404505 155595 21 None -10 3 Human 4.6 pKi = 4.6 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 186 1 1 3 1.8 c1ccc2oc(C3=NCCN3)cc2c1 10.1021/ml400232p
12114852 13320 0 None -31 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1192051 13320 0 None -31 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL543232 13320 0 None -31 2 Human 7.6 pKi = 7.6 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 774 10 6 6 6.1 O=C(NCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
2353 101112 82 None 1 4 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 336 2 0 4 3.1 COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2 nan
CHEMBL12089 101112 82 None 1 4 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 336 2 0 4 3.1 COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2 nan
CHEMBL295124 101112 82 None 1 4 Human 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 336 2 0 4 3.1 COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2 nan
10176433 20648 0 None -8 2 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 186 0 1 2 1.5 C1=NCC2(CCc3ccccc3C2)N1 10.1021/jm00020a021
CHEMBL130853 20648 0 None -8 2 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 186 0 1 2 1.5 C1=NCC2(CCc3ccccc3C2)N1 10.1021/jm00020a021
9894818 98925 0 None -125 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
CHEMBL279436 98925 0 None -125 7 Human 6.6 pKi = 6.6 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
44371744 50321 0 None -16 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 270 7 1 3 2.9 C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL157206 50321 0 None -16 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 270 7 1 3 2.9 C=CCc1cccc(CC=C)c1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
499 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
44579228 181654 0 None -13 3 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
CHEMBL477608 181654 0 None -13 3 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 467 7 2 7 2.9 CC(C)(C)Nc1ncccc1C(=O)NCCN1CCCN(CC2COc3ccccc3O2)CC1 10.1016/j.bmcl.2008.08.055
102 4127 48 None -10 49 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
3659 4127 48 None -10 49 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
8969 4127 48 None -10 49 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
CHEMBL15245 4127 48 None -10 49 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
DB01392 4127 48 None -10 49 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
9894818 98925 0 None -125 7 Human 6.6 pKi = 6.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98925 0 None -125 7 Human 6.6 pKi = 6.6 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
44371745 49289 0 None -11 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 218 4 1 3 2.0 CCc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL156336 49289 0 None -11 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 218 4 1 3 2.0 CCc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
70696790 76299 0 None 1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 3 1 3 1.5 CC1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058632 76299 0 None 1 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 3 1 3 1.5 CC1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
57403508 71252 0 None 2 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 308 3 1 4 2.3 c1ccc(C2(c3ccccc3)COC(C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956905 71252 0 None 2 2 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 308 3 1 4 2.3 c1ccc(C2(c3ccccc3)COC(C3=NCCN3)CO2)cc1 10.1016/j.bmc.2012.02.016
44329027 4168 0 None -14 6 Human 6.5 pKi = 6.5 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL100045 4168 0 None -14 6 Human 6.5 pKi = 6.5 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
10436842 100256 0 None -363 7 Human 6.5 pKi = 6.5 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL288772 100256 0 None -363 7 Human 6.5 pKi = 6.5 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
2105 3054 37 None -35 33 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 3054 37 None -35 33 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 3054 37 None -35 33 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 3054 37 None -35 33 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 3054 37 None -35 33 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
127035062 136451 0 None 3 19 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha 2B receptor expressed in HEKT cells after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human recombinant alpha 2B receptor expressed in HEKT cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
CHEMBL3735756 136451 0 None 3 19 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Rauwolscine from human recombinant alpha 2B receptor expressed in HEKT cells after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human recombinant alpha 2B receptor expressed in HEKT cells after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
16090627 81567 0 None -35 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 390 9 2 4 5.9 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(NCCN(CC)CC)cc1 10.1021/jm060262x
CHEMBL216197 81567 0 None -35 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 390 9 2 4 5.9 CCc1c(C)nc2c(C)cccc2c1Nc1ccc(NCCN(CC)CC)cc1 10.1021/jm060262x
2335 11848 22 None -2 12 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
8478 11848 22 None -2 12 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL1182210 11848 22 None -2 12 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
CHEMBL221753 11848 22 None -2 12 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 nan
16090635 82515 0 None -26 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 378 4 1 4 4.7 CCc1c(C)nc2c(c1Nc1ccc(N3CCN(C)C(C)C3)cc1)CCCC2 10.1021/jm060262x
CHEMBL217768 82515 0 None -26 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 378 4 1 4 4.7 CCc1c(C)nc2c(c1Nc1ccc(N3CCN(C)C(C)C3)cc1)CCCC2 10.1021/jm060262x
132075278 162644 0 None -52 5 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 308 3 0 3 3.1 c1ccc(CN2CCc3cc(N4CCOCC4)ccc3C2)cc1 10.1016/j.ejmech.2018.02.024
CHEMBL4169752 162644 0 None -52 5 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 308 3 0 3 3.1 c1ccc(CN2CCc3cc(N4CCOCC4)ccc3C2)cc1 10.1016/j.ejmech.2018.02.024
11293787 148213 0 None -27 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL393597 148213 0 None -27 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 10.1016/j.bmcl.2006.12.094
44324800 206948 0 None -22 7 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL91157 206948 0 None -22 7 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324800 206948 0 None -22 7 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
CHEMBL91157 206948 0 None -22 7 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptorInhibition of [3H]- rauwolscine binding to alpha-2B adrenergic receptor
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2 10.1021/jm049619s
102 4127 48 None -10 49 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
3659 4127 48 None -10 49 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
8969 4127 48 None -10 49 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
CHEMBL15245 4127 48 None -10 49 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
DB01392 4127 48 None -10 49 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2013.12.024
126225 94976 5 None -1 8 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL25467 94976 5 None -1 8 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
107715 200945 22 None -13 19 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 200945 22 None -13 19 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 200945 22 None -13 19 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
180 401 56 None -7 40 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 401 56 None -7 40 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 401 56 None -7 40 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 401 56 None -7 40 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 401 56 None -7 40 Human 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
49781887 17144 0 None -3 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 17144 0 None -3 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
10775000 107394 2 None 2 4 Rat 8.4 pKi = 8.4 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL317912 107394 2 None 2 4 Rat 8.4 pKi = 8.4 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
9837551 101624 0 None -25 3 Rat 7.5 pKi = 7.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 232 1 3 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCO2 10.1021/jm960359r
CHEMBL298936 101624 0 None -25 3 Rat 7.5 pKi = 7.5 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 232 1 3 5 1.2 Cc1c(NC2=NCCN2)ccc2c1NCCO2 10.1021/jm960359r
1201549 597 24 None -13 20 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 597 24 None -13 20 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 597 24 None -13 20 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 597 24 None -13 20 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 597 24 None -13 20 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 597 24 None -13 20 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
3584 3777 64 None -21 13 Human 7.5 pKi = 7.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
5401 3777 64 None -21 13 Human 7.5 pKi = 7.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
7302 3777 64 None -21 13 Human 7.5 pKi = 7.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
CHEMBL611 3777 64 None -21 13 Human 7.5 pKi = 7.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
DB01162 3777 64 None -21 13 Human 7.5 pKi = 7.5 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
5282379 194984 69 None -2 3 Human 5.5 pKi = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1 nan
CHEMBL547 194984 69 None -2 3 Human 5.5 pKi = 5.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1 nan
9813756 9016 0 None -5 3 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109848 9016 0 None -5 3 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
24839550 137315 14 None -4 15 Human 6.5 pKi = 6.5 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752576 137315 14 None -4 15 Human 6.5 pKi = 6.5 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
44549156 18570 0 None -42 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276218 18570 0 None -42 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
45487956 198367 0 None -13 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 3 1 3 2.6 CC(OC1=NCCN1)c1ccccc1C1CC1 10.1021/jm901262f
CHEMBL576623 198367 0 None -13 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 3 1 3 2.6 CC(OC1=NCCN1)c1ccccc1C1CC1 10.1021/jm901262f
44549156 18570 0 None -42 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276218 18570 0 None -42 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 CC(Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
44325049 111523 0 None -51 3 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C(\C)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL327875 111523 0 None -51 3 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C(\C)c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
2803 955 58 None -1 19 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
516 955 58 None -1 19 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
704 955 58 None -1 19 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
CHEMBL134 955 58 None -1 19 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
DB00575 955 58 None -1 19 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/j.bmc.2012.06.008
44324859 111612 0 None -67 3 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 461 6 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CC4=Cc5ccccc5C4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328377 111612 0 None -67 3 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 461 6 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CC4=Cc5ccccc5C4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
16090633 80461 0 None -83 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 380 4 2 5 3.8 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
CHEMBL214661 80461 0 None -83 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 380 4 2 5 3.8 C[C@@H]1CN(c2ccc(Nc3c(CO)cnc4ccc(F)cc34)cc2)CCN1C 10.1021/jm060262x
10324985 76781 8 None -234 17 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha-2B receptorBinding affinity to adrenergic alpha-2B receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL199824 76781 8 None -234 17 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha-2B receptorBinding affinity to adrenergic alpha-2B receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
CHEMBL2068762 76781 8 None -234 17 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha-2B receptorBinding affinity to adrenergic alpha-2B receptor
ChEMBL 423 7 0 8 1.7 COc1ccc2cccc(N3CCN(CCCCn4ncc(=O)n(C)c4=O)CC3)c2c1 10.1021/jm050725j
49836308 18784 0 None -10 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL1278084 18784 0 None -10 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 C[C@@H](Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
6604789 101047 5 None -12 10 Human 5.5 pKi = 5.5 Binding
Binding affinity against Alpha-2B adrenergic receptorBinding affinity against Alpha-2B adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL294649 101047 5 None -12 10 Human 5.5 pKi = 5.5 Binding
Binding affinity against Alpha-2B adrenergic receptorBinding affinity against Alpha-2B adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
2719 917 74 None -10 11 Human 4.5 pKi = 4.5 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
5535 917 74 None -10 11 Human 4.5 pKi = 4.5 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
607 917 74 None -10 11 Human 4.5 pKi = 4.5 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
CHEMBL76 917 74 None -10 11 Human 4.5 pKi = 4.5 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
DB00608 917 74 None -10 11 Human 4.5 pKi = 4.5 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC 10.1038/s41586-020-2286-9
3158 56267 27 None -218 20 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 56267 27 None -218 20 Human 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
10266032 188881 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 286 5 1 3 3.5 c1ccc(CCC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL50720 188881 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 286 5 1 3 3.5 c1ccc(CCC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
4150 788 39 None -81 11 Human 5.5 pKi = 5.5 Binding
Inhibition of alpha2B receptor (unknown origin)Inhibition of alpha2B receptor (unknown origin)
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1021/acs.jmedchem.0c00724
5288 788 39 None -81 11 Human 5.5 pKi = 5.5 Binding
Inhibition of alpha2B receptor (unknown origin)Inhibition of alpha2B receptor (unknown origin)
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1021/acs.jmedchem.0c00724
644019 788 39 None -81 11 Human 5.5 pKi = 5.5 Binding
Inhibition of alpha2B receptor (unknown origin)Inhibition of alpha2B receptor (unknown origin)
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1021/acs.jmedchem.0c00724
CHEMBL190461 788 39 None -81 11 Human 5.5 pKi = 5.5 Binding
Inhibition of alpha2B receptor (unknown origin)Inhibition of alpha2B receptor (unknown origin)
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1021/acs.jmedchem.0c00724
DB09061 788 39 None -81 11 Human 5.5 pKi = 5.5 Binding
Inhibition of alpha2B receptor (unknown origin)Inhibition of alpha2B receptor (unknown origin)
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1021/acs.jmedchem.0c00724
122186880 122980 0 None -33 5 Human 5.5 pKi = 5.5 Binding
Binding affinity to alpha2B adrenoceptor (unknown origin)Binding affinity to alpha2B adrenoceptor (unknown origin)
ChEMBL 415 3 0 5 4.8 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4 10.1016/j.bmcl.2015.07.012
CHEMBL3608450 122980 0 None -33 5 Human 5.5 pKi = 5.5 Binding
Binding affinity to alpha2B adrenoceptor (unknown origin)Binding affinity to alpha2B adrenoceptor (unknown origin)
ChEMBL 415 3 0 5 4.8 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4 10.1016/j.bmcl.2015.07.012
15675860 204429 0 None -4 4 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL72147 204429 0 None -4 4 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.1 Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
44312036 204565 1 None -5 4 Human 5.5 pKi = 5.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
CHEMBL72995 204565 1 None -5 4 Human 5.5 pKi = 5.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 305 1 2 5 2.2 CC1CN=C(Nc2ccc3nccnc3c2Br)N1 10.1016/0960-894X(95)00391-6
1530 2182 50 None -46 21 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
3827 2182 50 None -46 21 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
7206 2182 50 None -46 21 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
CHEMBL534 2182 50 None -46 21 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
DB00920 2182 50 None -46 21 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 nan
73353884 92322 0 None -2 8 Human 5.5 pKi = 5.5 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 295 3 1 3 2.7 c1cc2c(cc1CN[C@H]1C3C4CC5C6C4CC3C6C51)OCO2 10.1016/j.bmc.2013.07.045
CHEMBL2429890 92322 0 None -2 8 Human 5.5 pKi = 5.5 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 295 3 1 3 2.7 c1cc2c(cc1CN[C@H]1C3C4CC5C6C4CC3C6C51)OCO2 10.1016/j.bmc.2013.07.045
44438148 93490 0 None -34 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246229 93490 0 None -34 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 10.1016/j.bmcl.2006.12.094
11140347 204533 1 None -53 6 Human 6.5 pKi = 6.5 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 204533 1 None -53 6 Human 6.5 pKi = 6.5 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
57345625 71179 0 None -11 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 224 3 1 3 2.1 CC(Oc1ccccc1Cl)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956191 71179 0 None -11 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 224 3 1 3 2.1 CC(Oc1ccccc1Cl)C1=NCCN1 10.1016/j.bmc.2012.01.035
11380132 84419 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccccn1)C1=NCCN1 10.1021/jm0408215
CHEMBL221989 84419 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1ccccn1)C1=NCCN1 10.1021/jm0408215
132060733 162124 0 None -1 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 294 3 0 3 3.0 c1ccc(CN2Cc3ccc(N4CCOCC4)cc3C2)cc1 10.1016/j.ejmech.2018.02.024
CHEMBL4161503 162124 0 None -1 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 294 3 0 3 3.0 c1ccc(CN2Cc3ccc(N4CCOCC4)cc3C2)cc1 10.1016/j.ejmech.2018.02.024
3191 102858 97 None -9 25 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102858 97 None -9 25 Human 6.5 pKi = 6.5 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
70693375 77671 0 None -8 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL2089155 77671 0 None -8 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
24906198 187664 3 None -12 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
CHEMBL495095 187664 3 None -12 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
24906198 187664 3 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL495095 187664 3 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
45487145 197659 0 None -5 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 4 1 3 2.5 C=CCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL570973 197659 0 None -5 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 230 4 1 3 2.5 C=CCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
24906198 187664 3 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm100977d
CHEMBL495095 187664 3 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/jm100977d
70693375 77671 0 None -8 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL2089155 77671 0 None -8 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
24906198 187664 3 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml300064v
CHEMBL495095 187664 3 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1OC(C)C1=NCCN1 10.1021/ml300064v
2435 722 100 None -36 12 Human 7.5 pKi = 7.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 722 100 None -36 12 Human 7.5 pKi = 7.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 722 100 None -36 12 Human 7.5 pKi = 7.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 722 100 None -36 12 Human 7.5 pKi = 7.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 722 100 None -36 12 Human 7.5 pKi = 7.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 722 100 None -36 12 Human 7.5 pKi = 7.5 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
16090626 82135 0 None -218 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 378 3 1 4 4.9 Cc1nc2ccc(F)cc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL216727 82135 0 None -218 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 378 3 1 4 4.9 Cc1nc2ccc(F)cc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
16090622 82298 0 None -407 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 346 3 1 4 4.4 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)C2)cc1 10.1021/jm060262x
CHEMBL217202 82298 0 None -407 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 346 3 1 4 4.4 Cc1cnc2ccccc2c1Nc1ccc(N2CCN(C)C(C)C2)cc1 10.1021/jm060262x
57345626 71180 2 None -15 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1021/ml400232p
CHEMBL1956192 71180 2 None -15 4 Human 6.5 pKi = 6.5 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1021/ml400232p
57345626 71180 2 None -15 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956192 71180 2 None -15 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 268 3 1 3 2.2 CC(Oc1ccccc1Br)C1=NCCN1 10.1016/j.bmc.2012.01.035
11346584 136984 0 None -19 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm061487a
CHEMBL374584 136984 0 None -19 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm061487a
11346584 136984 0 None -19 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL374584 136984 0 None -19 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm0408215
11346584 136984 0 None -19 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
CHEMBL374584 136984 0 None -19 3 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1cccc(O)c1)C1=NCCN1 10.1021/jm100977d
11199593 137199 0 None -10 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 1 3 3.8 CC(Sc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL374954 137199 0 None -10 3 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 1 3 3.8 CC(Sc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL5094181 215480 22 None -11 5 Human 5.5 pKi = 5.5 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None O=C(NCCCn1ccnc1)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1 10.6019/CHEMBL5058647
CHEMBL5094181 215480 22 None -11 5 Human 5.5 pKi = 5.5 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None O=C(NCCCn1ccnc1)c1cc2nc(-c3ccccc3)cc(-c3ccccc3)n2n1 10.6019/CHEMBL5058647
44579187 189679 0 None -25 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
CHEMBL515331 189679 0 None -25 3 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 513 8 1 8 3.3 N#Cc1cccc(Oc2ncccc2C(=O)NCCN2CCCN(CC3COc4ccccc4O3)CC2)c1 10.1016/j.bmcl.2008.08.055
16090597 141470 0 None -9 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1nc2c(C)ccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL384318 141470 0 None -9 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1nc2c(C)ccc(C)c2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
70788951 27155 1 None -1 5 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL None None None None nan
CHEMBL1366 27155 1 None -1 5 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL None None None None nan
4209 3163 75 None -309 33 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3163 75 None -309 33 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3163 75 None -309 33 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3163 75 None -309 33 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3163 75 None -309 33 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3163 75 None -309 33 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL4802044 214058 1 None - 1 Human 5.4 pKi = 5.4 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None CC(=O)Nc1nc(CN2CCC[C@H](Cc3cc(C)nc(C)c3)C2)cs1 10.6019/CHEMBL4800731
9885114 119604 5 None -87 12 Rat 6.4 pKi = 6.4 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119604 5 None -87 12 Rat 6.4 pKi = 6.4 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
9885114 119604 5 None -87 12 Human 6.4 pKi = 6.4 Binding
Inhibition of alpha2B adrenergic receptor (unknown origin)Inhibition of alpha2B adrenergic receptor (unknown origin)
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/acs.jmedchem.7b00151
CHEMBL346389 119604 5 None -87 12 Human 6.4 pKi = 6.4 Binding
Inhibition of alpha2B adrenergic receptor (unknown origin)Inhibition of alpha2B adrenergic receptor (unknown origin)
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/acs.jmedchem.7b00151
CHEMBL4802044 214058 1 None - 1 Human 5.4 pKi = 5.4 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None CC(=O)Nc1nc(CN2CCC[C@H](Cc3cc(C)nc(C)c3)C2)cs1 10.6019/CHEMBL4800731
44438147 93489 0 None -19 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246228 93489 0 None -19 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 10.1016/j.bmcl.2006.12.094
44325044 207383 0 None -28 3 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4csc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93801 207383 0 None -28 3 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 479 6 0 8 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4csc5ccccc45)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
9923679 81762 0 None -7 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 332 3 1 4 4.0 Cc1cc(Nc2ccc(N3CCN(C)CC3)cc2)c2ccccc2n1 10.1021/jm060262x
CHEMBL216399 81762 0 None -7 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 332 3 1 4 4.0 Cc1cc(Nc2ccc(N3CCN(C)CC3)cc2)c2ccccc2n1 10.1021/jm060262x
10793963 99672 0 None -39 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284470 99672 0 None -39 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
2812 4779 101 None -29 34 Human 5.4 pKi = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4779 101 None -29 34 Human 5.4 pKi = 5.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
9931977 63040 0 None -269 4 Human 6.4 pKi = 6.4 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1788223 63040 0 None -269 4 Human 6.4 pKi = 6.4 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
2803 955 58 None -1 19 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 955 58 None -1 19 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 955 58 None -1 19 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 955 58 None -1 19 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 955 58 None -1 19 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
10682720 205162 0 None -9 3 Rat 6.4 pKi = 6.4 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 259 3 2 3 3.8 COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C 10.1021/jm9605142
CHEMBL78190 205162 0 None -9 3 Rat 6.4 pKi = 6.4 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 259 3 2 3 3.8 COc1cc(C)c(Nc2ncc[nH]2)cc1C(C)(C)C 10.1021/jm9605142
10818003 106421 0 None -7 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
CHEMBL313953 106421 0 None -7 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
10507651 206507 0 None -42 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88388 206507 0 None -42 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
122442272 138348 0 None -26 15 Human 6.4 pKi = 6.4 Binding
Binding affinity to human alpha-2B adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2B adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3769968 138348 0 None -26 15 Human 6.4 pKi = 6.4 Binding
Binding affinity to human alpha-2B adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2B adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
CHEMBL3771384 138348 0 None -26 15 Human 6.4 pKi = 6.4 Binding
Binding affinity to human alpha-2B adrenergic receptor by radioligand binding assayBinding affinity to human alpha-2B adrenergic receptor by radioligand binding assay
ChEMBL 239 5 1 2 2.6 C=CCOc1cc(F)c(F)cc1C1CC1CN 10.1021/acs.jmedchem.5b01153
4567175 82476 5 None -5 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 318 3 1 4 3.7 CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1 10.1021/jm060262x
CHEMBL217665 82476 5 None -5 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 318 3 1 4 3.7 CN1CCN(c2ccc(Nc3ccnc4ccccc34)cc2)CC1 10.1021/jm060262x
10177445 166042 0 None -74 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 4 1 4 5.2 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C(C)C 10.1021/jm060262x
CHEMBL425622 166042 0 None -74 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 374 4 1 4 5.2 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1C(C)C 10.1021/jm060262x
1028 291 71 None -128 30 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 291 71 None -128 30 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 291 71 None -128 30 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 291 71 None -128 30 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 291 71 None -128 30 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 291 71 None -128 30 Human 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
49836301 18567 1 None -11 4 Human 6.4 pKi = 6.4 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml400232p
CHEMBL1276140 18567 1 None -11 4 Human 6.4 pKi = 6.4 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml400232p
153287574 175247 0 None -5 10 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4572167 175247 0 None -5 10 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
11173544 166261 0 None -9 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccc(-c2ccccc2OC(C)C2=NCCN2)cc1 10.1021/jm0408215
CHEMBL426900 166261 0 None -9 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccc(-c2ccccc2OC(C)C2=NCCN2)cc1 10.1021/jm0408215
45487958 198391 0 None -11 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.5 Cc1ccccc1COC1=NCCN1 10.1021/jm901262f
CHEMBL576819 198391 0 None -11 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 190 2 1 3 1.5 Cc1ccccc1COC1=NCCN1 10.1021/jm901262f
49836301 18567 1 None -11 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/jm100977d
CHEMBL1276140 18567 1 None -11 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/jm100977d
49836301 18567 1 None -11 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml300064v
CHEMBL1276140 18567 1 None -11 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@@H](C)C1=NCCN1 10.1021/ml300064v
11140345 204171 0 None -26 6 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 204171 0 None -26 6 Human 5.4 pKi = 5.4 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
136019934 144530 0 None -12 3 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
CHEMBL390718 144530 0 None -12 3 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 462 7 1 7 3.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CN2 10.1016/j.bmc.2007.03.053
102 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
3659 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
8969 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL15245 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
DB01392 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
136 3292 32 None -5 15 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
223 3292 32 None -5 15 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
643606 3292 32 None -5 15 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL10347 3292 32 None -5 15 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
2274 3173 58 None -3 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3173 58 None -3 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3173 58 None -3 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3173 58 None -3 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3173 58 None -3 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
2216 446 50 None -1 6 Rat 8.3 pKi = 8.3 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
229 446 50 None -1 6 Rat 8.3 pKi = 8.3 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
7117 446 50 None -1 6 Rat 8.3 pKi = 8.3 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
CHEMBL647 446 50 None -1 6 Rat 8.3 pKi = 8.3 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
DB00964 446 50 None -1 6 Rat 8.3 pKi = 8.3 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 10.1021/jm960359r
44292385 101121 0 None -2 3 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 270 3 1 3 2.6 c1ccc(C[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL295186 101121 0 None -2 3 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 270 3 1 3 2.6 c1ccc(C[C@H]2C3CCC(C3)[C@H]2NC2=NCCO2)cc1 10.1021/jm9905256
10848826 188880 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 258 3 1 3 2.8 c1ccc(C[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL50719 188880 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 258 3 1 3 2.8 c1ccc(C[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
33630 178957 99 None -9 28 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assayDisplacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assay
ChEMBL 523 7 1 2 7.5 OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2018.10.036
CHEMBL47050 178957 99 None -9 28 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assayDisplacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assay
ChEMBL 523 7 1 2 7.5 OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2018.10.036
44324972 163372 0 None -70 4 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL419316 163372 0 None -70 4 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C(\C)c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
489 145 28 None -1174 12 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 28 None -1174 12 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 28 None -1174 12 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
57345628 71183 0 None -38 4 Human 6.4 pKi = 6.4 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1956195 71183 0 None -38 4 Human 6.4 pKi = 6.4 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
70695474 77672 0 None -70 4 Human 6.4 pKi = 6.4 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL2089156 77672 0 None -70 4 Human 6.4 pKi = 6.4 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml400232p
9894818 98925 0 None -125 7 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98925 0 None -125 7 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
57345628 71183 0 None -38 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956195 71183 0 None -38 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1016/j.bmc.2012.01.035
57345628 71183 0 None -38 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL1956195 71183 0 None -38 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 CC(Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
70695474 77672 0 None -70 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
CHEMBL2089156 77672 0 None -70 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 244 5 1 3 2.4 C[C@H](Oc1ccccc1CC1CC1)C1=NCCN1 10.1021/ml300064v
21509921 104458 0 None -40 24 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 104458 0 None -40 24 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
9894818 98925 0 None -125 7 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98925 0 None -125 7 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
21509921 104458 0 None -40 24 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 104458 0 None -40 24 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
11371902 141638 0 None -9 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
CHEMBL385310 141638 0 None -9 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm0408215
11371902 141638 0 None -9 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL385310 141638 0 None -9 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 CC(Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
10042547 76301 5 None -1 2 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 334 1 1 2 3.9 CC1CCC(Nc2ccc(I)cc2Cl)=N1 10.1016/j.bmc.2012.06.008
CHEMBL2058635 76301 5 None -1 2 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 334 1 1 2 3.9 CC1CCC(Nc2ccc(I)cc2Cl)=N1 10.1016/j.bmc.2012.06.008
3584 3777 64 None -21 13 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 3777 64 None -21 13 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 3777 64 None -21 13 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 3777 64 None -21 13 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 3777 64 None -21 13 Human 6.4 pKi = 6.4 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
44324765 111568 0 None -7 5 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL328114 111568 0 None -7 5 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
44324725 206817 0 None -21 3 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 451 8 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90419 206817 0 None -21 3 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 451 8 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(CCCc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
9846548 207325 0 None -6 3 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93489 207325 0 None -6 3 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 449 7 0 7 3.1 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
10382537 204166 12 None -6 6 Human 7.4 pKi = 7.4 Binding
Binding affinity for human alpha-2B adrenoceptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human alpha-2B adrenoceptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL70676 204166 12 None -6 6 Human 7.4 pKi = 7.4 Binding
Binding affinity for human alpha-2B adrenoceptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human alpha-2B adrenoceptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
68712 100338 60 None 1 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
CHEMBL289480 100338 60 None 1 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/j.bmc.2012.06.008
487 3634 21 None -1096 11 Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
60602 3634 21 None -1096 11 Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL405355 3634 21 None -1096 11 Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB09239 3634 21 None -1096 11 Human 6.4 pKi = 6.4 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
44390749 63910 0 None -223 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
CHEMBL180561 63910 0 None -223 6 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
10251036 81885 0 None -70 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 410 4 2 5 4.7 CN1CCN(c2ccc(Nc3c(CO)cnc4cc(Cl)ccc34)cc2)CC1(C)C 10.1021/jm060262x
CHEMBL216464 81885 0 None -70 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 410 4 2 5 4.7 CN1CCN(c2ccc(Nc3c(CO)cnc4cc(Cl)ccc34)cc2)CC1(C)C 10.1021/jm060262x
9859437 168022 0 None -69 3 Rat 6.4 pKi = 6.4 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
CHEMBL432155 168022 0 None -69 3 Rat 6.4 pKi = 6.4 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 230 2 3 4 2.3 Cc1c(Nc2ncc[nH]2)ccc2c1NCCO2 10.1021/jm9605142
66561967 74704 0 None -6 7 Human 5.4 pKi = 5.4 Binding
Inhibition of alpha2B adrenergic receptorInhibition of alpha2B adrenergic receptor
ChEMBL 213 2 0 1 2.0 C1CC2CCC1N2CC12C3C4C5C3C1C5C42 10.1016/j.bmcl.2012.04.077
CHEMBL2030626 74704 0 None -6 7 Human 5.4 pKi = 5.4 Binding
Inhibition of alpha2B adrenergic receptorInhibition of alpha2B adrenergic receptor
ChEMBL 213 2 0 1 2.0 C1CC2CCC1N2CC12C3C4C5C3C1C5C42 10.1016/j.bmcl.2012.04.077
CHEMBL4748908 214035 1 None -5 12 Human 6.4 pKi = 6.4 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None CN1CCN(c2ccnc(NCCc3ccccc3)n2)CC1 10.6019/CHEMBL4800732
2585 803 103 None -29 21 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 803 103 None -29 21 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 803 103 None -29 21 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 803 103 None -29 21 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 803 103 None -29 21 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
1971 2866 38 None -3 30 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
2404 2866 38 None -3 30 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
4543 2866 38 None -3 30 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
CHEMBL445 2866 38 None -3 30 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
DB00540 2866 38 None -3 30 Human 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
10198135 205125 3 None -43 3 Rat 6.4 pKi = 6.4 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 203 3 2 3 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1 10.1021/jm9605142
CHEMBL77913 205125 3 None -43 3 Rat 6.4 pKi = 6.4 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 203 3 2 3 2.5 COc1ccc(Nc2ncc[nH]2)c(C)c1 10.1021/jm9605142
73213196 104460 4 None -41 13 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 104460 4 None -41 13 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
9851486 206699 0 None -371 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL89685 206699 0 None -371 6 Human 6.4 pKi = 6.4 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
127036186 137414 0 None -13 19 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3753318 137414 0 None -13 19 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
73213196 104460 4 None -41 13 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 104460 4 None -41 13 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)Displacement of [125I]Clonidine from adrenergic alpha2B receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
12114853 13028 0 None -35 2 Human 7.4 pKi = 7.4 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189875 13028 0 None -35 2 Human 7.4 pKi = 7.4 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL539606 13028 0 None -35 2 Human 7.4 pKi = 7.4 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 803 12 6 6 6.9 O=C(NCCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
24906196 187246 0 None -1 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 261 6 1 5 1.8 CCO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
CHEMBL492639 187246 0 None -1 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 261 6 1 5 1.8 CCO/N=C/c1ccccc1OC(C)C1=NCCN1 10.1021/jm800250z
49836305 18576 0 None -10 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276248 18576 0 None -10 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
57401787 71253 0 None -1 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 308 3 1 4 2.3 c1ccc(C2(c3ccccc3)COCC(C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
CHEMBL1956906 71253 0 None -1 3 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenergic receptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 308 3 1 4 2.3 c1ccc(C2(c3ccccc3)COCC(C3=NCCN3)O2)cc1 10.1016/j.bmc.2012.02.016
2337 3256 77 None -12 62 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3256 77 None -12 62 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3256 77 None -12 62 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3256 77 None -12 62 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3256 77 None -12 62 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
132060743 162236 0 None -1 13 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 351 3 0 4 3.1 CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
CHEMBL4163428 162236 0 None -1 13 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human adrenergic alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 351 3 0 4 3.1 CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1 10.1016/j.ejmech.2018.02.024
92766 106542 35 None -4 6 Human 6.3 pKi = 6.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL31410 106542 35 None -4 6 Human 6.3 pKi = 6.3 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
9906978 42711 2 None -125 12 Human 5.3 pKi = 5.3 Binding
Binding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42711 2 None -125 12 Human 5.3 pKi = 5.3 Binding
Binding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
5511 5488 40 None - 1 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 4 0 2 3.3 Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1 nan
CHEMBL1076211 5488 40 None - 1 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 245 4 0 2 3.3 Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1 nan
57395732 71191 0 None -9 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 342 5 1 3 4.8 CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956203 71191 0 None -9 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 342 5 1 3 4.8 CC(Oc1c(-c2ccccc2)cccc1-c1ccccc1)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL4521594 213977 28 None 1 2 Human 5.3 pKi = 5.3 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000309b ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000309b ADRA2B
ChEMBL None None None NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1 10.6019/CHEMBL5212743
11765813 12978 0 None -60 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1189483 12978 0 None -60 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL538808 12978 0 None -60 2 Human 7.3 pKi = 7.3 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 788 11 6 6 6.5 O=C(NCCCCCCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
2398 954 62 None -2 29 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2801 954 62 None -2 29 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
701 954 62 None -2 29 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
CHEMBL415 954 62 None -2 29 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
DB01242 954 62 None -2 29 Human 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
90469115 185842 4 None -1513 17 Human 5.3 pKi = 5.3 Binding
Binding affinity to human adrenergic alpha2B receptorBinding affinity to human adrenergic alpha2B receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
CHEMBL4867565 185842 4 None -1513 17 Human 5.3 pKi = 5.3 Binding
Binding affinity to human adrenergic alpha2B receptorBinding affinity to human adrenergic alpha2B receptor
ChEMBL 410 3 1 6 3.0 O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21 10.1021/acs.jmedchem.1c00224
CHEMBL4513786 213967 7 None -851 8 Human 5.3 pKi = 5.3 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000289bCl ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000289bCl ADRA2B
ChEMBL None None None CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC 10.6019/CHEMBL5212743
CHEMBL4796803 213967 7 None -851 8 Human 5.3 pKi = 5.3 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000289bCl ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000289bCl ADRA2B
ChEMBL None None None CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC 10.6019/CHEMBL5212743
11465618 102398 23 None -173 19 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL3039528 102398 23 None -173 19 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL5191141 102398 23 None -173 19 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
44568614 187623 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 252 4 1 3 2.8 c1ccc(OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
CHEMBL494885 187623 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 252 4 1 3 2.8 c1ccc(OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
9944409 7613 0 None -1 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL108804 7613 0 None -1 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
164609539 184399 0 None -7 3 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2b adrenergic receptor (unknown origin)Inhibition of alpha2b adrenergic receptor (unknown origin)
ChEMBL 428 2 0 5 3.3 O=C1c2ccccc2C(=O)N1CC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4845850 184399 0 None -7 3 Human 5.3 pKi = 5.3 Binding
Inhibition of alpha2b adrenergic receptor (unknown origin)Inhibition of alpha2b adrenergic receptor (unknown origin)
ChEMBL 428 2 0 5 3.3 O=C1c2ccccc2C(=O)N1CC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4748908 214035 1 None -5 12 Human 6.3 pKi = 6.3 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None CN1CCN(c2ccnc(NCCc3ccccc3)n2)CC1 10.6019/CHEMBL4800732
2435 722 100 None -36 12 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 722 100 None -36 12 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 722 100 None -36 12 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 722 100 None -36 12 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 722 100 None -36 12 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 722 100 None -36 12 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
26987 949 33 None -281 21 Human 6.3 pKi = 6.3 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
6063 949 33 None -281 21 Human 6.3 pKi = 6.3 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
671 949 33 None -281 21 Human 6.3 pKi = 6.3 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
CHEMBL1626 949 33 None -281 21 Human 6.3 pKi = 6.3 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
DB00283 949 33 None -281 21 Human 6.3 pKi = 6.3 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41586-020-2286-9
24906241 192817 0 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
CHEMBL522151 192817 0 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 280 2 1 4 2.5 c1ccc(-c2cccc3c2OC(C2=NCCN2)CO3)cc1 10.1021/jm800250z
11173568 84641 0 None -12 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
CHEMBL222371 84641 0 None -12 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 281 4 2 4 2.7 CC(Oc1ccccc1-c1cccc(N)c1)C1=NCCN1 10.1021/jm0408215
2142 3096 58 None -5 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
4920903 3096 58 None -5 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
502 3096 58 None -5 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
5775 3096 58 None -5 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
CHEMBL597 3096 58 None -5 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
DB00692 3096 58 None -5 36 Human 7.3 pKi = 7.3 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
131829 204727 15 None -7 6 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 204727 15 None -7 6 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
11183468 109872 2 None 1 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323402 109872 2 None 1 5 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10603951 206516 0 None -23 6 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL88448 206516 0 None -23 6 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
44579185 181814 1 None -7 3 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL477816 181814 1 None -7 3 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 488 8 1 7 3.5 O=C(NCCN1CCCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
44215744 207442 0 None -15 3 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL94129 207442 0 None -15 3 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ccccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
11393666 192986 0 None -1258 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5201983 192986 0 None -1258 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5222597 192986 0 None -1258 19 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]RX 821002 from recombinant human alpha2B receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
44314198 104412 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 104412 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
9815707 101469 0 None -1 3 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL297752 101469 0 None -1 3 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCC[C@@H]1NC1=NCCO1 10.1021/jm9905256
10198108 208205 2 None -7 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 200 0 1 2 1.9 Cc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL98471 208205 2 None -7 2 Rat 7.3 pKi = 7.3 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 200 0 1 2 1.9 Cc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
137641762 158099 0 None -15 5 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2B receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2B receptor
ChEMBL 476 5 4 10 1.1 CCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.7b00141
CHEMBL4086593 158099 0 None -15 5 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2B receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2B receptor
ChEMBL 476 5 4 10 1.1 CCCNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.7b00141
137653203 158630 0 None -147 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2B receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2B receptor
ChEMBL 449 3 3 11 0.8 CNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)OC)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.7b00141
CHEMBL4092411 158630 0 None -147 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2B receptorDisplacement of [3H]Rauwolscine from human adrenergic alpha2B receptor
ChEMBL 449 3 3 11 0.8 CNc1nc(C#Cc2ccc(Cl)s2)nc2c1ncn2[C@@H]1O[C@H](C(=O)OC)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.7b00141
72947314 92490 0 None -6 4 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 5 1 3 2.0 c1ccc(OCC2=NCCN2)c(CC2CC2)c1 10.1021/ml400232p
CHEMBL2431281 92490 0 None -6 4 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 5 1 3 2.0 c1ccc(OCC2=NCCN2)c(CC2CC2)c1 10.1021/ml400232p
44352207 18856 1 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL128168 18856 1 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm800250z
44352207 18856 1 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL128168 18856 1 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
44352207 18856 1 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
CHEMBL128168 18856 1 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm0408215
11246610 84312 0 None -4 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccc([N+](=O)[O-])cc1)C1=NCCN1 10.1021/jm0408215
CHEMBL221523 84312 0 None -4 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1ccc([N+](=O)[O-])cc1)C1=NCCN1 10.1021/jm0408215
44352207 18856 1 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL128168 18856 1 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 CC(Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
155536080 172114 0 None -34 10 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 219 2 1 2 2.9 CC[C@H]1c2cc(OC)ccc2CC[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4472703 172114 0 None -34 10 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Rauwolscine from human recombinant adrenergic Alpha2B receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method
ChEMBL 219 2 1 2 2.9 CC[C@H]1c2cc(OC)ccc2CC[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
44328654 107185 0 None -134 6 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL316495 107185 0 None -134 6 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
16090631 82391 0 None -1047 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 390 4 2 5 4.5 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C(C)O 10.1021/jm060262x
CHEMBL217253 82391 0 None -1047 3 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 390 4 2 5 4.5 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C(C)O 10.1021/jm060262x
10531532 207094 0 None -58 6 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91956 207094 0 None -58 6 Human 6.3 pKi = 6.3 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
57400959 71188 0 None -16 3 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956200 71188 0 None -16 3 Human 4.3 pKi = 4.3 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 268 4 1 5 0.9 CC(Oc1ccccc1S(C)(=O)=O)C1=NCCN1 10.1016/j.bmc.2012.01.035
13091268 78224 0 None -562 14 Human 6.3 pKi = 6.3 Binding
Binding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL210578 78224 0 None -562 14 Human 6.3 pKi = 6.3 Binding
Binding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-2B receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
2435 722 100 None -3 12 Rat 7.3 pKi = 7.3 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
395 722 100 None -3 12 Rat 7.3 pKi = 7.3 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
520 722 100 None -3 12 Rat 7.3 pKi = 7.3 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
5386 722 100 None -3 12 Rat 7.3 pKi = 7.3 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
CHEMBL844 722 100 None -3 12 Rat 7.3 pKi = 7.3 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
DB00484 722 100 None -3 12 Rat 7.3 pKi = 7.3 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1021/jm9605142
240 944 43 None -11 24 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 944 43 None -11 24 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 944 43 None -11 24 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 944 43 None -11 24 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 944 43 None -11 24 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 944 43 None -11 24 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 944 43 None -11 24 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2765 943 19 None -15 9 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
515 943 19 None -15 9 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
CHEMBL13852 943 19 None -15 9 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
DB09202 943 19 None -15 9 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/ml400232p
2765 943 19 None -15 9 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
515 943 19 None -15 9 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
CHEMBL13852 943 19 None -15 9 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
DB09202 943 19 None -15 9 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1021/jm901262f
3033538 1319 39 None -11 9 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
7155 1319 39 None -11 9 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
781 1319 39 None -11 9 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
CHEMBL1201216 1319 39 None -11 9 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
DB00298 1319 39 None -11 9 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
1443 2028 34 None -12 10 Human 6.3 pKi = 6.3 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 2028 34 None -12 10 Human 6.3 pKi = 6.3 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 2028 34 None -12 10 Human 6.3 pKi = 6.3 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 2028 34 None -12 10 Human 6.3 pKi = 6.3 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 2028 34 None -12 10 Human 6.3 pKi = 6.3 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
44288874 101095 0 None -524 7 Human 6.3 pKi = 6.3 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL295001 101095 0 None -524 7 Human 6.3 pKi = 6.3 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
139406787 177145 0 None -5 4 Human 5.3 pKi = 5.3 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin)Binding affinity to adrenergic alpha2B receptor (unknown origin)
ChEMBL 492 5 2 5 5.8 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)c1 10.1021/acs.jmedchem.0c00745
CHEMBL4633982 177145 0 None -5 4 Human 5.3 pKi = 5.3 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin)Binding affinity to adrenergic alpha2B receptor (unknown origin)
ChEMBL 492 5 2 5 5.8 O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)cc(-c2cn(-c3ccc(C(F)(F)F)cc3)nn2)c1 10.1021/acs.jmedchem.0c00745
448537 160250 89 None -33 25 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 160250 89 None -33 25 Human 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
73291731 92491 0 None -38 4 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 232 5 1 3 2.4 CCCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
CHEMBL2431282 92491 0 None -38 4 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 232 5 1 3 2.4 CCCc1ccccc1OC(C)C1=NCCN1 10.1021/ml400232p
11277479 84750 0 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1cccc(-c2ccccc2OC(C)C2=NCCN2)c1 10.1021/jm0408215
CHEMBL222973 84750 0 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1cccc(-c2ccccc2OC(C)C2=NCCN2)c1 10.1021/jm0408215
45487955 198310 0 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 232 4 1 3 2.7 CCCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
CHEMBL576078 198310 0 None -10 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 232 4 1 3 2.7 CCCc1ccccc1C(C)OC1=NCCN1 10.1021/jm901262f
124 2981 47 None -977 33 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2981 47 None -977 33 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2981 47 None -977 33 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2981 47 None -977 33 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2981 47 None -977 33 Human 5.3 pKi = 5.3 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
44269013 30342 1 None -11 4 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 218 5 1 3 2.0 CCCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL13917 30342 1 None -11 4 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 218 5 1 3 2.0 CCCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
45487962 197485 0 None -11 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 218 4 1 3 2.1 CCCc1ccccc1COC1=NCCN1 10.1021/jm901262f
CHEMBL569933 197485 0 None -11 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 218 4 1 3 2.1 CCCc1ccccc1COC1=NCCN1 10.1021/jm901262f
122065 189549 3 None -112 8 Human 7.3 pKi = 7.3 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
CHEMBL51433 189549 3 None -112 8 Human 7.3 pKi = 7.3 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
73346042 91834 5 None -562 17 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin)Binding affinity to adrenergic alpha2B receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
CHEMBL2413153 91834 5 None -562 17 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha2B receptor (unknown origin)Binding affinity to adrenergic alpha2B receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
2406 100404 89 None -10 12 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
CHEMBL290106 100404 89 None -10 12 Human 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O nan
49836302 18566 1 None -5 3 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml400232p
CHEMBL1276139 18566 1 None -5 3 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml400232p
49836304 18571 1 None -12 3 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
CHEMBL1276219 18571 1 None -12 3 Human 6.3 pKi = 6.3 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/ml400232p
49836302 18566 1 None -5 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/jm100977d
CHEMBL1276139 18566 1 None -5 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/jm100977d
49836304 18571 1 None -12 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276219 18571 1 None -12 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 230 4 1 3 2.3 C[C@@H](Oc1ccccc1C1CC1)C1=NCCN1 10.1021/jm100977d
49836302 18566 1 None -5 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml300064v
CHEMBL1276139 18566 1 None -5 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation countingDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells after 30 mins by scintillation counting
ChEMBL 230 5 1 3 2.2 C=CCc1ccccc1O[C@H](C)C1=NCCN1 10.1021/ml300064v
9960497 100476 0 None -1778 6 Human 6.2 pKi = 6.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL290860 100476 0 None -1778 6 Human 6.2 pKi = 6.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
15730 71118 80 None -2 10 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
CHEMBL195437 71118 80 None -2 10 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 206 7 1 1 4.3 CCCCCCCCc1ccc(O)cc1 nan
145990586 166843 0 None -44 11 Human 6.2 pKi = 6.2 Binding
Binding affinity to andrenergic alpha2B receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic alpha2B receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
CHEMBL4285281 166843 0 None -44 11 Human 6.2 pKi = 6.2 Binding
Binding affinity to andrenergic alpha2B receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assayBinding affinity to andrenergic alpha2B receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay
ChEMBL 297 2 2 4 2.6 COc1cc2c3c(c1OC)-c1ccccc1[C@@H](O)[C@@H]3NCC2 10.1039/C7MD00656J
11057 176149 23 None -1 20 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
3468 176149 23 None -1 20 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL459265 176149 23 None -1 20 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
CHEMBL64894 176149 23 None -1 20 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 nan
10508332 105991 0 None -389 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
CHEMBL313160 105991 0 None -389 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
11801828 206544 0 None -35 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88628 206544 0 None -35 6 Human 6.2 pKi = 6.2 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
10362866 82299 0 None -114 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL217203 82299 0 None -114 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
124 2981 47 None -977 33 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2981 47 None -977 33 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2981 47 None -977 33 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2981 47 None -977 33 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2981 47 None -977 33 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
44438161 147141 0 None -63 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392771 147141 0 None -63 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 10.1016/j.bmcl.2006.12.094
10333157 151238 0 None -6 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
CHEMBL396013 151238 0 None -6 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm061487a
10333157 151238 0 None -6 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
CHEMBL396013 151238 0 None -6 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 266 4 1 3 3.1 C[C@H](Oc1ccccc1-c1ccccc1)C1=NCCN1 10.1021/jm100977d
176 398 66 None -4 31 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2157 398 66 None -4 31 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
2566 398 66 None -4 31 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
CHEMBL633 398 66 None -4 31 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
DB01118 398 66 None -4 31 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 nan
10489502 4518 2 None -6 3 Rat 6.2 pKi = 6.2 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 227 2 2 2 3.5 Clc1cccc(Cl)c1Nc1ncc[nH]1 10.1021/jm9605142
CHEMBL1022 4518 2 None -6 3 Rat 6.2 pKi = 6.2 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 227 2 2 2 3.5 Clc1cccc(Cl)c1Nc1ncc[nH]1 10.1021/jm9605142
2803 955 58 None -1 19 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 955 58 None -1 19 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 955 58 None -1 19 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 955 58 None -1 19 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 955 58 None -1 19 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
49781007 17241 0 None -4 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 4 1 2 3.3 CCCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256566 17241 0 None -4 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 254 4 1 2 3.3 CCCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
213041 17133 28 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 230 2 1 1 3.0 CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1 10.1021/jm1006269
CHEMBL1255582 17133 28 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 230 2 1 1 3.0 CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1 10.1021/jm1006269
49781887 17144 0 None -3 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
CHEMBL1255617 17144 0 None -3 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 222 1 1 1 2.9 c1ccc2c(c1)[C@H]1C[C@@]1(c1c[nH]cn1)C21CC1 10.1021/jm1006269
129211 3749 78 None -102 15 Rat 8.2 pKi = 8.2 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3749 78 None -102 15 Rat 8.2 pKi = 8.2 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3749 78 None -102 15 Rat 8.2 pKi = 8.2 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3749 78 None -102 15 Rat 8.2 pKi = 8.2 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3749 78 None -102 15 Rat 8.2 pKi = 8.2 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
10707358 179285 0 None -4 3 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 272 4 1 3 3.2 c1ccc(CC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
CHEMBL47313 179285 0 None -4 3 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 272 4 1 3 3.2 c1ccc(CC[C@H]2CCCC[C@@H]2NC2=NCCO2)cc1 10.1021/jm9905256
16090623 82454 0 None -77 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
CHEMBL217567 82454 0 None -77 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1ccc2c(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C)c(C)nc2c1C 10.1021/jm060262x
2750 204061 76 None -3 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
CHEMBL7002 204061 76 None -3 12 Human 5.2 pKi = 5.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 333 5 1 4 3.9 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 nan
28918670 92487 2 None -6 4 Human 6.2 pKi = 6.2 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 254 3 1 3 1.8 Brc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL2431279 92487 2 None -6 4 Human 6.2 pKi = 6.2 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 254 3 1 3 1.8 Brc1ccccc1OCC1=NCCN1 10.1021/ml400232p
57395731 71190 0 None -6 3 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956202 71190 0 None -6 3 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 232 4 1 4 1.7 CC(=O)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
1353 1911 93 None -85 83 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1911 93 None -85 83 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1911 93 None -85 83 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1911 93 None -85 83 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1911 93 None -85 83 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
9815610 99933 19 None -31 4 Human 6.2 pKi = 6.2 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
CHEMBL286246 99933 19 None -31 4 Human 6.2 pKi = 6.2 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm990569e
9815610 99933 19 None -31 4 Rat 6.2 pKi = 6.2 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
CHEMBL286246 99933 19 None -31 4 Rat 6.2 pKi = 6.2 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2ccsc2CC1 10.1021/jm000128r
10655607 204755 5 None -8 3 Rat 6.2 pKi = 6.2 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 199 2 3 3 2.0 c1c[nH]c(Nc2ccc3[nH]cnc3c2)n1 10.1021/jm9605142
CHEMBL74544 204755 5 None -8 3 Rat 6.2 pKi = 6.2 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 199 2 3 3 2.0 c1c[nH]c(Nc2ccc3[nH]cnc3c2)n1 10.1021/jm9605142
46869265 16257 0 None -30 7 Human 5.2 pKi = 5.2 Binding
Binding affinity to adrenergic alpha2B receptorBinding affinity to adrenergic alpha2B receptor
ChEMBL 295 1 3 3 3.1 Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21 10.1016/j.bmc.2010.07.052
CHEMBL1224527 16257 0 None -30 7 Human 5.2 pKi = 5.2 Binding
Binding affinity to adrenergic alpha2B receptorBinding affinity to adrenergic alpha2B receptor
ChEMBL 295 1 3 3 3.1 Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21 10.1016/j.bmc.2010.07.052
491 192 9 None -416 12 Rat 7.2 pKi = 7.2 Binding
Ancillary Binding affinity towards rat alpha-2B receptorAncillary Binding affinity towards rat alpha-2B receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -416 12 Rat 7.2 pKi = 7.2 Binding
Ancillary Binding affinity towards rat alpha-2B receptorAncillary Binding affinity towards rat alpha-2B receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -416 12 Rat 7.2 pKi = 7.2 Binding
Ancillary Binding affinity towards rat alpha-2B receptorAncillary Binding affinity towards rat alpha-2B receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
463 1405 22 None -57 12 Human 6.2 pKi = 6.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
6918097 1405 22 None -57 12 Human 6.2 pKi = 6.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
837 1405 22 None -57 12 Human 6.2 pKi = 6.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL2051956 1405 22 None -57 12 Human 6.2 pKi = 6.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB14068 1405 22 None -57 12 Human 6.2 pKi = 6.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
11361608 84745 1 None -10 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL222928 84745 1 None -10 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
11361608 84745 1 None -10 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm0408215
CHEMBL222928 84745 1 None -10 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm0408215
11361608 84745 1 None -10 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL222928 84745 1 None -10 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 CC(Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
9944467 9251 0 None -3 3 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
CHEMBL110751 9251 0 None -3 3 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
10176567 102800 3 None -24 4 Human 6.2 pKi = 6.2 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
CHEMBL30534 102800 3 None -24 4 Human 6.2 pKi = 6.2 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm990569e
10176567 102800 3 None -24 4 Rat 6.2 pKi = 6.2 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
CHEMBL30534 102800 3 None -24 4 Rat 6.2 pKi = 6.2 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 200 1 1 2 3.3 c1cc(-c2c[nH]cn2)c2ccsc2c1 10.1021/jm000128r
73349359 92543 0 None 1 8 Human 6.2 pKi = 6.2 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 341 6 1 4 2.9 COc1cc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc(OC)c1OC 10.1016/j.bmc.2013.07.045
CHEMBL2432051 92543 0 None 1 8 Human 6.2 pKi = 6.2 Binding
Inhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 341 6 1 4 2.9 COc1cc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc(OC)c1OC 10.1016/j.bmc.2013.07.045
1593 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
30668 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
9868 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
CHEMBL17860 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
DB04948 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1016/j.bmc.2012.01.035
164618319 184593 0 None -6 3 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2b adrenergic receptor (unknown origin)Inhibition of alpha2b adrenergic receptor (unknown origin)
ChEMBL 340 2 1 4 2.1 CC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
CHEMBL4848838 184593 0 None -6 3 Human 5.2 pKi = 5.2 Binding
Inhibition of alpha2b adrenergic receptor (unknown origin)Inhibition of alpha2b adrenergic receptor (unknown origin)
ChEMBL 340 2 1 4 2.1 CC(=O)NCC#Cc1ccc2c(c1)C=C([N+](=O)[O-])C(C(F)(F)F)O2 10.1016/j.bmcl.2021.128008
49783209 17609 0 None -338 26 Human 6.2 pKi = 6.2 Binding
Binding affinity to human adrenergic alpha2B receptorBinding affinity to human adrenergic alpha2B receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258223 17609 0 None -338 26 Human 6.2 pKi = 6.2 Binding
Binding affinity to human adrenergic alpha2B receptorBinding affinity to human adrenergic alpha2B receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
44288847 165309 0 None -478 5 Human 6.2 pKi = 6.2 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42335 165309 0 None -478 5 Human 6.2 pKi = 6.2 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
11109088 204180 0 None -144 6 Human 6.2 pKi = 6.2 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 204180 0 None -144 6 Human 6.2 pKi = 6.2 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
9904117 9402 3 None -6 4 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111554 9402 3 None -6 4 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
3952 1888 38 None -18 12 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1888 38 None -18 12 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1888 38 None -18 12 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1888 38 None -18 12 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1888 38 None -18 12 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1888 38 None -18 12 Human 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
3086326 204531 22 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 204531 22 None -1 6 Human 7.2 pKi = 7.2 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
44579271 187094 0 None -22 3 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL491419 187094 0 None -22 3 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 475 9 0 7 4.2 c1ccc(Oc2ncccc2COCCN2CCCN(CC3COc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
2662 11384 131 None -1 30 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL118 11384 131 None -1 30 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 nan
1209 1658 75 None -12 32 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
203 1658 75 None -12 32 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
3386 1658 75 None -12 32 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
CHEMBL41 1658 75 None -12 32 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
DB00472 1658 75 None -12 32 Human 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F nan
9805944 56227 37 None -11 9 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from adrenergic alpha2B receptorDisplacement of [125I]HEAT from adrenergic alpha2B receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
CHEMBL1627 56227 37 None -11 9 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from adrenergic alpha2B receptorDisplacement of [125I]HEAT from adrenergic alpha2B receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
102 4127 48 None -10 49 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards alpha-2b adrenergic receptorIn vitro binding affinity towards alpha-2b adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
3659 4127 48 None -10 49 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards alpha-2b adrenergic receptorIn vitro binding affinity towards alpha-2b adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
8969 4127 48 None -10 49 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards alpha-2b adrenergic receptorIn vitro binding affinity towards alpha-2b adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
CHEMBL15245 4127 48 None -10 49 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards alpha-2b adrenergic receptorIn vitro binding affinity towards alpha-2b adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
DB01392 4127 48 None -10 49 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards alpha-2b adrenergic receptorIn vitro binding affinity towards alpha-2b adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1016/j.bmcl.2005.03.116
11653915 124012 0 None -1 6 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL362954 124012 0 None -1 6 Human 8.1 pKi = 8.1 Binding
Binding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cellsBinding affinity towards human alpha-2B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
44325050 207281 0 None -38 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL93171 207281 0 None -38 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 463 7 0 7 3.5 COc1cc2c(cc1OC)C1=NOC(CN3CCN(C/C(C)=C/c4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
133 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
2142 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
4920903 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
502 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
5775 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
CHEMBL597 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
DB00692 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00018a001
3584 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
49781005 17214 0 None -3 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256503 17214 0 None -3 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 226 2 1 2 2.5 CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
102 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
68712 100338 60 None 1 5 Human 7.2 pKi = 7.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 100338 60 None 1 5 Human 7.2 pKi = 7.2 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
44269006 32353 1 None -10 4 Human 6.2 pKi = 6.2 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 216 5 1 3 1.8 C=CCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
CHEMBL14107 32353 1 None -10 4 Human 6.2 pKi = 6.2 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 216 5 1 3 1.8 C=CCc1ccccc1OCC1=NCCN1 10.1021/ml400232p
24906159 187405 12 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
CHEMBL493675 187405 12 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 233 4 2 5 1.3 CC(Oc1ccccc1/C=N/O)C1=NCCN1 10.1021/jm800250z
49836306 18575 0 None -4 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
CHEMBL1276247 18575 0 None -4 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 272 4 1 4 3.2 C[C@@H](Oc1ccccc1-c1ccsc1)C1=NCCN1 10.1021/jm100977d
490 191 8 None -354 12 Rat 7.2 pKi = 7.2 Binding
Ancillary Binding affinity towards rat alpha-2B receptorAncillary Binding affinity towards rat alpha-2B receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -354 12 Rat 7.2 pKi = 7.2 Binding
Ancillary Binding affinity towards rat alpha-2B receptorAncillary Binding affinity towards rat alpha-2B receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -354 12 Rat 7.2 pKi = 7.2 Binding
Ancillary Binding affinity towards rat alpha-2B receptorAncillary Binding affinity towards rat alpha-2B receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
118717248 115124 0 None -2 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
CHEMBL3343699 115124 0 None -2 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 219 1 2 3 0.5 Fc1ccc2cnn(N=C3NCCN3)c2c1 10.1016/j.ejmech.2014.09.083
10758200 63417 0 None -30 5 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
CHEMBL179648 63417 0 None -30 5 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 322 4 0 3 3.2 c1ccc(CN2CCN(CC3CCc4ccccc4O3)CC2)cc1 10.1016/j.bmcl.2008.08.055
1548953 207679 27 None -3 17 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
CHEMBL954 207679 27 None -3 17 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1 nan
44325038 206916 0 None -19 3 Human 6.1 pKi = 6.1 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ncccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90966 206916 0 None -19 3 Human 6.1 pKi = 6.1 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 474 6 0 8 3.2 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccc5ncccc5c4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
50878551 90745 61 None -18 18 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 270 8 1 2 3.4 C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL2391541 90745 61 None -18 18 Human 6.1 pKi = 6.1 Binding
Binding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-2B adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 270 8 1 2 3.4 C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12 10.1016/j.bmcl.2015.12.053
3652 46244 70 None -4 9 Human 4.1 pKi = 4.1 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 10.1038/s41586-020-2286-9
CHEMBL1535 46244 70 None -4 9 Human 4.1 pKi = 4.1 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 10.1038/s41586-020-2286-9
8447 188949 84 None 2 13 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
CHEMBL508112 188949 84 None 2 13 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 332 3 0 6 5.7 c1ccc2sc(SSc3nc4ccccc4s3)nc2c1 nan
16757089 92291 1 None -9 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
CHEMBL242693 92291 1 None -9 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm061487a
16757089 92291 1 None -9 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
CHEMBL242693 92291 1 None -9 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cellsDisplacement of [3H]RX821002 from human alpha2B adrenoceptor expressed in CHO cells
ChEMBL 311 5 1 5 3.0 C[C@@H](Oc1ccccc1-c1cccc([N+](=O)[O-])c1)C1=NCCN1 10.1021/jm100977d
16725934 147423 0 None -38 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL392992 147423 0 None -38 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 10.1016/j.bmcl.2006.12.094
44328920 108641 0 None -66 6 Human 6.1 pKi = 6.1 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
CHEMBL320736 108641 0 None -66 6 Human 6.1 pKi = 6.1 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
9960497 117075 0 None -229 6 Human 6.1 pKi = 6.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL3392246 117075 0 None -229 6 Human 6.1 pKi = 6.1 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
49783419 17749 0 None -371 12 Human 6.1 pKi = 6.1 Binding
Binding affinity to human adrenergic alpha2B receptorBinding affinity to human adrenergic alpha2B receptor
ChEMBL 366 6 1 6 2.8 CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258671 17749 0 None -371 12 Human 6.1 pKi = 6.1 Binding
Binding affinity to human adrenergic alpha2B receptorBinding affinity to human adrenergic alpha2B receptor
ChEMBL 366 6 1 6 2.8 CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1 10.1021/jm100668r
44289035 100514 0 None -407 7 Human 6.1 pKi = 6.1 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL291166 100514 0 None -407 7 Human 6.1 pKi = 6.1 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
11108001 10872 2 None -69 6 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10872 2 None -69 6 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10872 2 None -69 6 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
1960 2857 67 None -4 26 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
439260 2857 67 None -4 26 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
505 2857 67 None -4 26 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
CHEMBL1437 2857 67 None -4 26 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
DB00368 2857 67 None -4 26 Rat 7.1 pKi = 7.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960012o
CHEMBL179334 63303 0 None -4265 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
24882007 12473 1 None -1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
CHEMBL1186220 12473 1 None -1 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation countingDisplacement of [3H]RS-79948-197 from human alpha2B adrenoceptor expressed in CHO-K1 cells after 45 mins by liquid scintillation counting
ChEMBL 201 1 2 3 0.3 c1ccc2c(c1)cnn2N=C1NCCN1 10.1016/j.ejmech.2014.09.083
10575254 206883 0 None -63 3 Rat 7.1 pKi = 7.1 Binding
The compound's binding affinity against Alpha-2B adrenergic receptor from rat kidney homogenate in the presence of phentolamineThe compound's binding affinity against Alpha-2B adrenergic receptor from rat kidney homogenate in the presence of phentolamine
ChEMBL 443 8 1 5 4.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90746 206883 0 None -63 3 Rat 7.1 pKi = 7.1 Binding
The compound's binding affinity against Alpha-2B adrenergic receptor from rat kidney homogenate in the presence of phentolamineThe compound's binding affinity against Alpha-2B adrenergic receptor from rat kidney homogenate in the presence of phentolamine
ChEMBL 443 8 1 5 4.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1 10.1021/jm970166j
5029 15545 92 None -13 4 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C nan
CHEMBL1219 15545 92 None -13 4 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C nan
72947315 92489 0 None -10 4 Human 6.1 pKi = 6.1 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 232 5 1 4 1.6 c1ccc(OC2CC2)c(OCC2=NCCN2)c1 10.1021/ml400232p
CHEMBL2431280 92489 0 None -10 4 Human 6.1 pKi = 6.1 Binding
Binding affinity at human alpha2B ARBinding affinity at human alpha2B AR
ChEMBL 232 5 1 4 1.6 c1ccc(OC2CC2)c(OCC2=NCCN2)c1 10.1021/ml400232p
9809007 172564 8 None -1047 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL448620 172564 8 None -1047 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
44579186 181976 0 None -2 3 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 474 8 1 7 3.1 O=C(NCCN1CCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
CHEMBL478026 181976 0 None -2 3 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay
ChEMBL 474 8 1 7 3.1 O=C(NCCN1CCN(CC2COc3ccccc3O2)CC1)c1cccnc1Oc1ccccc1 10.1016/j.bmcl.2008.08.055
2142 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
2803 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
516 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
704 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
CHEMBL134 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
DB00575 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960012o
2803 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
516 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
704 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
CHEMBL134 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
DB00575 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm960359r
16655023 107441 2 None -5 7 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 107441 2 None -5 7 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cellsDisplacement of [3H]rawolscine from human cloned adrenergic alpha-2B receptor transfected in CHO cells
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
2284 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
185076 187090 5 None -2 7 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured LM(tk-) cells using [3H]- prazosinBinding affinity for human Alpha-2B adrenergic receptor from cultured LM(tk-) cells using [3H]- prazosin
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 187090 5 None -2 7 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured LM(tk-) cells using [3H]- prazosinBinding affinity for human Alpha-2B adrenergic receptor from cultured LM(tk-) cells using [3H]- prazosin
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
129211 3749 78 None -102 15 Rat 7.1 pKi = 7.1 Binding
Binding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligandBinding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
2562 3749 78 None -102 15 Rat 7.1 pKi = 7.1 Binding
Binding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligandBinding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
488 3749 78 None -102 15 Rat 7.1 pKi = 7.1 Binding
Binding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligandBinding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
CHEMBL836 3749 78 None -102 15 Rat 7.1 pKi = 7.1 Binding
Binding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligandBinding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
DB00706 3749 78 None -102 15 Rat 7.1 pKi = 7.1 Binding
Binding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligandBinding affinity towards rat alpha-2B adrenergic receptor was determined using [3H]yohimbine as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
9809007 172564 8 None -1047 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 172564 8 None -1047 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
24841480 183899 0 None -398 20 Human 6.1 pKi = 6.1 Binding
Antagonist activity at adrenergic alpha2B receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 340 3 0 4 4.5 O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
CHEMBL481153 183899 0 None -398 20 Human 6.1 pKi = 6.1 Binding
Antagonist activity at adrenergic alpha2B receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha2B receptor (unknown origin) by PDSP assay
ChEMBL 340 3 0 4 4.5 O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
44438152 93608 0 None -42 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 10.1016/j.bmcl.2006.12.094
CHEMBL246639 93608 0 None -42 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 10.1016/j.bmcl.2006.12.094
2683 102888 25 None -112 16 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL305906 102888 25 None -112 16 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
CHEMBL334255 102888 25 None -112 16 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 nan
11186227 84722 0 None -23 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccc(O)cc1)C1=NCCN1 10.1021/jm0408215
CHEMBL222798 84722 0 None -23 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 282 4 2 4 2.8 CC(Oc1ccccc1-c1ccc(O)cc1)C1=NCCN1 10.1021/jm0408215
10176999 103554 21 None -47 3 Rat 7.1 pKi = 7.1 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
CHEMBL308570 103554 21 None -47 3 Rat 7.1 pKi = 7.1 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 231 2 2 4 2.2 Cc1c(Nc2ncc[nH]2)ccc2c1OCCO2 10.1021/jm9605142
68617 205527 62 None -3 26 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL1709 205527 62 None -3 26 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
CHEMBL809 205527 62 None -3 26 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 nan
42574 15287 90 None -15 3 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 662 4 2 3 7.1 Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O nan
CHEMBL12131 15287 90 None -15 3 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 662 4 2 3 7.1 Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O nan
3823 50221 42 None -43 10 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 50221 42 None -43 10 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 50221 42 None -43 10 Human 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
10626982 111495 0 None -14 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL327775 111495 0 None -14 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
11300487 85002 0 None -17 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccccc1-c1ccccc1OC(C)C1=NCCN1 10.1021/jm0408215
CHEMBL223830 85002 0 None -17 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 280 4 1 3 3.4 Cc1ccccc1-c1ccccc1OC(C)C1=NCCN1 10.1021/jm0408215
237 204865 48 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL546257 204865 48 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL554190 204865 48 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
CHEMBL7568 204865 48 None -1 13 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 nan
289 242 12 None -75 14 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha2B receptor by radioligand displacement assayBinding affinity to adrenergic alpha2B receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
9948320 242 12 None -75 14 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha2B receptor by radioligand displacement assayBinding affinity to adrenergic alpha2B receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
CHEMBL1242950 242 12 None -75 14 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha2B receptor by radioligand displacement assayBinding affinity to adrenergic alpha2B receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
CHEMBL4520788 213975 10 None -39 25 Human 6.1 pKi = 6.1 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000743a ADRA2B
ChEMBL None None None CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1 10.6019/CHEMBL5212743
CHEMBL508338 188966 0 None -2 6 Human 7.1 pKi = 7.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL None None None None nan
11097789 102998 1 None -169 6 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102998 1 None -169 6 Human 6.1 pKi = 6.1 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
44312198 204589 0 None -3 4 Human 4.1 pKi = 4.1 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73164 204589 0 None -3 4 Human 4.1 pKi = 4.1 Binding
Binding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscineBinding affinity for human Alpha-2B adrenergic receptor from cultured Y-1 cells using [3H]rauwolscine
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
44438167 148970 0 None -1071 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL394218 148970 0 None -1071 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 10.1016/j.bmcl.2006.12.094
9809007 172564 8 None -1047 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 172564 8 None -1047 6 Human 6.1 pKi = 6.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
12488 1657 56 None -12 23 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1657 56 None -12 23 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1657 56 None -12 23 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1657 56 None -12 23 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
4601 206747 35 None -3 16 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL1201023 206747 35 None -3 16 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
CHEMBL900 206747 35 None -3 16 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 nan
10531766 206997 0 None -776 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL91415 206997 0 None -776 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
57345627 71182 0 None -12 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 230 4 1 3 2.5 C=C(C)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956194 71182 0 None -12 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 230 4 1 3 2.5 C=C(C)c1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
57402717 71187 2 None -15 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 220 4 1 4 1.5 COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL1956199 71187 2 None -15 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 220 4 1 4 1.5 COc1ccccc1OC(C)C1=NCCN1 10.1016/j.bmc.2012.01.035
24906197 187666 0 None -4 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 323 7 1 5 3.0 CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1 10.1021/jm800250z
CHEMBL495097 187666 0 None -4 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 323 7 1 5 3.0 CC(Oc1ccccc1/C=N/OCc1ccccc1)C1=NCCN1 10.1021/jm800250z
119584 2595 102 None -2 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
1848 2595 102 None -2 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
242 2595 102 None -2 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
CHEMBL60889 2595 102 None -2 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
DB11675 2595 102 None -2 5 Human 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl nan
CHEMBL4777443 214046 0 None -41 14 Human 6.1 pKi = 6.1 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a ADRA2BSelectivity interaction (GPCR panel (PDSP screen)) EUB0000741a ADRA2B
ChEMBL None None None CC(C)(C)OC(=O)N1CCCC1CN[C@H]1CC[C@@](c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1 10.6019/CHEMBL5212743
10318507 58953 0 None -104 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cc(Cl)ccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
CHEMBL1689423 58953 0 None -104 3 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 394 3 1 4 5.4 Cc1nc2cc(Cl)ccc2c(Nc2ccc(N3CCN(C)C(C)C3)cc2)c1C 10.1021/jm060262x
10508016 207156 0 None -24 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
CHEMBL92322 207156 0 None -24 6 Human 6.1 pKi = 6.1 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
294234 102893 3 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102893 3 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscineBinding affinity towards human Alpha-2B adrenergic receptor by the displacement of [3H]rauwolscine
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
49781006 17240 0 None -2 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 240 3 1 2 2.9 CCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
CHEMBL1256565 17240 0 None -2 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation countingDisplacement of [3H]-RX821002 from human adrenergic alpha2B receptor expressed in rat C6 cells after 120 mins by liquid scintillation counting
ChEMBL 240 3 1 2 2.9 CCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1c[nH]cn1 10.1021/jm1006269
10032383 110110 0 None -870 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 110110 0 None -870 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 110110 0 None -870 6 Human 6.0 pKi = 6.0 Binding
Binding affinity against human Alpha-2b adrenergic receptorBinding affinity against human Alpha-2b adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
6518171 168296 55 None -8 8 Human 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 495 12 2 6 4.9 CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1 nan
CHEMBL434063 168296 55 None -8 8 Human 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 495 12 2 6 4.9 CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1 nan
10769331 111533 0 None -173 6 Human 7.0 pKi = 7.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
CHEMBL327931 111533 0 None -173 6 Human 7.0 pKi = 7.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
44292232 101321 0 None -3 3 Human 7.0 pKi = 7.0 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
CHEMBL296660 101321 0 None -3 3 Human 7.0 pKi = 7.0 Binding
Inhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscineInhibitory constant against human Alpha-2B adrenergic receptor expressed in Y-1 cells using [3H]rauwolscine
ChEMBL 222 3 1 3 2.2 CCC[C@H]1C2CCC(C2)[C@H]1NC1=NCCO1 10.1021/jm9905256
11741010 83251 0 None -6 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1cc(C)c2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
CHEMBL218730 83251 0 None -6 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 388 3 1 4 5.4 Cc1cc(C)c2c(Nc3ccc(N4CCN(C)C(C)C4)cc3)c(C)c(C)nc2c1 10.1021/jm060262x
10841387 99618 0 None -257 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL284103 99618 0 None -257 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptorInhibition of [3H]rauwolscine binding to CHO cells expressing the human Alpha-2B adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
10627021 107095 0 None -660 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
CHEMBL315914 107095 0 None -660 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
9904606 9386 0 None -10 3 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
CHEMBL111463 9386 0 None -10 3 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
CHEMBL4802042 214056 2 None - 1 Human 5.0 pKi = 5.0 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1 10.6019/CHEMBL4800728
CHEMBL4802042 214056 2 None - 1 Human 5.0 pKi = 5.0 Binding
GPCRScan assay: inhibition of Alpha2BGPCRScan assay: inhibition of Alpha2B
ChEMBL None None None COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1 10.6019/CHEMBL4800728
13149 2545 36 None -154 17 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
3034396 2545 36 None -154 17 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
CHEMBL299031 2545 36 None -154 17 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
135423051 77832 0 None -169 3 Human 5.0 pKi = 5.0 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL2092926 77832 0 None -169 3 Human 5.0 pKi = 5.0 Binding
Compound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosinCompound is evaluated for binding affinity towards Alpha-2B adrenergic receptor using [3H]prazosin
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
10632290 204746 5 None -3 3 Rat 5.0 pKi = 5.0 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 211 2 2 4 2.1 c1c[nH]c(Nc2ccc3nccnc3c2)n1 10.1021/jm9605142
CHEMBL74449 204746 5 None -3 3 Rat 5.0 pKi = 5.0 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
ChEMBL 211 2 2 4 2.1 c1c[nH]c(Nc2ccc3nccnc3c2)n1 10.1021/jm9605142
10841387 99618 0 None -257 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284103 99618 0 None -257 6 Human 6.0 pKi = 6.0 Binding
Binding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptorBinding affinity determined by displacement of [3H]rauwolscine from alpha-2B adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
44269089 97005 0 None -12 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 232 4 1 3 2.6 CC(Oc1ccccc1C(C)C)C1=NCCN1 10.1016/j.bmc.2012.01.035
CHEMBL266613 97005 0 None -12 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
ChEMBL 232 4 1 3 2.6 CC(Oc1ccccc1C(C)C)C1=NCCN1 10.1016/j.bmc.2012.01.035
11265631 136409 0 None -14 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
CHEMBL373535 136409 0 None -14 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX 821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm061487a
7059292 76300 7 None 3 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 1 1 2 2.9 Clc1ccccc1NC1=NCCC1 10.1016/j.bmc.2012.06.008
CHEMBL2058633 76300 7 None 3 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
ChEMBL 194 1 1 2 2.9 Clc1ccccc1NC1=NCCC1 10.1016/j.bmc.2012.06.008
11265631 136409 0 None -14 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
CHEMBL373535 136409 0 None -14 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cellsDisplacement of [3H]RX821002 from human adrenergic alpha-2B receptor expressed in CHO cells
ChEMBL 267 4 1 4 2.5 CC(Oc1ccccc1-c1cccnc1)C1=NCCN1 10.1021/jm0408215
10474335 194692 23 None -323 10 Human 5.0 pKi = 5.0 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 370 6 0 3 4.8 COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1 10.1038/s41586-020-2286-9
CHEMBL53325 194692 23 None -323 10 Human 5.0 pKi = 5.0 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
ChEMBL 370 6 0 3 4.8 COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1 10.1038/s41586-020-2286-9
9837106 104157 2 None -35 4 Human 6.0 pKi = 6.0 Binding
Tested for Binding affinity towards alpha-2B adrenergic receptorTested for Binding affinity towards alpha-2B adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
CHEMBL30955 104157 2 None -35 4 Human 6.0 pKi = 6.0 Binding
Tested for Binding affinity towards alpha-2B adrenergic receptorTested for Binding affinity towards alpha-2B adrenergic receptor
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm990569e
9837106 104157 2 None -35 4 Rat 6.0 pKi = 6.0 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
CHEMBL30955 104157 2 None -35 4 Rat 6.0 pKi = 6.0 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 202 1 1 2 2.8 C1=C(c2c[nH]cn2)c2sccc2CC1 10.1021/jm000128r
11225732 93657 0 None -53 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 10.1016/j.bmcl.2006.12.094
CHEMBL246852 93657 0 None -53 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cellsDisplacement of [3H]MK912 from adrenergic alpha-2B receptor expressed in COS7 cells
ChEMBL 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 10.1016/j.bmcl.2006.12.094
11777109 116967 0 None -31 2 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 254 0 1 2 2.9 Clc1cc(Cl)c2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL338683 116967 0 None -31 2 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 254 0 1 2 2.9 Clc1cc(Cl)c2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
44324737 207238 0 None -12 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL92860 207238 0 None -12 5 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 473 6 0 7 3.8 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(Cc4ccc5ccccc5c4)CC3)[C@@H]1CO2 10.1016/s0960-894x(03)00525-0
24906200 193156 0 None -4 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
CHEMBL523048 193156 0 None -4 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cellsDisplacement of [3H]RS79948-197 from human recombinant adrenergic alpha2B receptor expressed in CHO cells
ChEMBL 328 5 1 3 4.5 c1ccc(-c2ccccc2OC(C2=NCCN2)c2ccccc2)cc1 10.1021/jm800250z
44288769 101148 0 None -870 7 Human 6.0 pKi = 6.0 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL295395 101148 0 None -870 7 Human 6.0 pKi = 6.0 Binding
In vivo inhibitory effect against alpha-2b Adrenergic receptorIn vivo inhibitory effect against alpha-2b Adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
16090621 141575 0 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 422 5 1 4 5.6 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1Cc1ccccc1 10.1021/jm060262x
CHEMBL384925 141575 0 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]rauwolscine from human ADRA2B expressed in S115 cellsDisplacement of [3H]rauwolscine from human ADRA2B expressed in S115 cells
ChEMBL 422 5 1 4 5.6 Cc1nc2ccccc2c(Nc2ccc(N3CCN(C)CC3)cc2)c1Cc1ccccc1 10.1021/jm060262x
3151 1462 97 None -97 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1462 97 None -97 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1462 97 None -97 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1462 97 None -97 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1462 97 None -97 27 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
10934575 204486 0 None -56 6 Human 6.0 pKi = 6.0 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 204486 0 None -56 6 Human 6.0 pKi = 6.0 Binding
Affinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cellsAffinity to human Alpha-2B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
9838192 111312 18 None -5 5 Rat 6.0 pKi = 6.0 Binding
Binding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lungBinding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lung
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 111312 18 None -5 5 Rat 6.0 pKi = 6.0 Binding
Binding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lungBinding affinity to Rattus norvegicus (rat) alpha2B receptor isolated from neonatal lung
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
9838192 111312 18 None -5 5 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
CHEMBL326702 111312 18 None -5 5 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assayIn vitro binding affinity towards alpha-2B adrenergic receptor of rat neonatal lung in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
124087 1389 114 None -28 15 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
7157 1389 114 None -28 15 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
814 1389 114 None -28 15 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
CHEMBL1172 1389 114 None -28 15 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
DB00967 1389 114 None -28 15 Human 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 nan
126720252 164675 0 None -34 12 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2B receptor expressed in HEK293T cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2B receptor expressed in HEK293T cell membranes after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
CHEMBL4216870 164675 0 None -34 12 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]Rauwolscine from human adrenergic alpha2B receptor expressed in HEK293T cell membranes after 90 mins by scintillation counting methodDisplacement of [3H]Rauwolscine from human adrenergic alpha2B receptor expressed in HEK293T cell membranes after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
9815633 99635 3 None -25 6 Human 7.0 pKi = 7 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
CHEMBL284213 99635 3 None -25 6 Human 7.0 pKi = 7 Binding
Binding affinity towards Alpha-2B adrenergic receptorBinding affinity towards Alpha-2B adrenergic receptor
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm990569e
10036255 21359 0 None -1 2 Rat 7.0 pKi = 7 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL131417 21359 0 None -1 2 Rat 7.0 pKi = 7 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1cccc2c1CC1(CC2)CN=CN1 10.1021/jm00020a021
10036256 23781 0 None -1 2 Rat 7.0 pKi = 7 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
CHEMBL133579 23781 0 None -1 2 Rat 7.0 pKi = 7 Binding
Binding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligandBinding affinity towards Alpha-2B adrenergic receptor in neonatal rat lung using [3H]-RX-821002 as radioligand
ChEMBL 216 1 1 3 1.6 COc1ccc2c(c1)CC1(CC2)CN=CN1 10.1021/jm00020a021
9815633 99635 3 None -25 6 Rat 7.0 pKi = 7 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
CHEMBL284213 99635 3 None -25 6 Rat 7.0 pKi = 7 Binding
in vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligandin vitro alpha-2B adrenergic receptor binding assay from rats, using RX 821002 as the displaceable ligand
ChEMBL 204 1 1 2 2.9 c1nc(C2CCCc3sccc32)c[nH]1 10.1021/jm000128r
10101373 13093 0 None -19 2 Human 6.0 pKi = 6 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL1190317 13093 0 None -19 2 Human 6.0 pKi = 6 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
CHEMBL540594 13093 0 None -19 2 Human 6.0 pKi = 6 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
ChEMBL 718 6 6 6 4.6 O=C(NCCCNC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 10.1016/s0960-894x(00)00068-8
44324900 206898 0 None -11 3 Human 6.0 pKi = 6 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 423 6 0 7 2.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
CHEMBL90843 206898 0 None -11 3 Human 6.0 pKi = 6 Binding
In vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscineIn vitro binding affinity towards human alpha-2B adrenergic receptor using [3H]rauwolscine
ChEMBL 423 6 0 7 2.6 COc1cc2c(cc1OC)C1=NOC(CN3CCN(Cc4ccccc4)CC3)C1CO2 10.1016/s0960-894x(03)00525-0
1816 2540 102 None -851 18 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
4205 2540 102 None -851 18 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
7241 2540 102 None -851 18 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
CHEMBL654 2540 102 None -851 18 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
DB00370 2540 102 None -851 18 Human 8.2 pIC50 = 8.2 Binding
Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
108094 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
108094 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
108094 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
526 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
526 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
526 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
528 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
528 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
528 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
CHEMBL10332 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
CHEMBL10332 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7908642
CHEMBL10332 3423 27 None -6 4 Human 8.1 pKd = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 8819505
136 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
136 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
136 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
223 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
223 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
223 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
643606 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
643606 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
643606 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
CHEMBL10347 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
CHEMBL10347 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
CHEMBL10347 3292 32 None -5 15 Human 8.7 pKd = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 8819505
1588 2325 27 3H-RX821002 -1 44 Human 9.9 pKi = 9.9 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2325 27 3H-RX821002 -1 44 Human 9.9 pKi = 9.9 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2325 27 3H-RX821002 -1 44 Human 9.9 pKi = 9.9 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2325 27 3H-RX821002 -1 44 Human 9.9 pKi = 9.9 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2325 27 3H-RX821002 -1 44 Human 9.9 pKi = 9.9 Binding
NoneNone
PDSP KiDatabase 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
5268 3656 40 3H-RAUWOLSCINE -3 18 Human 9.7 pKi = 9.7 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3656 40 3H-RAUWOLSCINE -3 18 Human 9.7 pKi = 9.7 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3656 40 3H-RAUWOLSCINE -3 18 Human 9.7 pKi = 9.7 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
None 216028 0 3H-RAUWOLSCINE -8 3 Rat 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 339 0 0 3 3.3 CN1CCC2(CCN3CCC4=C(C3C2)OC5=CC=CC=C45)N(C1=O)C None
5268 3656 40 3H-RAUWOLSCINE 1 18 Rat 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3656 40 3H-RAUWOLSCINE 1 18 Rat 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3656 40 3H-RAUWOLSCINE 1 18 Rat 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
138107169 215952 0 3H-RAUWOLSCINE -5 22 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 215952 0 3H-RAUWOLSCINE -5 22 Human 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
5268 3656 40 3H-RAUWOLSCINE 1 18 Rat 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3656 40 3H-RAUWOLSCINE 1 18 Rat 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3656 40 3H-RAUWOLSCINE 1 18 Rat 9.5 pKi = 9.5 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
138107169 215952 0 3H-RAUWOLSCINE -5 22 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 215952 0 3H-RAUWOLSCINE -5 22 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
2601 3780 33 3H-RX821002 -1 21 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 3780 33 3H-RX821002 -1 21 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 3780 33 3H-RX821002 -1 21 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 3780 33 3H-RX821002 -1 21 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 3780 33 3H-RX821002 -1 21 Human 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
138107169 215952 0 3H-RAUWOLSCINE -17 22 Rat 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 215952 0 3H-RAUWOLSCINE -17 22 Rat 9.4 pKi = 9.4 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
None 216029 0 3H-RAUWOLSCINE -3 3 Rat 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 953 28 10 12 0.9 CCOC1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(CC(=O)N)C(=O)NC(C=S)C(=O)NC(CCCCN)C(=O)N)NC(=O)CC3(CCCCC3)S None
46780481 107531 20 3H-RAUWOLSCINE -20 53 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107531 20 3H-RAUWOLSCINE -20 53 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107531 20 3H-RAUWOLSCINE -20 53 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107531 20 3H-RAUWOLSCINE -20 53 Human 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL1196898 216030 0 3H-RAUWOLSCINE -2 3 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 248 3 1 5 1.2 CCOC1(COC2=CC=CC=C2O1)C3=NCCN3 None
12576 514 94 3H-RAUWOLSCINE 2 6 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
71310 514 94 3H-RAUWOLSCINE 2 6 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
CHEMBL353972 514 94 3H-RAUWOLSCINE 2 6 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
DB11481 514 94 3H-RAUWOLSCINE 2 6 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 None
None 215961 0 3H-RAUWOLSCINE -1 5 Rat 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 295 5 2 3 3.0 C1CC2=CC=CC=C2C(=O)C1CNCCC3=CC=C(C=C3)O None
102 4127 48 3H-RAUWOLSCINE -10 49 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
102 4127 48 3H-RAUWOLSCINE -10 49 Rat 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 3H-RAUWOLSCINE -10 49 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 3H-RAUWOLSCINE -10 49 Rat 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 3H-RAUWOLSCINE -10 49 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 3H-RAUWOLSCINE -10 49 Rat 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 3H-RAUWOLSCINE -10 49 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 3H-RAUWOLSCINE -10 49 Rat 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 3H-RAUWOLSCINE -10 49 Human 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 3H-RAUWOLSCINE -10 49 Rat 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
102 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
102 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 3H-RAUWOLSCINE -10 49 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
138107169 215952 0 35S-GTPGammaS -5 22 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 215952 0 35S-GTPGammaS -5 22 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
41 1659 0 3H-RX821002 1 17 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
72036 1659 0 3H-RX821002 1 17 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
CHEMBL1765294 1659 0 3H-RX821002 1 17 Human 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 195 0 1 3 0.9 Fc1cccc2c1O[C@H]1CNC[C@@H]1O2 None
164512323 216031 0 3H-RAUWOLSCINE -12 5 Rat 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 216031 0 3H-RAUWOLSCINE -12 5 Rat 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
5268 3656 40 3H-MK912 -3 18 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3656 40 3H-MK912 -3 18 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3656 40 3H-MK912 -3 18 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
122211 462 0 3H-RAUWOLSCINE 6 6 Rat 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 462 0 3H-RAUWOLSCINE 6 6 Rat 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
108094 3423 27 35S-GTPGammaS -6 4 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3423 27 35S-GTPGammaS -6 4 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3423 27 35S-GTPGammaS -6 4 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3423 27 35S-GTPGammaS -6 4 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
5268 3656 40 3H-RAUWOLSCINE -3 18 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
53 3656 40 3H-RAUWOLSCINE -3 18 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
CHEMBL300555 3656 40 3H-RAUWOLSCINE -3 18 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 None
123981 16459 22 3H-RAUWOLSCINE 2 8 Rat 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
CHEMBL123349 16459 22 3H-RAUWOLSCINE 2 8 Rat 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
CHEMBL536803 16459 22 3H-RAUWOLSCINE 2 8 Rat 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 None
None 215959 0 3H-RAUWOLSCINE -2 6 Rat 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 358 4 0 3 2.8 CCCS(=O)(=O)N(C)C1CCN2CCC3=CC=CC=C3C2C1.Cl None
102 4127 48 3H-RX821002 -10 49 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 3H-RX821002 -10 49 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 3H-RX821002 -10 49 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 3H-RX821002 -10 49 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 3H-RX821002 -10 49 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2142 3096 58 3H-RX821002 -5 36 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 3H-RX821002 -5 36 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 3H-RX821002 -5 36 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 3H-RX821002 -5 36 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 3H-RX821002 -5 36 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 3H-RX821002 -5 36 Human 8.0 pKi = 8 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
46780481 107531 20 3H-CLONIDINE -20 53 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107531 20 3H-CLONIDINE -20 53 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107531 20 3H-CLONIDINE -20 53 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107531 20 3H-CLONIDINE -20 53 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
12575 1988 30 UNDEFINED -53 17 Human 7.0 pKi = 7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1988 30 UNDEFINED -53 17 Human 7.0 pKi = 7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1988 30 UNDEFINED -53 17 Human 7.0 pKi = 7 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
138107169 215952 0 3H-RAUWOLSCINE -17 22 Rat 7.0 pKi = 7 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 215952 0 3H-RAUWOLSCINE -17 22 Rat 7.0 pKi = 7 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
202 1508 77 UNDEFINED -9 30 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
60835 1508 77 UNDEFINED -9 30 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
972 1508 77 UNDEFINED -9 30 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
CHEMBL1175 1508 77 UNDEFINED -9 30 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
DB00476 1508 77 UNDEFINED -9 30 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 None
5656 203066 87 UNDEFINED -7 40 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 203066 87 UNDEFINED -7 40 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
54841 203127 52 UNDEFINED -1 27 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 None
CHEMBL641 203127 52 UNDEFINED -1 27 Mouse 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 255 6 1 2 3.7 CNCC[C@@H](Oc1ccccc1C)c1ccccc1 None
165193 215945 0 3H-RAUWOLSCINE -4265 30 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
62882 215945 0 3H-RAUWOLSCINE -4265 30 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
66366 215945 0 3H-RAUWOLSCINE -4265 30 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 259 6 2 3 2.6 CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O None
243 3202 91 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3052762 3202 91 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3502 3202 91 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
CHEMBL117287 3202 91 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
DB06480 3202 91 3H-RAUWOLSCINE -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
183782 3398 20 3H-RAUWOLSCINE -1737 13 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
237 3398 20 3H-RAUWOLSCINE -1737 13 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL85251 3398 20 3H-RAUWOLSCINE -1737 13 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 8 1 4 4.4 CCCCN1CCC(CC1)CCC(=O)c1cc(Cl)c(cc1OC)N None
2662 11384 131 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 None
CHEMBL118 11384 131 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 None
5090 15561 106 3H-CLONIDINE -1348 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 3 0 4 2.6 CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1 None
CHEMBL122 15561 106 3H-CLONIDINE -1348 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 3 0 4 2.6 CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1 None
156391 46800 99 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
CHEMBL1200806 46800 99 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
CHEMBL154 46800 99 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 None
10624 70300 19 125I-Clonidine -776 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
138543650 70300 19 125I-Clonidine -776 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
CHEMBL194378 70300 19 125I-Clonidine -776 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 284 5 3 3 1.7 CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 None
2244 94233 100 3H-CLONIDINE -1 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 180 2 1 3 1.3 CC(=O)Oc1ccccc1C(=O)O None
CHEMBL25 94233 100 3H-CLONIDINE -1 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 180 2 1 3 1.3 CC(=O)Oc1ccccc1C(=O)O None
3663 99967 83 3H-CLONIDINE -288 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 504 0 6 8 5.1 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 None
CHEMBL286494 99967 83 3H-CLONIDINE -288 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 504 0 6 8 5.1 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 None
5280343 188275 124 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL1520590 188275 124 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL50 188275 124 3H-CLONIDINE -147 32 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
3672 192533 136 3H-CLONIDINE -1 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 206 4 1 1 3.1 CC(C)Cc1ccc(C(C)C(=O)O)cc1 None
CHEMBL521 192533 136 3H-CLONIDINE -1 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 206 4 1 1 3.1 CC(C)Cc1ccc(C(C)C(=O)O)cc1 None
54676228 193615 112 3H-CLONIDINE -1 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 2 2 5 1.6 CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O None
CHEMBL527 193615 112 3H-CLONIDINE -1 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 331 2 2 5 1.6 CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O None
4495 196535 92 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 None
CHEMBL56367 196535 92 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 None
54677470 200551 115 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
CHEMBL1256873 200551 115 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
CHEMBL599 200551 115 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 351 2 2 6 2.0 Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1 None
5281600 203025 92 3H-CLONIDINE -275 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 538 3 6 10 5.1 O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12 None
CHEMBL63354 203025 92 3H-CLONIDINE -275 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 538 3 6 10 5.1 O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12 None
4054 205501 72 125I-Clonidine -1 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL1699 205501 72 125I-Clonidine -1 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
CHEMBL807 205501 72 125I-Clonidine -1 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 179 0 1 1 2.7 CC12CC3CC(C)(C1)CC(N)(C3)C2 None
119607 206203 113 3H-CLONIDINE -97 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 None
CHEMBL865 206203 113 3H-CLONIDINE -97 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 314 3 1 4 3.0 Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 None
None 215993 0 3H-RAUWOLSCINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 329 2 0 4 3.6 CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl None
104911 216019 0 3H-CLONIDINE -41686 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 530 7 0 5 5.1 COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4.Cl.Cl.Cl None
None 216027 0 3H-RAUWOLSCINE -10 12 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 453 9 2 6 2.6 COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CCNS(=O)(=O)C)Cl)N.Cl None
25137849 216179 0 3H-CLONIDINE -1 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
71290 216179 0 3H-CLONIDINE -1 40 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
None 216239 0 3H-CLONIDINE -89125 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 316 7 3 3 3.0 CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O None
None 216311 0 3H-CLONIDINE -1 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 240 7 4 6 -0.8 C(C(C(=O)O)N)SSCC(C(=O)O)N None
None 216312 0 3H-CLONIDINE -1 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 149 4 2 3 0.2 CSCCC(C(=O)O)N None
None 216313 0 3H-CLONIDINE -1 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 135 3 3 3 -0.3 C(CS)C(C(=O)O)N None
None 216314 0 3H-CLONIDINE -1 33 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 121 2 3 3 -0.7 C(C(C(=O)O)N)S None
None 216315 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 117 0 1 3 -0.0 C1CSC(=O)C1N None
None 216316 0 3H-CLONIDINE -1 39 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 153 3 3 3 -1.4 C(C(C(=O)O)N)S(=O)O None
None 216318 0 3H-CLONIDINE -1 30 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 183 4 3 4 -1.3 C(CS(=O)(=O)O)C(C(=O)O)N None
None 216327 0 3H-CLONIDINE -16 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 536 11 1 4 9.0 CC(C)C(=O)C12C(=O)C(=C(C(C1=O)(CC(C2(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)O)CC=C(C)C None
4978 216328 0 3H-CLONIDINE -16 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 520 1 7 9 4.3 CC1=CC(=C2C3=C1C4=C5C(=C(C=C4CO)O)C(=O)C6=C(C=C(C7=C6C5=C3C8=C7C(=CC(=C8C2=O)O)O)O)O)O None
None 216329 0 3H-CLONIDINE -3 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 464 4 8 12 -0.6 C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O None
None 216330 0 3H-CLONIDINE -281 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 610 6 10 16 -1.7 CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O None
None 216331 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 448 3 7 11 0.4 CC1C(C(C(C(O1)OC2=C(OC3=CC(=O)C=C(C3=C2O)O)C4=CC(=C(C=C4)O)O)O)O)O None
None 216342 0 3H-RX821002 -1862 19 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 246 2 1 4 1.6 CCCN1CCCC2C1CC3=CN=C(N=C3C2)N None
135269 216389 0 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 222 5 1 3 2.5 CCCCC(=O)OC1=CC=CC=C1C(=O)O None
23681059 216390 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 230 3 1 2 3.0 CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O None
5018304 216391 0 3H-CLONIDINE -1 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 317 4 1 3 0.0 C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+] None
84003 216392 0 3H-CLONIDINE -1 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 376 6 5 7 -0.0 C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O None
123619 216393 0 3H-CLONIDINE -1412 26 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 358 3 0 4 4.2 CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl None
119828 216394 0 3H-CLONIDINE -1 29 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 370 5 1 5 3.5 CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C None
None 216395 0 3H-CLONIDINE -7 28 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 517 8 2 5 5.2 CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)NCCC4=CC=C(C=C4)NC(=O)C None
None 216489 0 3H-CLONIDINE -4570 27 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 347 6 0 3 5.0 CC(=O)N(CC1=CC=CC=C1OC)C2=CC=CC=C2OC3=CC=CC=C3 None
242 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
1343 1889 62 3H-MK912 -91 9 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1889 62 3H-MK912 -91 9 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1889 62 3H-MK912 -91 9 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1889 62 3H-MK912 -91 9 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1889 62 3H-MK912 -91 9 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
242 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 470 124 3H-CLONIDINE -64 51 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
209 3057 97 3H-CLONIDINE -38 23 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 3057 97 3H-CLONIDINE -38 23 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 3057 97 3H-CLONIDINE -38 23 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 3057 97 3H-CLONIDINE -38 23 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 3057 97 3H-CLONIDINE -38 23 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
3658 4107 53 35S-GTPGammaS -114 8 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4107 53 35S-GTPGammaS -114 8 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4107 53 35S-GTPGammaS -114 8 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4107 53 35S-GTPGammaS -114 8 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4107 53 35S-GTPGammaS -114 8 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
7153 98020 77 3H-CLONIDINE -5 34 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 214 3 1 2 2.5 Cc1cc(Cl)ccc1OC(C)C(=O)O None
CHEMBL272942 98020 77 3H-CLONIDINE -5 34 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 214 3 1 2 2.5 Cc1cc(Cl)ccc1OC(C)C(=O)O None
134 2514 24 3H-CLONIDINE -93 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1775 2514 24 3H-CLONIDINE -93 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
9681 2514 24 3H-CLONIDINE -93 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
CHEMBL1065 2514 24 3H-CLONIDINE -93 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
DB00247 2514 24 3H-CLONIDINE -93 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1613 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
2389 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
1613 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2348 53 3H-CLONIDINE -7 44 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
2389 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 3H-CLONIDINE -104 67 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
4209 3163 75 3H-RAUWOLSCINE -48 33 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 3H-RAUWOLSCINE -48 33 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 3H-RAUWOLSCINE -48 33 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 3H-RAUWOLSCINE -48 33 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 3H-RAUWOLSCINE -48 33 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 3H-RAUWOLSCINE -48 33 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
2695 3841 81 3H-RAUWOLSCINE -20 6 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3841 81 3H-RAUWOLSCINE -20 6 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3841 81 3H-RAUWOLSCINE -20 6 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3841 81 3H-RAUWOLSCINE -20 6 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3841 81 3H-RAUWOLSCINE -20 6 Rat 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
4209 3163 75 3H-MK912 -309 33 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 3H-MK912 -309 33 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 3H-MK912 -309 33 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 3H-MK912 -309 33 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 3H-MK912 -309 33 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 3H-MK912 -309 33 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
6852400 215937 0 3H-RAUWOLSCINE -30 22 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 361 0 1 2 4.8 CC(C)(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O None
73759726 215937 0 3H-RAUWOLSCINE -30 22 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 361 0 1 2 4.8 CC(C)(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O None
102 4127 48 3H-MK912 -10 49 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 3H-MK912 -10 49 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 3H-MK912 -10 49 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 3H-MK912 -10 49 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 3H-MK912 -10 49 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
44438168 93818 0 UNDEFINED -389 3 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 None
CHEMBL247665 93818 0 UNDEFINED -389 3 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 533 7 0 7 4.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)N4CCC(N5CCCC5)CC4)cc13)CC2 None
5524 216464 0 35S-GTPGammaS -1 4 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 215 1 2 3 1.9 C1CCC2=C(C1)C=CC=C2NC3=NCCN3 None
1343 1889 62 35S-GTPGammaS -91 9 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1889 62 35S-GTPGammaS -91 9 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1889 62 35S-GTPGammaS -91 9 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1889 62 35S-GTPGammaS -91 9 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1889 62 35S-GTPGammaS -91 9 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
15897 2862 0 3H-CLONIDINE -63 36 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2862 0 3H-CLONIDINE -63 36 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2862 0 3H-CLONIDINE -63 36 Human 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
135 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
164512323 216031 0 3H-RAUWOLSCINE -7 5 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 216031 0 3H-RAUWOLSCINE -7 5 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
4209 3163 75 3H-CLONIDINE -309 33 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 3H-CLONIDINE -309 33 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 3H-CLONIDINE -309 33 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 3H-CLONIDINE -309 33 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 3H-CLONIDINE -309 33 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 3H-CLONIDINE -309 33 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
1220 187 55 3H-RAUWOLSCINE -117 44 Rat 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
31 187 55 3H-RAUWOLSCINE -117 44 Rat 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
7 187 55 3H-RAUWOLSCINE -117 44 Rat 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
CHEMBL56 187 55 3H-RAUWOLSCINE -117 44 Rat 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC None
None 216707 0 UNDEFINED -8 3 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 390 1 2 4 3.1 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O.Cl None
44438166 93817 0 UNDEFINED -371 3 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 None
CHEMBL247664 93817 0 UNDEFINED -371 3 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 467 8 2 7 3.5 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCC(C)(C)N)cc13)CC2 None
1576 216326 0 3H-CLONIDINE -2 40 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 163 3 1 2 1.5 CC(C(=O)C1=CC=CC=C1)NC None
102 4127 48 3H-RX821002 -10 49 Rat 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 3H-RX821002 -10 49 Rat 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 3H-RX821002 -10 49 Rat 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 3H-RX821002 -10 49 Rat 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 3H-RX821002 -10 49 Rat 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
931 216463 0 35S-GTPGammaS -5 4 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 128 0 0 0 2.8 C1=CC=C2C=CC=CC2=C1 None
11750482 147421 0 UNDEFINED -19 3 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 None
CHEMBL392991 147421 0 UNDEFINED -19 3 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 419 6 0 6 5.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccco4)cc13)CC2 None
3294 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
3294 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 2006 111 3H-RX821002 -47 45 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
15897 2862 0 3H-CLONIDINE -63 36 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2862 0 3H-CLONIDINE -63 36 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2862 0 3H-CLONIDINE -63 36 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
214 3860 58 3H-CLONIDINE -39 30 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 3860 58 3H-CLONIDINE -39 30 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 3860 58 3H-CLONIDINE -39 30 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 3860 58 3H-CLONIDINE -39 30 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 3860 58 3H-CLONIDINE -39 30 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 3860 58 3H-CLONIDINE -39 30 Human 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
None 215958 0 3H-RAUWOLSCINE -112 19 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
68712 100338 60 35S-GTPGammaS 1 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 100338 60 35S-GTPGammaS 1 5 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
124 2981 47 35S-GTPGammaS -977 33 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 35S-GTPGammaS -977 33 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 35S-GTPGammaS -977 33 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 35S-GTPGammaS -977 33 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 35S-GTPGammaS -977 33 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
1615 167791 24 3H-CLONIDINE -4 44 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
CHEMBL43048 167791 24 3H-CLONIDINE -4 44 Human 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 193 3 1 3 1.6 CNC(C)Cc1ccc2c(c1)OCO2 None
None 216035 0 3H-RAUWOLSCINE -2 3 Rat 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 200 3 1 1 2.8 CC1=C(C(=CC=C1)C)CCC2=CN=CN2 None
135398745 2914 112 3H-RAUWOLSCINE -37 65 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2914 112 3H-RAUWOLSCINE -37 65 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2914 112 3H-RAUWOLSCINE -37 65 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2914 112 3H-RAUWOLSCINE -37 65 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
25137849 216179 0 3H-CLONIDINE -1 40 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
71290 216179 0 3H-CLONIDINE -1 40 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
122211 462 0 3H-MK912 -6 6 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 462 0 3H-MK912 -6 6 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
68602 205126 80 35S-GTPGammaS -3 7 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 205126 80 35S-GTPGammaS -3 7 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
3337 206367 27 3H-CLONIDINE -14 40 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 206367 27 3H-CLONIDINE -14 40 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 206367 27 3H-CLONIDINE -14 40 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 206367 27 3H-CLONIDINE -14 40 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 206367 27 3H-CLONIDINE -14 40 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
1524 2181 96 3H-RAUWOLSCINE -27 52 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
197 2181 96 3H-RAUWOLSCINE -27 52 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
3822 2181 96 3H-RAUWOLSCINE -27 52 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
88 2181 96 3H-RAUWOLSCINE -27 52 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
CHEMBL51 2181 96 3H-RAUWOLSCINE -27 52 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
DB12465 2181 96 3H-RAUWOLSCINE -27 52 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
68602 205126 80 3H-RX821002 -3 7 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 205126 80 3H-RX821002 -3 7 Human 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
6040 216033 0 3H-RAUWOLSCINE -1 3 Rat 8.7 pKi = 8.7 Binding
NoneNone
PDSP KiDatabase 233 2 0 3 2.3 C1CCN(CC1)CC2COC3=CC=CC=C3O2 None
122211 462 0 3H-RAUWOLSCINE -6 6 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
524 462 0 3H-RAUWOLSCINE -6 6 Human 8.6 pKi = 8.6 Binding
NoneNone
PDSP KiDatabase 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C None
44438165 166784 0 UNDEFINED -223 3 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 None
CHEMBL428407 166784 0 UNDEFINED -223 3 Human 5.7 pKi = 5.7 Binding
NoneNone
PDSP KiDatabase 467 9 1 7 3.3 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NCCN(C)C)cc13)CC2 None
164512323 216031 0 3H-RAUWOLSCINE -12 5 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 216031 0 3H-RAUWOLSCINE -12 5 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
124 2981 47 3H-RAUWOLSCINE -977 33 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 3H-RAUWOLSCINE -977 33 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 3H-RAUWOLSCINE -977 33 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 3H-RAUWOLSCINE -977 33 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 3H-RAUWOLSCINE -977 33 Human 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2726 919 68 3H-RAUWOLSCINE -13 72 Rat 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 3H-RAUWOLSCINE -13 72 Rat 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 3H-RAUWOLSCINE -13 72 Rat 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 3H-RAUWOLSCINE -13 72 Rat 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 3H-RAUWOLSCINE -13 72 Rat 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
135398737 958 93 3H-RAUWOLSCINE -9 89 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-RAUWOLSCINE -9 89 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-RAUWOLSCINE -9 89 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-RAUWOLSCINE -9 89 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-RAUWOLSCINE -9 89 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
1524 2181 96 3H-RAUWOLSCINE -169 52 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
197 2181 96 3H-RAUWOLSCINE -169 52 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
3822 2181 96 3H-RAUWOLSCINE -169 52 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
88 2181 96 3H-RAUWOLSCINE -169 52 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
CHEMBL51 2181 96 3H-RAUWOLSCINE -169 52 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
DB12465 2181 96 3H-RAUWOLSCINE -169 52 Rat 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
4209 3163 75 3H-RAUWOLSCINE -309 33 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 3H-RAUWOLSCINE -309 33 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 3H-RAUWOLSCINE -309 33 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 3H-RAUWOLSCINE -309 33 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 3H-RAUWOLSCINE -309 33 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 3H-RAUWOLSCINE -309 33 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
162265 202274 22 3H-CLONIDINE -16 43 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 202274 22 3H-CLONIDINE -16 43 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 202274 22 3H-CLONIDINE -16 43 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
3337 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
4158 205341 21 125I-Clonidine -1 21 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL1722 205341 21 125I-Clonidine -1 21 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL796 205341 21 125I-Clonidine -1 21 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
3337 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 206367 27 3H-CLONIDINE -14 40 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
15897 2862 0 3H-CLONIDINE -63 36 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
215 2862 0 3H-CLONIDINE -63 36 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
CHEMBL1979333 2862 0 3H-CLONIDINE -63 36 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 203 2 1 1 2.6 CC(Cc1cccc(c1)C(F)(F)F)N None
2726 919 68 3H-RAUWOLSCINE -13 72 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 3H-RAUWOLSCINE -13 72 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 3H-RAUWOLSCINE -13 72 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 3H-RAUWOLSCINE -13 72 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 3H-RAUWOLSCINE -13 72 Rat 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
2 3261 23 3H-RX821002 -524 29 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
54562 3261 23 3H-RX821002 -524 29 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
CHEMBL240773 3261 23 3H-RX821002 -524 29 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 219 2 1 2 2.0 CCCN1CCC[C@H]2[C@H]1Cc1cn[nH]c1C2 None
1028 291 71 3H-RAUWOLSCINE -128 30 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 291 71 3H-RAUWOLSCINE -128 30 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 291 71 3H-RAUWOLSCINE -128 30 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 291 71 3H-RAUWOLSCINE -128 30 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 291 71 3H-RAUWOLSCINE -128 30 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 291 71 3H-RAUWOLSCINE -128 30 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
100 3805 58 3H-RAUWOLSCINE -125 55 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 3H-RAUWOLSCINE -125 55 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 3H-RAUWOLSCINE -125 55 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 3H-RAUWOLSCINE -125 55 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 3H-RAUWOLSCINE -125 55 Rat 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
135398737 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2726 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
135398737 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398737 958 93 3H-RAUWOLSCINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-RAUWOLSCINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-RAUWOLSCINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-RAUWOLSCINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-CLONIDINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-RAUWOLSCINE -9 89 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135 2532 43 3H-RAUWOLSCINE -8 58 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2532 43 3H-RAUWOLSCINE -8 58 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2532 43 3H-RAUWOLSCINE -8 58 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2532 43 3H-RAUWOLSCINE -8 58 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2532 43 3H-RAUWOLSCINE -8 58 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
185 4006 60 3H-CLONIDINE -831 37 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
5311271 4006 60 3H-CLONIDINE -831 37 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
CHEMBL74355 4006 60 3H-CLONIDINE -831 37 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
DB16351 4006 60 3H-CLONIDINE -831 37 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 373 7 1 4 3.8 COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O None
484 2858 51 35S-GTPGammaS -2 35 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2858 51 35S-GTPGammaS -2 35 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2858 51 35S-GTPGammaS -2 35 Human 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2726 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 3H-CLONIDINE -8 72 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
3952 1888 38 35S-GTPGammaS -18 12 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1888 38 35S-GTPGammaS -18 12 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1888 38 35S-GTPGammaS -18 12 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1888 38 35S-GTPGammaS -18 12 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1888 38 35S-GTPGammaS -18 12 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1888 38 35S-GTPGammaS -18 12 Human 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
2202 3132 96 3H-RX821002 -1 21 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 3132 96 3H-RX821002 -1 21 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 3132 96 3H-RX821002 -1 21 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 3132 96 3H-RX821002 -1 21 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 3132 96 3H-RX821002 -1 21 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
2216 446 50 35S-GTPGammaS -2 6 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 446 50 35S-GTPGammaS -2 6 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 446 50 35S-GTPGammaS -2 6 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 446 50 35S-GTPGammaS -2 6 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 446 50 35S-GTPGammaS -2 6 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
124 2981 47 3H-MK912 -977 33 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 3H-MK912 -977 33 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 3H-MK912 -977 33 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 3H-MK912 -977 33 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 3H-MK912 -977 33 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
11293787 148213 0 UNDEFINED -27 3 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 None
CHEMBL393597 148213 0 UNDEFINED -27 3 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 447 6 0 5 5.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4F)cc13)CC2 None
2136 3095 30 3H-RAUWOLSCINE -3 6 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
4768 3095 30 3H-RAUWOLSCINE -3 6 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
7268 3095 30 3H-RAUWOLSCINE -3 6 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
CHEMBL753 3095 30 3H-RAUWOLSCINE -3 6 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
DB00925 3095 30 3H-RAUWOLSCINE -3 6 Human 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
2142 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
108094 3423 27 3H-MK912 -6 4 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
526 3423 27 3H-MK912 -6 4 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
528 3423 27 3H-MK912 -6 4 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
CHEMBL10332 3423 27 3H-MK912 -6 4 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 None
4209 3163 75 3H-RAUWOLSCINE -309 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 3H-RAUWOLSCINE -309 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 3H-RAUWOLSCINE -309 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 3H-RAUWOLSCINE -309 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 3H-RAUWOLSCINE -309 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 3H-RAUWOLSCINE -309 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
124 2981 47 3H-RAUWOLSCINE -213 33 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 3H-RAUWOLSCINE -213 33 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 3H-RAUWOLSCINE -213 33 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 3H-RAUWOLSCINE -213 33 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 3H-RAUWOLSCINE -213 33 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2803 955 58 35S-GTPGammaS -1 19 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 35S-GTPGammaS -1 19 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 35S-GTPGammaS -1 19 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 35S-GTPGammaS -1 19 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 35S-GTPGammaS -1 19 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
164512323 216031 0 3H-RAUWOLSCINE -12 5 Rat 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 216031 0 3H-RAUWOLSCINE -12 5 Rat 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
2695 3841 81 35S-GTPGammaS -69 6 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3841 81 35S-GTPGammaS -69 6 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3841 81 35S-GTPGammaS -69 6 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3841 81 35S-GTPGammaS -69 6 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3841 81 35S-GTPGammaS -69 6 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2105 3054 37 3H-RX821002 -35 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 3054 37 3H-RX821002 -35 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 3054 37 3H-RX821002 -35 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 3054 37 3H-RX821002 -35 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 3054 37 3H-RX821002 -35 33 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
1212 1662 50 3H-RAUWOLSCINE -645 65 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1662 50 3H-RAUWOLSCINE -645 65 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1662 50 3H-RAUWOLSCINE -645 65 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1662 50 3H-RAUWOLSCINE -645 65 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1662 50 3H-RAUWOLSCINE -645 65 Rat 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2142 3096 58 35S-GTPGammaS -5 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 35S-GTPGammaS -5 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 35S-GTPGammaS -5 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 35S-GTPGammaS -5 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 35S-GTPGammaS -5 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 35S-GTPGammaS -5 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
68602 205126 80 35S-GTPGammaS -3 7 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
CHEMBL77921 205126 80 35S-GTPGammaS -3 7 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C None
44438148 93490 0 UNDEFINED -34 3 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 None
CHEMBL246229 93490 0 UNDEFINED -34 3 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 430 6 0 6 5.1 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccn4)cc13)CC2 None
484 2858 51 35S-GTPGammaS -2 35 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2858 51 35S-GTPGammaS -2 35 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2858 51 35S-GTPGammaS -2 35 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
31101 729 40 3H-RX821002 -33 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 729 40 3H-RX821002 -33 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 729 40 3H-RX821002 -33 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 729 40 3H-RX821002 -33 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 729 40 3H-RX821002 -33 36 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
100 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
100 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 3H-CLONIDINE -35 55 Human 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
523 4106 93 35S-GTPGammaS -1 5 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
5707 4106 93 35S-GTPGammaS -1 5 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
CHEMBL297362 4106 93 35S-GTPGammaS -1 5 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
DB11477 4106 93 35S-GTPGammaS -1 5 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C None
162265 202274 22 3H-CLONIDINE -16 43 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 202274 22 3H-CLONIDINE -16 43 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 202274 22 3H-CLONIDINE -16 43 Human 5.5 pKi = 5.5 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
2181 3128 46 3H-RAUWOLSCINE -13 35 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 3128 46 3H-RAUWOLSCINE -13 35 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 3128 46 3H-RAUWOLSCINE -13 35 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 3128 46 3H-RAUWOLSCINE -13 35 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 3128 46 3H-RAUWOLSCINE -13 35 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
12575 1988 30 35S-GTPGammaS -53 17 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1988 30 35S-GTPGammaS -53 17 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1988 30 35S-GTPGammaS -53 17 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
44438147 93489 0 UNDEFINED -19 3 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 None
CHEMBL246228 93489 0 UNDEFINED -19 3 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 406 5 1 9 2.5 COc1cc2c(cc1OC)CN(Cc1cnc(N)n3nc(-c4ccco4)nc13)CC2 None
2803 955 58 3H-RX821002 -1 19 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 3H-RX821002 -1 19 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 3H-RX821002 -1 19 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 3H-RX821002 -1 19 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 3H-RX821002 -1 19 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
162265 202274 22 3H-CLONIDINE -16 43 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 202274 22 3H-CLONIDINE -16 43 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 202274 22 3H-CLONIDINE -16 43 Human 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
3652 46244 70 None -4 9 Human 8.4 pKi = 8.4 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 None
CHEMBL1535 46244 70 None -4 9 Human 8.4 pKi = 8.4 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 335 9 2 4 3.8 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 None
None 215958 0 3H-RAUWOLSCINE -112 19 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
2719 917 74 None -10 11 Human 8.4 pKi = 8.4 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
5535 917 74 None -10 11 Human 8.4 pKi = 8.4 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
607 917 74 None -10 11 Human 8.4 pKi = 8.4 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
CHEMBL76 917 74 None -10 11 Human 8.4 pKi = 8.4 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
DB00608 917 74 None -10 11 Human 8.4 pKi = 8.4 Binding
Activity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscineActivity of compound against Alpha 2B (ADRA2B) adrenergic receptor by displacement of [3H]-rauwolscine
Drug Central 319 8 1 3 4.8 CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC None
2216 446 50 3H-RAUWOLSCINE -2 6 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 446 50 3H-RAUWOLSCINE -2 6 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 446 50 3H-RAUWOLSCINE -2 6 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 446 50 3H-RAUWOLSCINE -2 6 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 446 50 3H-RAUWOLSCINE -2 6 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
219050 3373 25 3H-RX821002 -29 21 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
52 3373 25 3H-RX821002 -29 21 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
CHEMBL431367 3373 25 3H-RX821002 -29 21 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 None
138107169 215952 0 3H-MK912 -5 22 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 215952 0 3H-MK912 -5 22 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
12575 1988 30 3H-RAUWOLSCINE -3 17 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
54459 1988 30 3H-RAUWOLSCINE -3 17 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
CHEMBL10316 1988 30 3H-RAUWOLSCINE -3 17 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 None
2726 919 68 3H-RAUWOLSCINE -8 72 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 3H-RAUWOLSCINE -8 72 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 3H-RAUWOLSCINE -8 72 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 3H-RAUWOLSCINE -8 72 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 3H-RAUWOLSCINE -8 72 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
55245 18580 81 None -3 3 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 429 2 1 3 5.4 CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C None
CHEMBL1276308 18580 81 None -3 3 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 429 2 1 3 5.4 CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C None
28417 40039 49 None -1 12 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C None
CHEMBL1479 40039 49 None -1 12 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 337 0 1 3 4.2 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C None
10297 27112 30 3H-CLONIDINE -1 42 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 None
CHEMBL136560 27112 30 3H-CLONIDINE -1 42 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 None
11079 2733 63 35S-GTPGammaS -3 5 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2733 63 35S-GTPGammaS -3 5 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2733 63 35S-GTPGammaS -3 5 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2733 63 35S-GTPGammaS -3 5 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2733 63 35S-GTPGammaS -3 5 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2733 63 35S-GTPGammaS -3 5 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
2435 3590 83 3H-CLONIDINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
2435 3590 83 3H-RAUWOLSCINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3590 83 3H-CLONIDINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3590 83 3H-RAUWOLSCINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3590 83 3H-CLONIDINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3590 83 3H-RAUWOLSCINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3590 83 3H-CLONIDINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3590 83 3H-RAUWOLSCINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3590 83 3H-CLONIDINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3590 83 3H-RAUWOLSCINE -104 48 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
135 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2532 43 3H-RAUWOLSCINE -13 58 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
164512323 216031 0 3H-RAUWOLSCINE -12 5 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
6419959 216031 0 3H-RAUWOLSCINE -12 5 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 352 1 1 4 3.2 CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 None
1222 1664 49 3H-RAUWOLSCINE -30 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 1664 49 3H-RAUWOLSCINE -30 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 1664 49 3H-RAUWOLSCINE -30 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 1664 49 3H-RAUWOLSCINE -30 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 1664 49 3H-RAUWOLSCINE -30 33 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
2865 4143 73 3H-CLONIDINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
2865 4143 73 3H-RAUWOLSCINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4143 73 3H-CLONIDINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4143 73 3H-RAUWOLSCINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4143 73 3H-CLONIDINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4143 73 3H-RAUWOLSCINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4143 73 3H-CLONIDINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4143 73 3H-RAUWOLSCINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4143 73 3H-CLONIDINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4143 73 3H-RAUWOLSCINE -38 53 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
1353 1911 93 3H-CLONIDINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
1353 1911 93 3H-RAUWOLSCINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1911 93 3H-CLONIDINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1911 93 3H-RAUWOLSCINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1911 93 3H-CLONIDINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1911 93 3H-RAUWOLSCINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1911 93 3H-CLONIDINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1911 93 3H-RAUWOLSCINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1911 93 3H-CLONIDINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1911 93 3H-RAUWOLSCINE -85 83 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
122295 9868 7 3H-RAUWOLSCINE -1 9 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
CHEMBL114166 9868 7 3H-RAUWOLSCINE -1 9 Rat 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 None
103 4153 61 3H-CLONIDINE -5 53 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4153 61 3H-CLONIDINE -5 53 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4153 61 3H-CLONIDINE -5 53 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4153 61 3H-CLONIDINE -5 53 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4153 61 3H-CLONIDINE -5 53 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
3823 50221 42 None -43 10 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
76973198 50221 42 None -43 10 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL157101 50221 42 None -43 10 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
2142 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 3H-RAUWOLSCINE -1 36 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
None 216032 0 3H-RAUWOLSCINE -9 3 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 401 6 1 5 0.6 CS(=O)(=O)NCCN(C1CCN2CCC3=CC=CC=C3C2C1)S(=O)(=O)C None
176 398 66 None -4 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2157 398 66 None -4 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
2566 398 66 None -4 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
CHEMBL633 398 66 None -4 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
DB01118 398 66 None -4 31 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 None
448537 160250 89 None -33 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 160250 89 None -33 25 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
67409 216034 0 3H-RAUWOLSCINE 2 3 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 235 2 0 1 3.9 C=CCN1CC2=CC=CC=C2C3=CC=CC=C3C1 None
8966 216034 0 3H-RAUWOLSCINE 2 3 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 235 2 0 1 3.9 C=CCN1CC2=CC=CC=C2C3=CC=CC=C3C1 None
4209 3163 75 3H-RAUWOLSCINE -48 33 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 3H-RAUWOLSCINE -48 33 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 3H-RAUWOLSCINE -48 33 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 3H-RAUWOLSCINE -48 33 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 3H-RAUWOLSCINE -48 33 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 3H-RAUWOLSCINE -48 33 Rat 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
2812 4779 101 None -29 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
CHEMBL104 4779 101 None -29 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
2695 3841 81 None -69 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3841 81 None -69 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3841 81 None -69 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3841 81 None -69 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3841 81 None -69 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5282379 194984 69 None -2 3 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1 None
CHEMBL547 194984 69 None -2 3 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1 None
3198 205513 76 None -24 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1201049 205513 76 None -24 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL808 205513 76 None -24 34 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
4158 205341 21 None -1 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL1722 205341 21 None -1 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
CHEMBL796 205341 21 None -1 21 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 233 3 1 3 2.1 COC(=O)C(c1ccccc1)C1CCCCN1 None
134 2514 24 None -93 67 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1775 2514 24 None -93 67 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
9681 2514 24 None -93 67 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
CHEMBL1065 2514 24 None -93 67 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
DB00247 2514 24 None -93 67 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO None
1210 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
1213 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
2725 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
33036 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
4411 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
616 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
6976 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
716121 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL1201353 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL1554789 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
CHEMBL505 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
DB01114 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
DB13679 918 51 None -234 21 Human 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C None
103 4153 61 3H-RAUWOLSCINE -5 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4153 61 3H-RAUWOLSCINE -5 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4153 61 3H-RAUWOLSCINE -5 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4153 61 3H-RAUWOLSCINE -5 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4153 61 3H-RAUWOLSCINE -5 53 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2247 505 81 None -57 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
249 505 81 None -57 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2603 505 81 None -57 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
CHEMBL296419 505 81 None -57 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
DB00637 505 81 None -57 42 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2540 4401 111 None -1 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 None
CHEMBL1014 4401 111 None -1 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 None
2351 3286 64 None -15 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2820 3286 64 None -15 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
5035 3286 64 None -15 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
CHEMBL81 3286 64 None -15 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
DB00481 3286 64 None -15 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
5353853 17986 47 None -17 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
9556529 17986 47 None -17 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL1262 17986 47 None -17 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
1016 3747 78 None -18 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2561 3747 78 None -18 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2733526 3747 78 None -18 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
5384 3747 78 None -18 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
CHEMBL83 3747 78 None -18 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
DB00675 3747 78 None -18 35 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
5318 15576 49 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1200348 15576 49 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1221 15576 49 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 396 6 0 3 6.5 Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
4189 206922 96 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL1559 206922 96 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
CHEMBL91 206922 96 None -18 34 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 414 6 0 3 6.5 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 None
4098 32505 30 None -23 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
CHEMBL1255739 32505 30 None -23 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
CHEMBL1411979 32505 30 None -23 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 261 6 0 4 2.7 CN(C)CCN(Cc1cccs1)c1ccccn1 None
3117 207841 103 None -2 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
CHEMBL964 207841 103 None -2 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
3236 67609 43 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 259 5 0 2 3.6 CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 None
CHEMBL1902981 67609 43 None -1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 259 5 0 2 3.6 CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 None
36811 1454 37 None -4 7 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
535 1454 37 None -4 7 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
937 1454 37 None -4 7 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
CHEMBL926 1454 37 None -4 7 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
DB00841 1454 37 None -4 7 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
441383 20333 57 None -4 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL1306 20333 57 None -4 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
5210 33338 48 None 123 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 None
CHEMBL1200765 33338 48 None 123 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 None
CHEMBL1419 33338 48 None 123 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 279 5 0 1 4.7 CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 None
3658 4107 53 None -114 8 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4107 53 None -114 8 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4107 53 None -114 8 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4107 53 None -114 8 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4107 53 None -114 8 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
1547484 940 74 None -12 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
654 940 74 None -12 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
9072 940 74 None -12 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
CHEMBL43064 940 74 None -12 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
DB00568 940 74 None -12 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
11954259 215979 0 3H-CLONIDINE -165 43 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 443 5 0 5 3.5 CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C None
11954259 215979 0 3H-CLONIDINE -165 43 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 443 5 0 5 3.5 CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C None
104870 98880 47 35S-GTPGammaS -3 21 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98880 47 35S-GTPGammaS -3 21 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98880 47 35S-GTPGammaS -3 21 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
1830 2590 44 3H-CLONIDINE -10 28 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 2590 44 3H-CLONIDINE -10 28 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 2590 44 3H-CLONIDINE -10 28 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 2590 44 3H-CLONIDINE -10 28 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 2590 44 3H-CLONIDINE -10 28 Human 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
115237 55585 119 3H-CLONIDINE -67 54 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55585 119 3H-CLONIDINE -67 54 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
44438161 147141 0 UNDEFINED -63 3 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 None
CHEMBL392771 147141 0 UNDEFINED -63 3 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 543 10 1 7 5.0 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4cccc(C(=O)NCCN(C)C)c4)cc13)CC2 None
None 216036 0 3H-RAUWOLSCINE 5 3 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 334 4 1 4 4.6 CN(C)CCCN1C2=C(C=C(C=C2)O)SC3=C1C=C(C=C3)Cl None
3075702 217332 0 3H-RAUWOLSCINE -1 37 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 198 3 1 3 1.5 C1CNC1COC2=CN=C(C=C2)Cl None
12574 2605 88 None -12 6 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
4810 2605 88 None -12 6 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
CHEMBL19236 2605 88 None -12 6 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
DB09242 2605 88 None -12 6 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC None
124087 1389 114 None -28 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 None
7157 1389 114 None -28 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 None
814 1389 114 None -28 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 None
CHEMBL1172 1389 114 None -28 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 None
DB00967 1389 114 None -28 15 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 None
3151 1462 97 None -97 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 1462 97 None -97 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 1462 97 None -97 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 1462 97 None -97 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 1462 97 None -97 27 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
12488 1657 56 None -12 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
941361 1657 56 None -12 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
CHEMBL30008 1657 56 None -12 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
DB04841 1657 56 None -12 23 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
119584 2595 102 None -2 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
1848 2595 102 None -2 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
242 2595 102 None -2 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
CHEMBL60889 2595 102 None -2 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
DB11675 2595 102 None -2 5 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 421 7 2 5 3.1 CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl None
4601 206747 35 None -3 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
CHEMBL1201023 206747 35 None -3 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
CHEMBL900 206747 35 None -3 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 None
237 204865 48 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL546257 204865 48 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL554190 204865 48 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
CHEMBL7568 204865 48 None -1 13 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 399 9 1 4 6.0 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12 None
16362 3125 71 None -363 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 3125 71 None -363 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 3125 71 None -363 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 3125 71 None -363 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 3125 71 None -363 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
5029 15545 92 None -13 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C None
CHEMBL1219 15545 92 None -13 4 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C None
9906855 217743 0 None -1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 359 8 1 5 3.0 COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C None
2402 3370 62 None -4 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
5095 3370 62 None -4 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
7295 3370 62 None -4 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
CHEMBL589 3370 62 None -4 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
DB00268 3370 62 None -4 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
2337 3256 77 None -12 62 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3256 77 None -12 62 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3256 77 None -12 62 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3256 77 None -12 62 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3256 77 None -12 62 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
10836 14467 14 None 1 9 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
CHEMBL1201201 14467 14 None 1 9 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
1548955 88581 20 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
2800 88581 20 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
CHEMBL2355051 88581 20 None -1 18 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 None
1209 1658 75 None -12 32 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
203 1658 75 None -12 32 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
3386 1658 75 None -12 32 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
CHEMBL41 1658 75 None -12 32 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
DB00472 1658 75 None -12 32 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
2662 11384 131 None -1 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 None
CHEMBL118 11384 131 None -1 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 381 3 1 4 3.5 Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 None
2342 599 39 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
331 599 39 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
7124 599 39 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
CHEMBL1201250 599 39 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
DB00767 599 39 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 404 6 0 6 2.4 CCN(C(=O)C1CN2CCc3c(C2CC1OC(=O)C)cc(c(c3)OC)OC)CC None
463 1405 22 None -57 12 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1405 22 None -57 12 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1405 22 None -57 12 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1405 22 None -57 12 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1405 22 None -57 12 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
124 2981 47 None -977 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 None -977 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 None -977 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 None -977 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 None -977 33 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
119570 3159 96 None -48 40 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3159 96 None -48 40 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3159 96 None -48 40 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3159 96 None -48 40 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3159 96 None -48 40 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
11057 176149 23 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
3468 176149 23 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
CHEMBL459265 176149 23 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
CHEMBL64894 176149 23 None -1 20 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 None
2406 100404 89 None -10 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O None
CHEMBL290106 100404 89 None -10 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O None
1830 2590 44 None -10 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 2590 44 None -10 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 2590 44 None -10 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 2590 44 None -10 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 2590 44 None -10 28 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
1443 2028 34 None -12 10 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 2028 34 None -12 10 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 2028 34 None -12 10 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 2028 34 None -12 10 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 2028 34 None -12 10 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
240 944 43 None -11 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2769 944 43 None -11 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
44279790 944 43 None -11 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
660 944 43 None -11 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL1729 944 43 None -11 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL560739 944 43 None -11 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
DB00604 944 43 None -11 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
3033538 1319 39 None -11 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
7155 1319 39 None -11 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
781 1319 39 None -11 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
CHEMBL1201216 1319 39 None -11 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
DB00298 1319 39 None -11 9 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
1353 1911 93 None -85 83 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1911 93 None -85 83 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1911 93 None -85 83 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1911 93 None -85 83 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1911 93 None -85 83 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
5511 5488 40 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 245 4 0 2 3.3 Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1 None
CHEMBL1076211 5488 40 None - 1 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 245 4 0 2 3.3 Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1 None
2435 3590 83 None -104 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3590 83 None -104 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3590 83 None -104 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3590 83 None -104 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3590 83 None -104 48 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
11079 2733 63 None -3 5 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
3369 2733 63 None -3 5 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
4436 2733 63 None -3 5 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
5509 2733 63 None -3 5 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
CHEMBL761 2733 63 None -3 5 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
DB06711 2733 63 None -3 5 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 None
1028 291 71 None -128 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 291 71 None -128 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 291 71 None -128 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 291 71 None -128 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 291 71 None -128 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 291 71 None -128 30 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
33630 178957 99 None -9 28 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assayDisplacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assay
Drug Central 523 7 1 2 7.5 OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 None
CHEMBL47050 178957 99 None -9 28 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assayDisplacement of [3H]Rauwolscine from human alpha 2B adrenergic receptor expressed in HEK293T cells by radioligand binding assay
Drug Central 523 7 1 2 7.5 OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 None
3191 102858 97 None -9 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
CHEMBL305660 102858 97 None -9 25 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
100 3805 58 None -35 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 None -35 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 None -35 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 None -35 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 None -35 55 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
1530 2182 50 None -46 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
3827 2182 50 None -46 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
7206 2182 50 None -46 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
CHEMBL534 2182 50 None -46 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
DB00920 2182 50 None -46 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 None
2284 3182 33 None -3 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 3182 33 None -3 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 3182 33 None -3 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 3182 33 None -3 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 3182 33 None -3 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
2335 11848 22 None -2 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
8478 11848 22 None -2 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
CHEMBL1182210 11848 22 None -2 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
CHEMBL221753 11848 22 None -2 12 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 None
2202 3132 96 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 3132 96 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 3132 96 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 3132 96 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 3132 96 None -1 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
162265 202274 22 None 5 43 Rat 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 202274 22 None 5 43 Rat 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 202274 22 None 5 43 Rat 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
191 403 98 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
201 403 98 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
2170 403 98 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
CHEMBL1113 403 98 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
DB00543 403 98 None -30 29 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
3561 19077 39 None -1 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl None
CHEMBL1289 19077 39 None -1 11 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 360 2 0 1 4.4 Clc1cc(Cl)c(OCC#CI)cc1Cl None
66265 94013 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL248702 94013 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
1890 2759 49 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
4449 2759 49 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
7247 2759 49 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
CHEMBL623 2759 49 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
DB01149 2759 49 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
150 2509 21 None -27 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
1764 2509 21 None -27 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
8226 2509 21 None -27 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
CHEMBL1201356 2509 21 None -27 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
DB00353 2509 21 None -27 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO None
104870 98880 47 None -3 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98880 47 None -3 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98880 47 None -3 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
1524 2181 96 None -27 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
197 2181 96 None -27 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
3822 2181 96 None -27 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
88 2181 96 None -27 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
CHEMBL51 2181 96 None -27 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
DB12465 2181 96 None -27 52 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
6075 150108 42 None -6 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
CHEMBL395110 150108 42 None -6 16 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
213 3853 55 None -3 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3853 55 None -3 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3853 55 None -3 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3853 55 None -3 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3853 55 None -3 44 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
26757 207978 31 None 1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 None
CHEMBL972 207978 31 None 1 2 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 None
3294 2006 111 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 2006 111 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 2006 111 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 2006 111 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 2006 111 None -47 45 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
214 3860 58 None -39 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 3860 58 None -39 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 3860 58 None -39 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 3860 58 None -39 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 3860 58 None -39 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 3860 58 None -39 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2142 3096 58 3H-RAUWOLSCINE -5 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 3H-RAUWOLSCINE -5 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 3H-RAUWOLSCINE -5 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 3H-RAUWOLSCINE -5 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 3H-RAUWOLSCINE -5 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 3H-RAUWOLSCINE -5 36 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
26987 949 33 None -281 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
6063 949 33 None -281 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
671 949 33 None -281 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
CHEMBL1626 949 33 None -281 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
DB00283 949 33 None -281 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
5472 205818 75 None 1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
CHEMBL1717 205818 75 None 1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
CHEMBL833 205818 75 None 1 3 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 None
5524 216464 0 None -1 4 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 215 1 2 3 1.9 C1CCC2=C(C1)C=CC=C2NC3=NCCN3 None
1042 1581 23 None -47 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
148 1581 23 None -47 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
443884 1581 23 None -47 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
CHEMBL119443 1581 23 None -47 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
DB01253 1581 23 None -47 17 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 325 3 3 3 1.5 OC[C@@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C None
4011 82408 49 None -16 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 82408 49 None -16 24 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
135398737 958 93 3H-RAUWOLSCINE -9 89 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-RAUWOLSCINE -9 89 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-RAUWOLSCINE -9 89 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-RAUWOLSCINE -9 89 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-RAUWOLSCINE -9 89 Rat 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
3584 3777 64 None -21 13 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3777 64 None -21 13 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3777 64 None -21 13 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3777 64 None -21 13 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3777 64 None -21 13 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
1613 2348 53 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2348 53 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2348 53 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2348 53 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2348 53 None -7 44 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
209 3057 97 None -38 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 3057 97 None -38 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 3057 97 None -38 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 3057 97 None -38 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 3057 97 None -38 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
242 470 124 None -64 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 470 124 None -64 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 470 124 None -64 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 470 124 None -64 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 470 124 None -64 51 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
119570 3159 96 3H-RX821002 -48 40 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3159 96 3H-RX821002 -48 40 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3159 96 3H-RX821002 -48 40 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3159 96 3H-RX821002 -48 40 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3159 96 3H-RX821002 -48 40 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
1028 291 71 35S-GTPGammaS -128 30 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 291 71 35S-GTPGammaS -128 30 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 291 71 35S-GTPGammaS -128 30 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 291 71 35S-GTPGammaS -128 30 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 291 71 35S-GTPGammaS -128 30 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 291 71 35S-GTPGammaS -128 30 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
25137849 216179 0 3H-CLONIDINE -1 40 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
71290 216179 0 3H-CLONIDINE -1 40 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 165 3 2 2 1.3 CC(C(C1=CC=CC=C1)O)NC None
121850 726 0 3H-MK912 -131 3 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
525 726 0 3H-MK912 -131 3 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
CHEMBL216097 726 0 3H-MK912 -131 3 Human 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 None
25058166 215960 0 3H-RX821002 -33 27 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 267 0 2 3 2.9 CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O None
6852389 215960 0 3H-RX821002 -33 27 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 267 0 2 3 2.9 CN1CCC2=CC=CC3=C2C1CC4=C3C(=C(C=C4)O)O None
None 216240 0 3H-RX821002 -47 2 Rat 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 457 7 1 3 4.9 CCC(=O)NC1=C(C=C(C=C1C)C(=O)N2CCC(CC2)N(C)CCC3=CC=CC=C3)C.Cl None
133621 2012 0 35S-GTPGammaS -1 5 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
3470 2012 0 35S-GTPGammaS -1 5 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
CHEMBL347695 2012 0 35S-GTPGammaS -1 5 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 None
119570 3159 96 3H-CLONIDINE -48 40 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
2233 3159 96 3H-CLONIDINE -48 40 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
953 3159 96 3H-CLONIDINE -48 40 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
CHEMBL301265 3159 96 3H-CLONIDINE -48 40 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
DB00413 3159 96 3H-CLONIDINE -48 40 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N None
6917970 3691 61 3H-CLONIDINE -1584 34 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
8370 3691 61 3H-CLONIDINE -1584 34 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
CHEMBL487387 3691 61 3H-CLONIDINE -1584 34 Human 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O None
2803 955 58 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 35S-GTPGammaS -1 19 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3168 9262 92 None -39 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
CHEMBL1108 9262 92 None -39 21 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
1971 2866 38 None -3 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2404 2866 38 None -3 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
4543 2866 38 None -3 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
CHEMBL445 2866 38 None -3 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
DB00540 2866 38 None -3 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
68617 205527 62 None -3 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL1709 205527 62 None -3 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL809 205527 62 None -3 26 Human 8.2 pKi = 8.2 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
1212 1662 50 None -38 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1662 50 None -38 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1662 50 None -38 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1662 50 None -38 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1662 50 None -38 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
135398745 2914 112 None -37 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2914 112 None -37 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2914 112 None -37 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2914 112 None -37 65 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
3389 217711 0 None -1 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 549 12 0 6 6.8 CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 None
37 778 60 None -9 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
460 778 60 None -9 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
54746 778 60 None -9 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
CHEMBL1201087 778 60 None -9 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
DB00248 778 60 None -9 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
1960 2857 67 None -4 26 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2857 67 None -4 26 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2857 67 None -4 26 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2857 67 None -4 26 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2857 67 None -4 26 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat Alpha-2B adrenergic receptorBinding affinity for rat Alpha-2B adrenergic receptor
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
3952 1888 38 None -18 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1888 38 None -18 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1888 38 None -18 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1888 38 None -18 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1888 38 None -18 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1888 38 None -18 12 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
1593 2340 66 None -6 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
30668 2340 66 None -6 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
9868 2340 66 None -6 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
CHEMBL17860 2340 66 None -6 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
DB04948 2340 66 None -6 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cellsDisplacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells
Drug Central 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl None
228 445 28 None -3 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
33 445 28 None -3 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
6005 445 28 None -3 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
CHEMBL53 445 28 None -3 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
DB00714 445 28 None -3 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
2803 955 58 3H-RAUWOLSCINE -1 19 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 3H-RAUWOLSCINE -1 19 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 3H-RAUWOLSCINE -1 19 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 3H-RAUWOLSCINE -1 19 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 3H-RAUWOLSCINE -1 19 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
2435 722 100 None -3 12 Rat 8.1 pKi = 8.1 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 722 100 None -3 12 Rat 8.1 pKi = 8.1 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 722 100 None -3 12 Rat 8.1 pKi = 8.1 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 722 100 None -3 12 Rat 8.1 pKi = 8.1 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 722 100 None -3 12 Rat 8.1 pKi = 8.1 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 722 100 None -3 12 Rat 8.1 pKi = 8.1 Binding
Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cellsDisplacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
212 3806 47 None -6 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2639 3806 47 None -6 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
941651 3806 47 None -6 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
CHEMBL1201 3806 47 None -6 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
DB01623 3806 47 None -6 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
1222 1664 49 None -30 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 1664 49 None -30 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 1664 49 None -30 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 1664 49 None -30 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 1664 49 None -30 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
2865 4143 73 None -38 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4143 73 None -38 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4143 73 None -38 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4143 73 None -38 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4143 73 None -38 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
2398 954 62 None -2 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2801 954 62 None -2 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
701 954 62 None -2 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
CHEMBL415 954 62 None -2 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
DB01242 954 62 None -2 29 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2585 803 103 None -29 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 803 103 None -29 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 803 103 None -29 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 803 103 None -29 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 803 103 None -29 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
68712 100338 60 None 1 5 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 100338 60 None 1 5 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
135398737 958 93 None -9 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 None -9 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 None -9 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 None -9 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 None -9 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2181 3128 46 None -13 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 3128 46 None -13 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 3128 46 None -13 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 3128 46 None -13 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 3128 46 None -13 35 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
2803 955 58 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 None -1 19 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counterDisplacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
31101 729 40 None -33 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 729 40 None -33 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 729 40 None -33 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 729 40 None -33 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 729 40 None -33 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
2105 3054 37 None -35 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 3054 37 None -35 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 3054 37 None -35 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 3054 37 None -35 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 3054 37 None -35 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
1201549 597 24 None -13 20 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
333 597 24 None -13 20 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
7601 597 24 None -13 20 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL1201203 597 24 None -13 20 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL438151 597 24 None -13 20 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
DB00245 597 24 None -13 20 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
135 2532 43 None -8 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2532 43 None -8 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2532 43 None -8 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2532 43 None -8 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2532 43 None -8 58 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
2726 919 68 None -8 72 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 None -8 72 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 None -8 72 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 None -8 72 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 None -8 72 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
2286 3183 51 None -4 30 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
4927 3183 51 None -4 30 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
7282 3183 51 None -4 30 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
CHEMBL643 3183 51 None -4 30 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
DB01069 3183 51 None -4 30 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
115237 55585 119 None -67 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55585 119 None -67 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
277 1301 62 None -13 50 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 1301 62 None -13 50 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 1301 62 None -13 50 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 1301 62 None -13 50 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 1301 62 None -13 50 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
11978813 721 79 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
5014 721 79 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
7672 721 79 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
CHEMBL2105760 721 79 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
DB09128 721 79 None -9 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
2389 3331 118 None -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 None -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 None -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 None -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 None -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
4209 3163 75 None -309 33 Human 8.1 pKi = 8.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 None -309 33 Human 8.1 pKi = 8.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 None -309 33 Human 8.1 pKi = 8.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 None -309 33 Human 8.1 pKi = 8.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 None -309 33 Human 8.1 pKi = 8.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 None -309 33 Human 8.1 pKi = 8.1 Binding
Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptorAbility to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
None 215958 0 3H-RAUWOLSCINE -52 19 Rat 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
134551 358 27 None -7 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
271 358 27 None -7 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
885 358 27 None -7 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
CHEMBL1403281 358 27 None -7 21 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
5284550 41721 15 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 None
CHEMBL1492500 41721 15 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 None
2216 446 50 None -2 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 446 50 None -2 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 446 50 None -2 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 446 50 None -2 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 446 50 None -2 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
124 2981 47 3H-RAUWOLSCINE -213 33 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 3H-RAUWOLSCINE -213 33 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 3H-RAUWOLSCINE -213 33 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 3H-RAUWOLSCINE -213 33 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 3H-RAUWOLSCINE -213 33 Rat 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 216341 0 3H-RX821002 -95 19 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 451 8 2 4 3.2 CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C None
10836 14467 14 3H-CLONIDINE 1 9 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
CHEMBL1201201 14467 14 3H-CLONIDINE 1 9 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 149 3 1 1 1.8 CN[C@@H](C)Cc1ccccc1 None
2337 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2337 3256 77 125I-Clonidine -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2337 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3256 77 125I-Clonidine -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3256 77 125I-Clonidine -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3256 77 125I-Clonidine -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3256 77 125I-Clonidine -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3256 77 3H-CLONIDINE -12 62 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
16725934 147423 0 UNDEFINED -38 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 None
CHEMBL392992 147423 0 UNDEFINED -38 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 429 6 0 5 5.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4)cc13)CC2 None
124 2981 47 3H-RAUWOLSCINE -977 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 3H-RAUWOLSCINE -977 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 3H-RAUWOLSCINE -977 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 3H-RAUWOLSCINE -977 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 3H-RAUWOLSCINE -977 33 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2402 3370 62 3H-RX821002 -4 24 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
5095 3370 62 3H-RX821002 -4 24 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
7295 3370 62 3H-RX821002 -4 24 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
CHEMBL589 3370 62 3H-RX821002 -4 24 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
DB00268 3370 62 3H-RX821002 -4 24 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O None
2683 3834 60 3H-RAUWOLSCINE -1 4 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
5487 3834 60 3H-RAUWOLSCINE -1 4 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
7308 3834 60 3H-RAUWOLSCINE -1 4 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
CHEMBL1079 3834 60 3H-RAUWOLSCINE -1 4 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
DB00697 3834 60 3H-RAUWOLSCINE -1 4 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
138107169 215952 0 3H-RAUWOLSCINE -5 22 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
22831402 215952 0 3H-RAUWOLSCINE -5 22 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 354 1 2 4 2.6 COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O None
None 215958 0 3H-MK912 -112 19 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
2803 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 None -1 19 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3584 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3777 64 None -3 13 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
2142 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 None -5 36 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-2B adrenergic receptor from human clones.Binding affinity against Alpha-2B adrenergic receptor from human clones.
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
133 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
1723 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
28693 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
CHEMBL19215 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
DB13520 2496 52 None -14 42 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
129211 3749 78 None -102 15 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3749 78 None -102 15 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3749 78 None -102 15 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3749 78 None -102 15 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3749 78 None -102 15 Rat 8.1 pKi = 8.1 Binding
Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligandBinding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
103 4153 61 None -5 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4153 61 None -5 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4153 61 None -5 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4153 61 None -5 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4153 61 None -5 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2216 446 50 None -1 6 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
229 446 50 None -1 6 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
7117 446 50 None -1 6 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
CHEMBL647 446 50 None -1 6 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
DB00964 446 50 None -1 6 Rat 8.1 pKi = 8.1 Binding
Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cellsCompound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells
Drug Central 244 1 3 4 1.9 Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 None
2274 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
107715 200945 22 None -13 19 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL1255837 200945 22 None -13 19 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL601773 200945 22 None -13 19 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
2136 3095 30 None -3 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
4768 3095 30 None -3 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
7268 3095 30 None -3 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
CHEMBL753 3095 30 None -3 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
DB00925 3095 30 None -3 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
2389 3331 118 3H-RAUWOLSCINE -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 3H-RAUWOLSCINE -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 3H-RAUWOLSCINE -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 3H-RAUWOLSCINE -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 3H-RAUWOLSCINE -104 67 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
102 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 None -10 49 Human 8.1 pKi = 8.1 Binding
Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandBinding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
102 4127 48 None -10 49 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 None -10 49 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 None -10 49 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 None -10 49 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 None -10 49 Rat 8.1 pKi = 8.1 Binding
Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptorInhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
None 215958 0 3H-RAUWOLSCINE -52 19 Rat 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
46780481 107531 20 None -20 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107531 20 None -20 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107531 20 None -20 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107531 20 None -20 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
10531 1420 21 None -10 23 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
121 1420 21 None -10 23 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
888 1420 21 None -10 23 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
CHEMBL1732 1420 21 None -10 23 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
DB00320 1420 21 None -10 23 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
11954224 215953 0 None -398 58 Human 8.1 pKi = 8.1 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
44438152 93608 0 UNDEFINED -42 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 None
CHEMBL246639 93608 0 UNDEFINED -42 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 459 7 0 6 5.7 COc1cccc(-c2cc3c(CN4CCc5cc(OC)c(OC)cc5C4)ccc(OC)c3o2)c1 None
104870 98880 47 3H-RX821002 -3 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
5374 98880 47 3H-RX821002 -3 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
CHEMBL279085 98880 47 3H-RX821002 -3 21 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 None
1212 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
135398745 2914 112 3H-CLONIDINE -37 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2914 112 3H-CLONIDINE -37 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2914 112 3H-CLONIDINE -37 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2914 112 3H-CLONIDINE -37 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1212 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1662 50 3H-CLONIDINE -38 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
135398745 2914 112 3H-CLONIDINE -37 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2914 112 3H-CLONIDINE -37 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2914 112 3H-CLONIDINE -37 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2914 112 3H-CLONIDINE -37 65 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
16362 3125 71 3H-CLONIDINE -363 30 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 3125 71 3H-CLONIDINE -363 30 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 3125 71 3H-CLONIDINE -363 30 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 3125 71 3H-CLONIDINE -363 30 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 3125 71 3H-CLONIDINE -363 30 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
135398737 958 93 3H-RAUWOLSCINE -9 89 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-RAUWOLSCINE -9 89 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-RAUWOLSCINE -9 89 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-RAUWOLSCINE -9 89 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-RAUWOLSCINE -9 89 Rat 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
44438167 148970 0 UNDEFINED -1071 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 None
CHEMBL394218 148970 0 UNDEFINED -1071 3 Human 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 505 7 1 7 3.8 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(C(=O)NC4CN5CCC4CC5)cc13)CC2 None
11954224 215953 0 3H-CLONIDINE -398 58 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
None 216239 0 3H-CLONIDINE -89125 30 Human 5.1 pKi = 5.1 Binding
NoneNone
PDSP KiDatabase 316 7 3 3 3.0 CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O None
4209 3163 75 35S-GTPGammaS -309 33 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 35S-GTPGammaS -309 33 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 35S-GTPGammaS -309 33 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 35S-GTPGammaS -309 33 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 35S-GTPGammaS -309 33 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 35S-GTPGammaS -309 33 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
6761 67799 19 None -1 18 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL1909072 67799 19 None -1 18 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
2601 3780 33 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 3780 33 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 3780 33 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 3780 33 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 3780 33 None -1 21 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
115237 55585 119 3H-RAUWOLSCINE -67 54 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55585 119 3H-RAUWOLSCINE -67 54 Human 8.0 pKi = 8.0 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
1588 2325 27 None -1 44 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2325 27 None -1 44 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2325 27 None -1 44 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2325 27 None -1 44 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2325 27 None -1 44 Human 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
521 1404 69 None -12 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1404 69 None -12 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1404 69 None -12 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1404 69 None -12 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1404 69 None -12 7 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2337 3256 77 3H-RAUWOLSCINE -12 62 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3256 77 3H-RAUWOLSCINE -12 62 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3256 77 3H-RAUWOLSCINE -12 62 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3256 77 3H-RAUWOLSCINE -12 62 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3256 77 3H-RAUWOLSCINE -12 62 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
None 216325 0 3H-CLONIDINE -1 40 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 149 2 1 2 1.2 CC(C(=O)C1=CC=CC=C1)N None
11225732 93657 0 UNDEFINED -53 3 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 None
CHEMBL246852 93657 0 UNDEFINED -53 3 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 497 6 0 5 6.7 COc1cc2c(cc1OC)CN(Cc1ccc(OC)c3oc(-c4ccccc4C(F)(F)F)cc13)CC2 None
135409468 2035 69 3H-CLONIDINE -33 39 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
333 2035 69 3H-CLONIDINE -33 39 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
CHEMBL845 2035 69 3H-CLONIDINE -33 39 Human 7.0 pKi = 7.0 Binding
NoneNone
PDSP KiDatabase 312 1 2 4 1.7 Clc1ccc2c(c1)NC(=c1c(=N2)cccc1)N1CCNCC1 None
2435 722 100 35S-GTPGammaS -36 12 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 722 100 35S-GTPGammaS -36 12 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 722 100 35S-GTPGammaS -36 12 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 722 100 35S-GTPGammaS -36 12 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 722 100 35S-GTPGammaS -36 12 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 722 100 35S-GTPGammaS -36 12 Human 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
1593 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
30668 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
9868 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
CHEMBL17860 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
DB04948 2340 66 None -6 4 Human 7.2 pKi = 7.2 Binding
Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.Calculated from [<sup>3</sup>H]RS-79948-197 radioligand competition binding to membrane preparations from CHO cells expressing human &alpha;<sub>2B</sub>-AR.
Guide to Pharmacology 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 22341244
2695 3841 81 None -69 6 Human 5.5 pKi = 5.5 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
5504 3841 81 None -69 6 Human 5.5 pKi = 5.5 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
7310 3841 81 None -69 6 Human 5.5 pKi = 5.5 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
CHEMBL770 3841 81 None -69 6 Human 5.5 pKi = 5.5 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
DB00797 3841 81 None -69 6 Human 5.5 pKi = 5.5 Binding
Inhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S bindingInhibition of agonist-stimulated [<sup>35</sup>S]GTP&gamma;S binding
Guide to Pharmacology 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 9605427
2136 3095 30 None -3 6 Human 6.4 pKi = 6.4 Binding
Two site bindingTwo site binding
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 35224877
4768 3095 30 None -3 6 Human 6.4 pKi = 6.4 Binding
Two site bindingTwo site binding
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 35224877
7268 3095 30 None -3 6 Human 6.4 pKi = 6.4 Binding
Two site bindingTwo site binding
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 35224877
CHEMBL753 3095 30 None -3 6 Human 6.4 pKi = 6.4 Binding
Two site bindingTwo site binding
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 35224877
DB00925 3095 30 None -3 6 Human 6.4 pKi = 6.4 Binding
Two site bindingTwo site binding
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 35224877
1028 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
1028 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
139148732 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
139148732 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
479 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
479 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
5816 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
5816 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
CHEMBL679 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL679 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
DB00668 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00668 291 71 None -128 30 Human 4.4 pKi = 4.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 9605427
12574 2605 88 None -3890 6 Human 4.6 pKi = 4.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
4810 2605 88 None -3890 6 Human 4.6 pKi = 4.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
CHEMBL19236 2605 88 None -3890 6 Human 4.6 pKi = 4.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
DB09242 2605 88 None -3890 6 Human 4.6 pKi = 4.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 36101495
1960 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
1960 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
1960 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
439260 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
439260 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
439260 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
505 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
505 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
505 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
CHEMBL1437 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
CHEMBL1437 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
CHEMBL1437 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
DB00368 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 36101495
DB00368 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9605427
DB00368 2857 67 None -69 26 Human 4.8 pKi = 4.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 9824686
3658 4107 53 None -114 8 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
517 4107 53 None -114 8 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
5709 4107 53 None -114 8 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
CHEMBL312448 4107 53 None -114 8 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
DB06694 4107 53 None -114 8 Human 5.4 pKi = 5.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 36101495
523 4106 93 None -1 5 Human 5.5 pKi = 5.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
523 4106 93 None -1 5 Human 5.5 pKi = 5.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
5707 4106 93 None -1 5 Human 5.5 pKi = 5.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
5707 4106 93 None -1 5 Human 5.5 pKi = 5.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
CHEMBL297362 4106 93 None -1 5 Human 5.5 pKi = 5.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
CHEMBL297362 4106 93 None -1 5 Human 5.5 pKi = 5.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
DB11477 4106 93 None -1 5 Human 5.5 pKi = 5.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 36101495
DB11477 4106 93 None -1 5 Human 5.5 pKi = 5.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 220 1 1 3 3.2 Cc1cccc(c1NC1=NCCCS1)C 9605427
124 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
124 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
124 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
2032 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
2032 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
2032 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
4636 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
4636 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
4636 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
CHEMBL762 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
CHEMBL762 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
CHEMBL762 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
DB00935 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 36101495
DB00935 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7996470
DB00935 2981 47 None -977 33 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 9605427
4508 3139 98 None -398 12 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 9605427
4866774 3139 98 None -398 12 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 9605427
509 3139 98 None -398 12 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 9605427
838 3139 98 None -398 12 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 9605427
CHEMBL1740 3139 98 None -398 12 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O 9605427
121850 726 0 None -131 3 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 35224877
121850 726 0 None -131 3 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
525 726 0 None -131 3 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 35224877
525 726 0 None -131 3 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
CHEMBL216097 726 0 None -131 3 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 35224877
CHEMBL216097 726 0 None -131 3 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 215 2 1 3 1.6 CC1N(CC2=NCCN2)Cc2c1cccc2 7996470
2683 3834 60 None -20 4 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
5487 3834 60 None -20 4 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
7308 3834 60 None -20 4 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
CHEMBL1079 3834 60 None -20 4 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
DB00697 3834 60 None -20 4 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 36101495
3952 1888 38 None -18 12 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5353646 1888 38 None -18 12 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5443 1888 38 None -18 12 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
5702063 1888 38 None -18 12 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL1331786 1888 38 None -18 12 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
CHEMBL420 1888 38 None -18 12 Human 6.0 pKi = 6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 36101495
1343 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
1343 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
3519 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
3519 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
522 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
522 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
CHEMBL862 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
CHEMBL862 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
DB01018 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 36101495
DB01018 1889 62 None -91 9 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 9605427
1816 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
1816 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 35224877
4205 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
4205 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 35224877
7241 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
7241 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 35224877
CHEMBL654 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
CHEMBL654 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 35224877
DB00370 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10636247
DB00370 2540 102 None -851 18 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 35224877
12575 1988 30 None -53 17 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
54459 1988 30 None -53 17 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
CHEMBL10316 1988 30 None -53 17 Human 6.4 pKi = 6.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 35224877
4209 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
4209 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 35224877
4209 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
4209 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
4893 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
4893 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 35224877
4893 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
4893 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
503 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
503 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 35224877
503 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
503 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
5385 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
5385 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 35224877
5385 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
5385 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
CHEMBL2 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
CHEMBL2 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 35224877
CHEMBL2 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
CHEMBL2 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
DB00457 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 1353247
DB00457 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 35224877
DB00457 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7908642
DB00457 3163 75 None -309 33 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7996470
2435 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
2435 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
2435 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
2435 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
395 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
395 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
395 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
395 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
520 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
520 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
520 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
520 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
5386 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
5386 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
5386 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
5386 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
CHEMBL844 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
CHEMBL844 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
CHEMBL844 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
CHEMBL844 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
DB00484 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 36101495
DB00484 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9605427
DB00484 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9760042
DB00484 722 100 None -36 12 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 9824686
31101 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
31101 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 35224877
35 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
35 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 35224877
403 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
403 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 35224877
CHEMBL493 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
CHEMBL493 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 35224877
DB01200 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 12388666
DB01200 729 40 None -33 36 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 35224877
133621 2012 0 None 1 5 Rat 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 1970500
3470 2012 0 None 1 5 Rat 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 1970500
CHEMBL347695 2012 0 None 1 5 Rat 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 244 3 0 4 2.3 CCn1ccnc1CC1COc2c(O1)cccc2 1970500
2726 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
2726 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 35224877
2726 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
621 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
621 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 35224877
621 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
83 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
83 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 35224877
83 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
CHEMBL71 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
CHEMBL71 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 35224877
CHEMBL71 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
DB00477 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 1353247
DB00477 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 35224877
DB00477 919 68 None -8 72 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 7908642
2142 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
2142 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 35224877
2142 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
4920903 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
4920903 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 35224877
4920903 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
502 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
502 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 35224877
502 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
5775 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
5775 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 35224877
5775 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
CHEMBL597 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
CHEMBL597 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 35224877
CHEMBL597 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
DB00692 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 1353247
DB00692 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 35224877
DB00692 3096 58 None -5 36 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7908642
499 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
499 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 35224877
499 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
499 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
5685 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
5685 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 35224877
5685 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
5685 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
CHEMBL25554 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 1353247
CHEMBL25554 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 35224877
CHEMBL25554 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7908642
CHEMBL25554 4077 18 None -85 14 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7996470
122211 462 0 None -6 6 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 1353247
122211 462 0 None -6 6 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 35224877
122211 462 0 None -6 6 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7908642
122211 462 0 None -6 6 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7996470
524 462 0 None -6 6 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 1353247
524 462 0 None -6 6 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 35224877
524 462 0 None -6 6 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7908642
524 462 0 None -6 6 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 5 0 5 3.6 COc1ccccc1N1CCN(CC1)CCC1C(=O)c2ccccc2C(C1=O)(C)C 7996470
2803 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
2803 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
2803 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
2803 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
516 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
516 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
516 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
516 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
704 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
704 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
704 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
704 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
CHEMBL134 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
CHEMBL134 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
CHEMBL134 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
CHEMBL134 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
DB00575 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 36101495
DB00575 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9605427
DB00575 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9760042
DB00575 955 58 None -1 19 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 9824686
12576 514 94 None -7 6 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
71310 514 94 None -7 6 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
CHEMBL353972 514 94 None -7 6 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
DB11481 514 94 None -7 6 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 212 2 1 1 2.9 CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 35224877
108094 3423 27 None -6 4 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
108094 3423 27 None -6 4 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
526 3423 27 None -6 4 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
526 3423 27 None -6 4 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
528 3423 27 None -6 4 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
528 3423 27 None -6 4 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
CHEMBL10332 3423 27 None -6 4 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 35224877
CHEMBL10332 3423 27 None -6 4 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 234 2 1 5 0.8 COC1(COc2c(O1)cccc2)C1=NCCN1 7996470
12577 2563 0 None -50 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 0 0 3 3.3 CN1CC[C@]2(CCN3CCC4=C([C@@H]3C2)OC5=CC=CC=C45)N(C1=O)C 35224877
189711 2563 0 None -50 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 0 0 3 3.3 CN1CC[C@]2(CCN3CCC4=C([C@@H]3C2)OC5=CC=CC=C45)N(C1=O)C 35224877
CHEMBL1257057 2563 0 None -50 3 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 339 0 0 3 3.3 CN1CC[C@]2(CCN3CCC4=C([C@@H]3C2)OC5=CC=CC=C45)N(C1=O)C 35224877
103 4153 61 None -5 53 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 8935801
2875 4153 61 None -5 53 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 8935801
5736 4153 61 None -5 53 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 8935801
CHEMBL285802 4153 61 None -5 53 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 8935801
DB09225 4153 61 None -5 53 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 8935801
102 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
102 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
102 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
102 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
3659 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
3659 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
3659 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
3659 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
8969 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
8969 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
8969 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
8969 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
CHEMBL15245 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
CHEMBL15245 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
CHEMBL15245 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
CHEMBL15245 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
DB01392 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 1353247
DB01392 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 35224877
DB01392 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7908642
DB01392 4127 48 None -10 49 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
5268 3656 40 None -3 18 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 35224877
5268 3656 40 None -3 18 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
53 3656 40 None -3 18 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 35224877
53 3656 40 None -3 18 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
CHEMBL300555 3656 40 None -3 18 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 35224877
CHEMBL300555 3656 40 None -3 18 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 7996470
2136 3095 30 None -3 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 1834671
4768 3095 30 None -3 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 1834671
7268 3095 30 None -3 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 1834671
CHEMBL753 3095 30 None -3 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 1834671
DB00925 3095 30 None -3 6 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 1834671
521 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
521 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
521 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
521 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
521 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
5311068 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
5311068 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
5311068 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
5311068 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
5311068 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
835 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
835 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
835 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
835 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
835 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
CHEMBL778 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
CHEMBL778 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
CHEMBL778 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
CHEMBL778 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
CHEMBL778 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
DB00633 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 36101495
DB00633 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9227000
DB00633 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9605427
DB00633 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9760042
DB00633 1404 69 None -12 7 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C 9824686
13128 3400 0 None -6 3 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 364 3 0 4 2.4 CCS(=O)(=O)N1CCC[C@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C=C(C=C4)OC 35224877
9908992 3400 0 None -6 3 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 364 3 0 4 2.4 CCS(=O)(=O)N1CCC[C@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C=C(C=C4)OC 35224877
CHEMBL4303564 3400 0 None -6 3 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 364 3 0 4 2.4 CCS(=O)(=O)N1CCC[C@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C=C(C=C4)OC 35224877
1588 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
1588 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 35224877
28864 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
28864 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 35224877
43 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
43 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 35224877
CHEMBL157138 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL157138 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 35224877
DB00589 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB00589 2325 27 None -1 44 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 35224877
2601 3780 33 None -1 21 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
443951 3780 33 None -1 21 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
56 3780 33 None -1 21 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL73151 3780 33 None -1 21 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB13399 3780 33 None -1 21 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
162265 202274 22 None -16 43 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 202274 22 None -16 43 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 202274 22 None -16 43 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
1960 2857 67 None -69 26 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2857 67 None -69 26 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2857 67 None -69 26 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2857 67 None -69 26 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2857 67 None -69 26 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
3337 206367 27 None -14 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 206367 27 None -14 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 206367 27 None -14 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 206367 27 None -14 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 206367 27 None -14 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
37 778 60 None -9 17 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
460 778 60 None -9 17 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
54746 778 60 None -9 17 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
CHEMBL1201087 778 60 None -9 17 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
DB00248 778 60 None -9 17 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
228 445 28 None -3 24 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
33 445 28 None -3 24 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
6005 445 28 None -3 24 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
CHEMBL53 445 28 None -3 24 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
DB00714 445 28 None -3 24 Human 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 12388666
2105 3054 37 None -35 33 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
47811 3054 37 None -35 33 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
48 3054 37 None -35 33 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
CHEMBL531 3054 37 None -35 33 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
DB01186 3054 37 None -35 33 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 12388666
136 3292 32 None -5 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
223 3292 32 None -5 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
643606 3292 32 None -5 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
CHEMBL10347 3292 32 None -5 15 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 7996470
219050 3373 25 None -29 21 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
52 3373 25 None -29 21 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
CHEMBL431367 3373 25 None -29 21 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666